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CHARACTERIZATION OF LOW DENSITY INTRACRANIAL LESIONS USING DUALENERGY COMPUTED TOMOGRAPHY

Jessica Nute, M.S.
Supervisory Professor: Dianna Cody, Ph.D.
Abstract
Calcific and hemorrhagic foci of susceptibility are frequently encountered on routine
brain MR studies. Both etiologies cause variations in local magnetic field strength, leading
to dark regions on the MR images that cannot be classified. Single-energy CT (SECT) can
be used to identify lesions with attenuation over 100 HU as calcific, however lesions with
lower attenuation cannot be reliably identified. While calcific lesions are unlikely to cause
harm, hemorrhagic lesions carry a risk of subsequent intracranial bleeding; as such,
identification of hemorrhage is vital in preventing the inappropriate use of anticoagulant
medications in patients with hemorrhagic lesions.
Given there currently exists no clinically available means of differentiating between
these two lesions over their full biological attenuation ranges, there is a clear need for a
reliable imaging method to differentiate low intensity calcification and hemorrhage.
Recently, several vendors have released new computed tomography (CT) scanner models
with dual-energy capabilities, which may be successfully applied to this issue. By acquiring
data at two different energies, dual-energy CT (DECT) collects information about the
energy-dependent attenuation changes in a material and may help distinguish between two
materials with similar linear attenuation measurements which would be impossible to
differentiate using SECT.
This work applies the unique capabilities of DECT to the characterization of
intracranial hemorrhage and calcification using biologically-relevant and spectrallyvii

equivalent models. Lesion and acquisition parameters were varied to elucidate their impact
on DECT’s ability to differentiate and subsequently classify intracranial lesions. DECT’s
characterization ability was shown to improve with increasing CTDIvol, image thickness and
lesion size. Using an optimized protocol, intracranial lesions were correctly classified with
over 90% confidence down to a minimum attenuation of 56 HU, representing a significant
improvement beyond the 100 HU limit imposed by the current standard. Since this data
collection spanned several years, a dual-energy quality control program was designed to
validate the comparison of collected data. The added characterization ability of DECT will
assist physicians in the correct prescription of anticoagulant medications, hopefully sparing
hemorrhagic patients from prophylaxis that might cause them harm.
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Chapter 1

1

Introduction

Calcific and hemorrhagic foci of susceptibility are frequently encountered in routine
brain Magnetic Resonance (MR) studies. Both etiologies cause variations in magnetic field
strength leading to dark regions on the MR images that cannot be classified (1). Singleenergy computed tomography (SECT) can be used to identify lesions with attenuation over
100 Hounsfield Units (HU) as calcific (2), however lesions with lower attenuation cannot be
reliably identified. While calcific lesions are unlikely to cause harm (3), hemorrhagic lesions
carry a risk of subsequent intracranial bleeding (4,5); as such, identification of hemorrhage
is vital in preventing the inappropriate use of anticoagulant medications in patients with
hemorrhagic lesions. The relatively high incidence of deep vein thrombosis and pulmonary
embolism in cancer patients (6–10) has led many practitioners to treat prophylactically for
these conditions. The proper differentiation of calcification and hemorrhage will allow
physicians to guide therapy for patients with hemorrhagic lesions away from therapy or
prophylaxis that might cause them harm (11,12). Given that there currently exists no
clinically available means of differentiating between these two lesion types over their full
biological attenuation ranges, there is a clear need for a reliable imaging method to
differentiate low intensity calcification and hemorrhage. A novel computed tomography
(CT) modality has been developed which collects temporally and anatomically registered
CT scans at two different tube voltages. By collecting data at two different energies, dualenergy CT (DECT) identifies energy-dependent attenuation changes which can be used to
gain information about the material characteristics within a specific voxel. The rationale
behind this research is that the difference in the energy-dependent attenuation
characteristics of calcium, found in calcification, and iron, found in hemorrhage should

1

result in unique signatures using DECT, permitting the differentiation of the two lesion
types.

1.1

Objectives and Hypothesis
Therefore, the objective of this project is to model intracranial calcification and

hemorrhage over a wide range of biological conditions and image using DECT in order to
determine if material characteristic information derived from DECT images can be used to
differentiate between calcification and hemorrhage. The central hypothesis is that DECT
can be used to differentiate between intracranial calcium associated with
calcification and iron associated with hemorrhage below the attenuation level
possible using traditional SECT.

1.2

Specific Aims
To test this central hypothesis, four specific aims were constructed:

Specific Aim 1: Determine the SECT attenuation (HU) level at which hemorrhage and
calcification models can be differentiated on DECT images to within 90% accuracy using an
agar gel-based phantom.
Specific Aim 2:
A: Design and create a biologically relevant phantom that more realistically replicates
the attenuation characteristics of the human brain, and includes various intracranial
lesion sizes and locations.
B: Determine the DECT technique that provides optimal differentiation of calcification
and hemorrhage models based on the lesion pair’s size and location within the
biologically relevant phantom (Specific Aim 2A).
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Specific Aim 3: Assess the ability of DECT to classify unknown intracranial lesions with
SECT attenuation levels under 100 HU as either calcific or hemorrhagic using the
biologically relevant phantom model described in Specific Aim 2.
Specific Aim 4: Develop a dual-energy CT quality control phantom and program to provide
inter- and intra-scanner quality assurance data for long term clinical DECT applications.
To achieve these specific aims, models of calcification and hemorrhage will be
designed and fabricated. The models will be imaged in anthropomorphic phantoms using
both single-energy and dual-energy techniques. Calcification and hemorrhage models will
be organized into pairs consisting of a calcification model and a hemorrhage model that
display equivalent single-energy attenuation. The material characteristic information for all
matched attenuation pairs will be derived from the dual-energy images. The accuracy of
the differentiation between calcification and hemorrhage model will be calculated for each
matched model pair and the SECT attenuation (HU) level at which the accuracy exceeds
90% will be determined. In specific aim 2, the models of calcification and hemorrhage will
be improved to better mimic the typical biology as well as to simulate a range of lesion
sizes, intracranial locations and imaging parameters. The resulting material characteristic
information from the dual-energy images will be compared to the results in specific aim 1
and used to determine the imaging technique, patient population constraints and analysis
methods for a prospective human trial. These conclusions will be verified using unknown
lesion models of varying attenuation, size and intracranial location in the biologically
relevant phantom system designed in Specific Aim 2. Given that this work will span several
years, verification that the results are intercomparable is necessary. Unfortunately, since
DECT is a novel and emerging modality, a true quality control standard has yet to be
determined. Specific Aim 4 will strive to develop a quality control phantom and program
designed specifically to verify the dual-energy capabilities of the scanners used in this
study. Through the completion of Specific Aims 1-4 we propose to develop a clinically
3

feasible method for the differentiation, and hopefully correct classification, of intracranial
hemorrhage and calcification.

1.3

Dissertation Organization
The remaining chapters of this dissertation are organized as follows: Chapter 2

introduces background concepts specific to DECT as well as competing modalities.
Chapter 3 addresses Specific Aim 1 and presents the results of a simple agar-gel based
phantom for the differentiation of calcification and hemorrhage.

Chapter 4 addresses

Specific Aim 2 and covers the development of the biologically relevant phantom model and
the determination of optimal DECT techniques based on lesion size and location within the
phantom. Chapter 5 addresses Specific Aim 3 and includes preliminary results on unknown
lesion characterization. Chapter 6 addresses Specific Aim 4 and covers the design and
development of the DECT quality control phantom and protocol as well as preliminary
results and clinical insights. Finally, Chapter 7 summarizes the dissertation and comments
on future work.
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Chapter 2

2

Background

Intracranial hemorrhagic and calcific lesions are associated with very different
outcomes and may require different management strategies. Intracranial calcifications are
relatively common but in general are benign and have little clinical importance (3). They
can be caused by a number of conditions and treatments including radiation therapy and
chemotherapy (13) and are typically found in the pineal gland, choroid plexus, habenula,
and blood vessels. Their size and structure can range from small and punctuate to large
and more laminar (2) and typically consist of a combination of calcium phosphorus, silicon,
potassium, magnesium and zinc (14).
Intracranial hemorrhagic lesions due to cavernomata, however, carry a risk of
subsequent intracranial bleeding, with rehemorrhage rates as high as 4-10% per lesion per
year (4,5). The lesions range in size from 1 mm up to several centimeters (4) and can be
found throughout the nervous system, but are most commonly found in the cerebrum (15).
They present in approximately 0.1 to 0.5% of the population and comprise roughly 5-13% of
all vascular lesions (4).
Due to the risk of brain hemorrhage, the use of anticoagulants in patients with
intracranial cavernomata or hemorrhagic lesions is contraindicated (11,12). However,
driven by the high incidence of deep vein thrombosis and pulmonary embolism in cancer
patients (6–10) and other high risk populations, many practitioners are prescribing
prophylactic anticoagulants (16). Cohen et al. investigated the risk for venous
thromboembolism (VTE) and the application of anticoagulant prophylaxis based on all
hospital impatients over the age of 40 admitted to the medical ward, or over the age of 18
admitted to the surgical ward over 358 hospitals spanning 32 countries (17). They found
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that of the 68,183 patients admitted, 64% of surgical patients and 42% of medical patients
were at risk of VTE. Of the at risk population, 59% of at risk surgical patients and 40% of at
risk medical patients were administered anticoagulants. Zwicker et al. investigated cancer
patients specifically and found that of the 775 patients at risk of VTE, 68% had no
contraindication for prophylaxis and of those a full 75% were administered anticoagulants
(18). Beyond inpatients, a recent study has shown that approximately 5% of people
between the ages of 65 and 74, and 10% of people over the age of 75 have been
prescribed prophylactic anticoagulants (19). Based on these facts it is evident that accurate
differentiation of intracranial calcification and hemorrhage would benefit a large patient
population by allowing physicians to steer patients with hemorrhagic lesions away from
common anticoagulant prophylaxis that might harm them.
Accurate differentiation of intracranial calcification and hemorrhage would allow
physicians to steer patients with hemorrhagic lesions away from anticoagulation that might
harm them.
Currently there exists no clinically available means of differentiating calcification and
hemorrhage over their full biological ranges. Traditional SECT is considered the gold
standard modality for the identification of calcification. Generally, any lesion with SECT
attenuation levels >100 HU is classified as a calcification (2). However, lesions with SECT
attenuation levels <100 HU present a clinical problem, since hemorrhage and calcifications
overlap in this attenuation range, making classification difficult.
Magnetic Resonance (MR) has long been the gold standard for hemorrhage
detection where the characteristic appearance is a ring of hypo-intensity due to
susceptibility artifacts caused by the iron-rich hemosiderin deposits in the lesion (15).
However, calcifications also induce this susceptibility artifact which leads to a similar hypointense region within the image.
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Susceptibility artifacts occur due to variations in magnetic field strength which are
caused by paramagnetic materials, diamagnetic materials or interfaces between regions of
very different magnetic susceptibility. These intra-voxel variations in the magnetic field
strength result in variations in the protons’ precession frequency and thus phase shifts.
Secondly, intra-voxel variations create spin incoherence resulting in a hypo-intense or
signal void region on the image (20,21). Since foci of susceptibility can be caused by either
calcification or hemorrhage, conventional MR is of little help in differentiating these two
lesion types.
Given that at this time there are no clinically available means of differentiating
between these two lesions over their full biological attenuation ranges, there is a clear need
for a reliable imaging method to differentiate low intensity calcification and hemorrhage.
Recently, several vendors have released new CT scanner models with dual-energy
capabilities, which may be successfully applied to this issue. By collecting data at two
different energies, DECT provides information about energy-dependent changes in linear
attenuation which can be used to derive information about the material characteristics
within a specific voxel. This information may help distinguish between two materials with
similar linear attenuation measurements which would be impossible to differentiate using
SECT (22).
Although the technique of dual-energy Computed Tomography (DECT) has been
known since the 1970s (23–25), the application of the technique has been hampered by a
range of issues including high image noise, motion misregistration and long acquisition
times resulting in excessive patient dose (26). Only recently have advances in scanner
hardware helped overcome these issues and allowed DECT to enter the realm of clinical
applications. With the release of the first clinical DECT scanner by Siemens (SOMATOM
Flash) in 2005 (27), and the subsequent release of the General Electric (GE) Discovery
750HD and Siemens SOMATOM Definition Flash in 2008 (28,29), dual-energy CT (or
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spectral CT) research and applications have grown at an increasing rate (Figure 2.1).
Given the recent release of the Siemens SOMATOM Force, as well as the scheduled
release of the dual-energy package on the GE Revolution CT within the next year, it can be
expected that this trend will continue as new hardware and software advance the
capabilities of material decomposition. The Siemens SOMATOM Force x-ray tube is
capable a generating peak kilovoltage (kVp) beams from 70kVp to 150kVp and has higher
milliampere (mA) limits, both hopefully leading to better characterized material
decomposition (30–32). The GE Revolution CT, once equipped with dual-energy software,
will provide a much larger beam width of 16 cm (33), opening up a wealth of applications in
cardiac imaging and perfusion measurements. These advances in dual-energy data
collection are sure to lead to further research into the expanding clinical applications of
dual-energy CT.
700

Number of Publications
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200

Title

100
0

Year of Publication

Figure 2.1: Increase in DECT publications from January 1, 2000 to December 31, 2014 based
on occurrence of “Dual-Energy CT” or “Spectral CT” using the Web of Science database tool
(34).
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2.1 Basics of DECT
In traditional single-energy CT (SECT), the x-ray absorption through the patient is
expressed as an attenuation value normalized to the linear attenuation of water. The
resulting CT numbers, measured in Hounsfield units (HU), are displayed in shades of gray
on the CT image. While intuitive to view, these Hounsfield units do not accurately represent
material composition within the voxel. First, linear attenuation is dependent on the effective
energy of the X-ray beam. Since the effective energy of the beam varies with location due
to X-ray beam hardening and scatter, the same material could have different CT numbers
at two different locations within the scan field of view. Second, two very different materials
could have the same CT number by having the same linear attenuation coefficient even
though they possess very different elemental composition, mass attenuation coefficient and
density.
Dual-energy CT is based on the premise that by measuring the attenuation of a
voxel at two different energies, energy-dependent attenuation characteristics can be
derived allowing for material-specific information to be deduced. This information would
then help distinguish between two materials with similar linear attenuation measurements
which would be impossible to differentiate using single energy CT (22,35,36). The energydependent changes in attenuation are relatively specific for every material. Materials with
high atomic number, such as iodine, display much larger changes in attenuation over
diagnostic CT energies than low atomic number materials, such as water, due to the higher
relative dominance of the photoelectric effect. By obtaining attenuation information at two
different energies, material specific information can be deduced and images can be created
that highlight the distribution of selected materials within the body. Useful dual-energy
attenuation data relies on an adequate separation between the high and low energy,
accurate temporal registration and accurate spatial registration (22).
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2.2 DECT Implementations
Three vendors have developed dual-energy CT systems which use different
methods for obtaining dual-energy attenuation data. Siemens has implemented a dualsource dual-energy CT design (SOMATOM FLASH®, Siemens AG, Forchheim, Germany)
that employs two X-ray tubes mounted 90 to 95 degrees apart, operating at two different
tube potentials (27,35). Generally, 80 and 140 peak kilovoltage (kVp) are used; however,
100 and 140 kVp may be employed for larger patients to help with X-ray penetration (35).
The two separate tubes allow for the tube current associated with each energy in dualenergy mode to be modified based on the patient size and anatomy to be imaged. It also
allows for an additional filter to be inserted to constrain the energy spread of the X-ray
spectra and achieve better spectral separation between the two energies (37). While using
two tubes can improve the spectral separation, it can also lead to registration issues as the
data is collected at slightly different times. Siemens has resolved this issue by minimizing
the temporal related offset by using two sets of 64-row detectors in conjunction with a
moving focal spot which can collect 128 isotropic 0.6-mm slices in 0.4ms (38). The use of
two tubes can also lead to cross scatter from tube A into the detector associated with tube
B. The effect of the cross scatter is reduced through the use measurement based scatter
correction using scatter sensors positioned close to the detectors but outside the fan beam
penumbra (39). Additionally, in order to fit two x-ray tubes and two sets of detectors in the
scanner, one of the detectors had to be reduced in size. Due to this, the dual-energy
capabilities of the system are currently limited to a 33 cm field of view (26).
General Electric has designed a fast kilovoltage switching dual-energy CT scanner
(Discovery CT 750HD, GE Healthcare, Milwaukee, USA) that uses a single X-ray tube that
quickly switches between 80 and 140 kVp every 0.5ms as it rotates around the patient (40).
To capture the alternating high and low energy projections individually, the scanner is
equipped with a garnet crystal scintillator detector. The detector has a 100 times faster
10

response time than the typical gadolinium oxysulfide scintillator detector and four times less
afterglow. The data acquisition system is also enhanced with fast sampling capabilities
which enables 2.5 times the data sampling possible in a conventional 64-channel CT
scanner (40–42).
Unlike the Siemens system where the current for each X-ray tube can be adjusted,
the single tube on the GE system is forced to maintain a constant tube current since it is not
possible to alternate the mA as rapidly as the tube voltage (37). The exposure time ratio is
adjusted to 60% at 80 kVp and 40% at 140kVp to help account for the higher tube output at
the higher energy (43). A number of preset protocols are available on the scanner with
varying bowtie filters, beam widths, rotation times and dose levels depending on the
anatomy to be imaged and the patient size. By utilizing a single fast switching X-ray tube,
both axial and helical scanning are possible, and dual-energy analysis is available over the
full 50 cm field of view. The close timing of the alternating high- and low-kVp projections
provides excellent temporal resolution (40,41).
Similar to the GE fast-kilovoltage switching system, Toshiba offers a single-source
dual-energy scanner based on kV switching (Aquilion ONE; Toshiba Medical Systems,
Otawara, Japan). The system contains 320 detector rows covering 160 mm in the zdirection allowing volumetric data collection (44,45). The system switches from 80 to
135kV between rotations rather than between projections like the GE variant (44,45). This
rotation-based kV switching allows for different tube currents to be used for the high and
low kV rotations, as well as the application of tube current modulation (46). It also allows
for perfect spatial matching between the initial high-kV tube rotation and the subsequent
low-kV tube rotation. However, the time difference between the high and low kV data
collection results in spatial misregistration of the two data sets which may adversely affect
the dual-energy processing (45). The extent of spatial misregistration will depend on
patient motion, the rotation time, and the time interval between the high and low kV data
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collection (44,45). This interval subsequently depends on the difference in the tube
currents in the two rotations and can vary from 180 to 800 milliseconds (45).
The last vendor to develop a dual-energy CT system, Phillips, has designed a
scanner (Brilliance CT, Phillips Healthcare) that uses a single X-ray tube and a modified
detector with two scintillation layers. The top layer of the detector captures low energy
data, while the bottom layer captures high energy data. The low and high energy data are
then reconstructed to allow for dual-energy analysis. While anticipated for multiple years,
the scanner was just officially released at the Radiologic Society of North America 2015
conference in Chicago. At the time of this publication however, no publications can be
found based on clinical use of this system.

2.3 Dual-Energy Image Reconstruction
Given the prevalence of the Siemens and GE scanners over the Toshiba and
Phillips variants, discussion of image reconstruction processes will be limited to the two
major vendors, Siemens and GE.
Processing of the dual-energy data from the Siemens SOMATOM FLASH® system
is performed in the imaging domain after the independent reconstruction of the high and low
energy images. Three data sets are automatically produced: a pure 140 kVp image, a pure
80 kVp image and a “blended” set combining partial contributions of the 140 and 80 kVp
images. The percent contribution of the two energies can be customized for the desired
application. The combination can be linear, where the intensity of each pixel is weighed
equally, or non-linear sigmoidal, where the intensity of each pixel is weighed by its CT
number. Non-linear sigmoidal blending is particularly useful for iodine signal enhancement
(35,47). Material specific information is generated using a “three-material decomposition
algorithm” which is based on the fixed attenuation values of two fixed materials, soft tissue
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and fat, at both the high and low energy as well as a third varied material (35,36). This third
material, usually iodine, can be selectively mapped or removed from the images (37).
Unlike Siemens systems, the GE Discovery CT 750HD system processes dualenergy data in the projection domain before the images are reconstructed. This allows for
greater flexibility in material decomposition as well as the reduction of beam hardening
artifacts (48–51). Reducing beam hardening can provide images with improved CT
attenuation linearity, lower image noise and improved contrast-to-noise ratio (CNR)
compared to their single-energy counterparts (35,52). Because the processing of the dualenergy data takes time to complete, the 140 kVp projections are reconstructed and
immediately displayed to allow for a quick anatomic coverage check. These images should
not be used for analysis, however, since they are not fully corrected for scanner calibration
(52).
Material specific information is generated using a “basis material decomposition
algorithm” which proposes that the attenuation coefficients of a material can be
characterized as a weighted sum of the attenuation coefficients of two basis materials
(35,36). This idea is based on the concept that any material can be characterized as the
linear combination of its photoelectric and Compton scatter properties (Equation 1) (22,51)
.
Equation 1

ࣆሺܧሻ ൌ ࢻ݂ ݁ሺܧሻ  ࢼ݂ܿ ሺܧሻ

Equation 2

ߤͳ ሺܧሻ ൌ  ߙͳ ݂݁ሺܧሻ ߚͳ݂ܿ ሺܧሻ

Equation 3

ߤʹ ሺܧሻ ൌ  ߙʹ ݂݁ሺܧሻ ߚʹ ݂ܿ ሺܧሻ

Applying the concept described in Equation 1 to two materials (Equation 2, Equation
3), one can derive equations that express the photoelectric and Compton components of
attenuation in terms of the two basis materials (Equation 4, Equation 5).
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Equation 4

݂ ݁ሺܧሻ ൌ 

Equation 5

݂ܿ ሺܧሻ ൌ 

ߚʹ ߤͳ ሺܧሻ െ ߚͳ ߤʹ ሺܧሻ
ߙͳ ߚʹ െ ߙʹ ߚͳ

ߙʹ ߤͳ ሺܧሻ െ ߙͳ ߤʹ ሺܧሻ
ߚͳ ߙʹ െ ߚʹ ߙͳ

The algorithm then selects a target voxel of unknown composition. This voxel can
also be expressed as a linear combination of photoelectric and Compton scatter properties
(Equation 6).

Equation 6

ߤ ݈݁ݔݒሺܧሻ ൌ ߙ݂ ݁ሺܧሻ  ߚ݂ܿ ሺܧሻ

Equations 4 and 5, which express photoelectric and Compton scatter properties in
terms of the two basis materials, can then be substituted into Equation 6 resulting in
Equation 7.

Equation 7

ߙʹ ߤͳ ሺܧሻ െ ߙͳ ߤʹ ሺܧሻ
ߚʹ ߤͳ ሺܧሻ െ ߚͳ ߤʹ ሺܧሻ
ߤ ݈݁ݔݒሺܧሻ ൌ ߙ ቆ
ቇ  ߚ ቆ
ቇ
ߚͳ ߙʹ െ ߚʹ ߙͳ
ߙͳ ߚʹ െ ߙʹ ߚͳ

This equation can be further rearranged (Equation 8) and simplified into an
expression that characterizes the attenuation of the target voxel in terms of the weighted
sum of the attenuation coefficients of the two basis materials (Equation 9).

Equation 8

ߙߚʹ െ ߚߙʹ
ߚߙͳ െ ߙߚͳ
ߤ ݈݁ݔݒሺܧሻ ൌ  ൬
൰ ߤͳ ሺܧሻ   ൬
൰ ߤ ሺܧሻ
ߙͳ ߚʹ െ ߙʹ ߚͳ
ߚʹ ߙͳ െ ߙʹ ߚͳ ʹ
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Equation 9

ߤ ݈݁ݔݒሺܧሻ ൌ  ܽͳ ߤͳ ሺܧሻ   ܽʹ ߤʹ ሺܧሻ݁ݎ݄݁ݓ
ߙߚʹ െ ߚߙʹ
ߚߙͳ െ ߙߚͳ
ܽͳ ൌ  ൬
൰ ܽ݊݀ߙʹ ൌ  ൬
൰
ߙͳ ߚʹ െ  ߙʹ ߚͳ
ߚʹ ߙͳ െ ߙʹ ߚͳ

Since the attenuation coefficients of the two basis materials would be known, the
equation contains two unknown factors: the weighting factor of basis material 1 and the
weighting factor of basis material 2. By collecting attenuation data on the target voxel at
two separate energies, two equations can be written (Equation 10, Equation 11). This
system of equations can then be solved for the factors for the two material basis pairs
(22,51). These factors, expressed in material density, are then displayed in shades of gray
to produce two material density images of the object.

Equation 10

ߤ ݈݁ݔݒ൫ ݄݄݃݅ܧ൯ ൌ  ܽͳ ߤͳ ൫ ݄݄݃݅ܧ൯   ܽʹ ߤʹ ሺ ݄݄݃݅ܧሻ

Equation 11

ߤ ݈݁ݔݒሺ ݓ݈ܧሻ ൌ  ܽͳ ߤͳ ሺ ݓ݈ܧሻ  ܽʹ ߤʹ ሺ ݓ݈ܧሻ

The two materials used as the basis material pair can be selected by the user. A
range of materials are included in the GE Discovery CT 750HD software package; however,
additional materials may be added to the software database by the user using published
attenuation coefficients. Care should be taken in the selection of the basis material pair, as
the two materials must have sufficiently different atomic numbers and thus sufficiently
different attenuation properties (22,51). Water and Iodine are currently the most common
pair in use. The atomic numbers of the materials adequately frame the range of atomic
numbers of materials commonly found in medical imaging thus allowing for optimal
separation of tissues, bone and iodinated contrast (53). Measurements of iodine density
from the material density image can also be used to detect iodinated contrast enhancement
(54). Iodine material density images have proven to be semi-quantitative and thus may be
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used to measure relative iodine concentrations in the body (53,55). The water material
density image produced from a water/Iodine material decomposition of a contrast scan has
its own unique use as a virtual non-contrast image. This approach reduces patient dose by
eliminating the need for a true non-contrast image and can improve image quality of the
non-contrast image due to the inherent reductions in beam hardening from a dual-energy
scan (56–59).
In addition to the material density images, the GE system also supports a virtual
monoenergetic spectral (VMS) image output. The VMS images depict an object as if it
were imaged not by a polychromatic kVp beam but by a single monoenergetic kilo-electron
volt (keV) beam (50,60). VMS images are derived from the material density images by
applying the known energy-specific attenuation of each basis material to the image,
converting the material density values into attenuation values. The resulting attenuation
images, one for each basis material, are then summed to create the final VMS image.
Using this method, VMS images can be created at any specific energy level
between 40 and 140 keV (61). Low-energy VMS images have been shown to provide
excellent contrast for iodinated structures due to higher attenuation closer to Iodine’s kedge, allowing for a 50% reduction in the required amount of iodinated contrast delivered to
the patient (54,62). Several studies have also shown that VMS images in the range of 6570 keV have less noise, decreased beam hardening artifact and higher contrast-to-noise
ratio (CNR) than traditional 120 kVp single-energy CT images acquired using the same
dose (41,48,63)(41),(48) (63). In fact, both the “blended” images produced by Siemens
systems and the VMS images produced by GE have been shown to “provide equivalent
structural information” as compared to single-energy scans using the same dose over a
wide range of patient sizes (41,64).
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2.4 Tissue Differentiation using Dual-Energy CT
Although no other studies to our knowledge have explored the potential of applying
dual-energy CT to differentiate calcific and hemorrhagic lesions, the differentiating power of
dual-energy CT has been shown in many previously published studies. Dual-energy CT has
been used to distinguish between non-enhancing and enhancing renal lesions (54) as well
as benign and malignant tumors in the liver, thyroid and adrenal glands (53,55,65). It has
also been shown useful in the detection and characterization of endoleaks, pulmonary
embolism, liver metastases, urinary stones, myocardial ischemia and renal corticomedullary
sodium gradients(57,58,63,66–71). In two studies using Siemens dual-source dual-energy
CT scanners and a three-material decomposition algorithm, hemorrhage was distinguished
from iodinated contrast on the basis of the pattern of hyper-attenuation on the virtual
unenhanced image relative to the iodine overlay image (72,73).

2.5 MR for the Differentiation of Calcification and Hemorrhage
Data derived from the phase component of magnetic resonance imaging has been
investigated in the differentiation of intracranial calcification from hemorrhage for several
years.

Corrected gradient echo (GRE) phase imaging (20,74,75), susceptibility-weighted

imaging (SWI) (21,76,77), and quantitative susceptibility mapping (QSM) (78–81), have
each been proposed, however none has found wide clinical acceptance at this point in time.
GRE-based approaches are prone to errors due to either low T2* decay signal or low
proton density, noise, lesion orientation, the influence of non-local susceptibility effects and
differences in vendor phase sign conventions (74,75,82–87). However, techniques such
as SWI have been found to improve calcification and hemorrhage detection and
characterization compared to these earlier techniques (88–90). Although these phase
based methods have provided positive results in the differentiation of these two lesion
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types, SECT was employed as the criterion standard for calcification detection. As such,
the usefulness of these methods can only be applied to intracranial hemorrhage and
calcification above 100 HU. Preliminary work by Berberat, et al suggests that calcification
and hemorrhage in glioma could be differentiable under 100 HU using SWI (77), however
further work is needed to confirm these results for low density lesions. While these
methods for the differentiation of calcification and hemorrhage are of note, the transition of
phase dependent MR techniques from research to clinical use has traditionally proved
difficult due the sensitivity of these techniques to commonly encountered magnetic field
inhomogeneities (83,91).
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Chapter 3

3

Lesion Differentiation using an Agar-Gel Based Phantom

This chapter investigates the differentiation of calcium, present in calcification, and
iron, present in hemorrhage, using dual-energy CT. A simplified physics approach based
on agar get models was developed. SECT attenuation (HU) matched model pairs,
consisting of a hemorrhage and a calcification model, were evaluated using an
anthropomorphic phantom and the SECT attenuation (HU) necessary for 90%
differentiation accuracy were determined.

This chapter is taken from:
JL Nute, LG Le Roux, AG Chandler, V Baladandayuthapani, D Schellingerhout, DD Cody.
Differentiation of low-attenuation intracranial hemorrhage and calcification using dualenergy computed tomography in a phantom system. Invest Radiol. 2015; 50(1): 9-16. doi:
10.1097/RLI.0000000000000089
Written permission has been obtained from the journal for use of these materials in
this dissertation. Wolters Kluwer Health Lippincott Williams & Wilkins © No modifications
will be permitted.

3.1

Introduction
The ability to characterize cerebral lesions in terms of material composition,

especially at low Hounsfield values, has many important clinical applications, such as the
distinction of hemorrhagic from calcific lesions. There is overlap in the Hounsfield densities
of blood and calcium on conventional CT, particularly below 100 Hounsfield Units (HU).
This difference is clinically important, for example in differentiating benign cerebral
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calcifications, which require no treatment (3), from cavernous angiomata which carry a risk
of bleeding and are a contra-indication for anticoagulant therapy (4,5). Oligodendrogliomas
are commonly calcified, and need to be distinguished from glioblastomas, which commonly
contain intratumoral hemorrhages. The treatment strategies for these tumors are
completely different, and would be better informed if calcification and hemorrhage could be
reliably separated.
Currently, conventional single-energy computed tomography (SECT) is considered
the gold standard modality for the identification of calcification. In general, any lesion with
SECT attenuation levels >100 HU is classified as a calcification (2). However, this gold
standard fails for lesions with SECT attenuation levels <100 HU, where blood and
calcifications overlap in attenuation.
In clinical practice, MR is often used as a characterizing modality to add to the
information derived from CT. However, conventional MR is of little help in distinguishing
hemorrhagic from calcific lesions. Both types of lesion manifest as signal voids on Gradient
Echo images, with little characterizing information available without the use of specialized
experimental phase contrast MR techniques (1). There is a significant clinical need for an
imaging technology to distinguish hemorrhage from calcification at low Hounsfield values,
and dual-energy CT is a strong candidate to fill this gap in our imaging armamentarium.
Dual-energy CT is based on the knowledge that the relationship between
attenuation and x-ray energy is material dependent. By collecting attenuation information at
two distinct energies, assumptions can be made about the shape of the energy-dependent
attenuation curve for a given tissue, and thus about its material characteristics. This
represents a significant advance from SECT, where only a single attenuation value is
derived, with no further information available on the material characteristics of the
tissue(35,36,51).
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Dual-energy CT has already been used with success in distinguishing blood from
iodinated contrast staining in patients after intra-arterial stroke therapies (72,73,92), in
distinguishing iodine enhancement from calcification in artificial pulmonary nodules (93),
and in distinguishing complimentary contrast media (iodine and tungsten, or iodine and
bismuth subsalicylate) (94). All are clinically significant problems where the attenuations of
the two main differential diagnostic possibilities have significant overlap on conventional
SECT. Dual-energy CT’s success has also been shown in the characterization of renal
calculi (26,95,96), distinguishing non-enhancing and enhancing renal lesions(54),
distinguishing benign and malignant tumors in the liver (53), thyroid (53) and adrenal glands
(55,97,98). It has also been shown useful in the detection and characterization of
endoleaks, pulmonary embolism, liver metastases, urinary stones, myocardial ischemia and
renal corticomedullary sodium gradients (57,58,63,66–69,71).
In this study, we apply dual-energy CT to the more subtle problem of distinguishing
calcification and hemorrhage. We provide a phantom-based proof-of-concept that the
differentiation of these two intracranial lesion types below 100 HU is both possible and
clinically feasible using dual-energy CT.

3.2
3.2.1

Materials and Methods
Calcification and Hemorrhage Phantom Models
Powdered ferric oxide (#529311; Sigma-Aldrich, St. Louis, MO) and hydroxyapatite

(#289396; Sigma-Aldrich) were used to model hemorrhage and calcification, respectively.
Ferric oxide and hydroxyapatite were added to separate sets of 1.8-mL cryo-vials
(#375418; Thermo Scientific, Waltham, MA), and 500 μL of 0.01% Tween-20 (#P9416;
Sigma-Aldrich) solution was added to each vial as an emulsificant to promote a uniform
mixture. The hydroxyapatite vials were agitated for 24 hours using a Max Q2000 shaker
(#4314; Thermo Scientific). The iron oxide particles used to model hemorrhage were not
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adequately emulsified by Tween alone, and required the addition of small 7 mm × 2 mm
magnetic stir bars (#14-513-63; Fisher Scientific, Waltham, MA) to provide mechanical
agitation. Iron oxide vials were agitated for 24 hours using a PC-220 stirrer plate (Corning,
Corning, NY).
The stirrer bars were removed from the iron oxide vials using a strong magnet, and
both sets of vials were moved to a water bath, where they were heated to 75°C. Heated
1% agar gel solution (2 mL) (#0710; Amresco, Solon, OH) was added to both sets, and the
vials were tightly capped. The warm vials were then manually agitated by vigorous shaking
for approximately 10 minutes until the solution cooled into a gel with uniform compound
distribution. These gel models were stored at 4°C prior to scanning.
An anthropomorphic head phantom (The Phantom Laboratory, Salem, NY) (Figure
3.1) consisting of a human skull cast in tissue-equivalent Alderson material with anatomical
airways was obtained from the Radiological Physics Center (Houston, TX). A cylindrical
insert was placed in the cranium, and a custom insert was fabricated that allowed for
simultaneous imaging of six agar gels (Figure 3.2).

Figure 3.1: Anthropomorphic head phantom.

22

Figure 3.2: (a) Custom water-filled insert for the anthropomorphic head phantom. The lateral
view (top), the axial view (bottom left), and the relative position of the insert in the head
phantom (bottom right) are shown. The orientation of the imaging volume is represented by
the yellow shaded region. (b) A lateral scout image of the anthropomorphic head phantom
with custom water-filled insert and gel models in place.

3.2.2

Imaging and Region-of-Interest Analysis
The calcification and hemorrhage gel model were scanned in the phantom on a

Discovery CT750 HD CT scanner (GE Healthcare, Waukesha, WI) using two protocols: a) a
single-energy in-house routine brain protocol and b) a dual-energy protocol designed to
match the imaging parameters and dose of the single-energy protocol (Table 3.1). To
improve the spatial resolution of the gel images, the display field of view was reduced to the
minimum of 12 cm. Images were viewed with Gemstone Spectral Imaging (GSI) viewer
software (version 2; GE Healthcare), and data were collected on eight consecutive images
using a circular 39-mm2 (7 mm diameter) region of interest covering approximately twothirds of the vial diameter. The total number of voxels per region of interest was 754, for a
total of 6,032 voxels in a volume of interest per vial. The 6,032-voxel volume of interest
covered 952 mm3 and constituted 37% of the total gel volume of approximately 2.5 mL. For
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each voxel in the volume of interest, the following data were recorded: a) SECT attenuation
(HU), b) calcium density from a water/calcium material decomposition based on the dualenergy CT data (see ‘Dual-Energy Data Processing’ below), c) water density from a
water/calcium material decomposition based on the dual-energy CT data (see ‘Dual-Energy
Data Processing’ below), and d) material composition of the gel model (iron oxide-based
hemorrhage model or hydroxyapatite-based calcification model).

Table 3.1: Imaging parameters for the single- and dual-energy CT protocols used in the
study. For both protocols: Image thickness: 3.75 mm, Table Speed: 10.62 mm/rotation, Pitch:
0.531, Interval: 3 mm, Scan Field of View (SFOV): Head, Display Field of View (DFOV): 12 cm,
Reconstruction Algorithm: Soft.

Protocol

Scan type

Rot time [s]

kVp

mA

CTDIvol* [mGy]

Single-energy

Helical

0.8

140

440

66

Dual-energy

GSI-26

0.7

80/140

375

67

*Computed Tomography Dose Index Volumetric (CTDIvol)

3.2.3

Fabrication of Matched Hemorrhage and Calcification Gel Models
Iron oxide and hydroxyapatite gels were created at concentrations between 1

mg/mL and 100 mg/mL and scanned in the phantom using the single-energy CT protocol
(Table 3.1). Images were viewed as described above. Each gel model’s mean SECT
attenuation (HU) was calculated and plotted against the gel model’s concentration. The
SECT attenuation (HU) was fitted to a linear function of the known concentration of each
material and the concentration required to achieve a given SECT attenuation (HU) was then
calculated from the fit.
Pairs of agar gels were fabricated with similar SECT attenuation (HU) levels and
differed only in their composition (iron oxide-based hemorrhage model or hydroxyapatite24

based calcification model). These matched gel models were fabricated at SECT attenuation
levels ranging from 0 to 100 HU, in roughly 10-HU intervals. Paired vials of similar
attenuation (within 2 HU) were then scanned in the anthropomorphic head phantom and
scanned using a) the single-energy in-house routine brain protocol, to verify the SECT
attenuation (HU) level of each gel model, and b) the dual-energy protocol, to collect
material density information.

3.2.4

Dual-Energy Data Processing
To extract the dual-energy signature of a material from the high- and low-kilovolt-

peak data gathered in the dual-energy CT scan, GE Healthcare (Waukesha, WI) uses a
process called material decomposition. This process is based on the concept that the
energy-dependent attenuation of any material can be characterized as the linear
combination of the energy-dependent attenuations of two basis materials (35,36). One of
the unique capabilities of this approach is allowing the user to independently choose the
basis materials. Theoretically, any two materials could be chosen, but biologically relevant
pairs such as water and iodine give more meaningful results (26,40). Materials with kedges within the relevant x-ray energy range of 40-140 keV should also be avoided as
these discontinuities can give rise to erroneous material decomposition results. The
materials chosen should also have sufficiently different atomic numbers and thus
sufficiently different attenuation properties to produce meaningful material separation, thus
generating clinically useful data (22,99). We chose calcium and water as our working pair
because of their biological relevance and dissimilar attenuation properties. Iron-water and
iodine –water material basis pairs were also investigated, however, preliminary data
indicated the calcium-water material density pair as yielding separation plots that were
more meaningful and convenient for our application. (Data not shown)
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Data from the dual-energy images were collected using the GE Gemstone Spectral
Imaging viewer in material density mode with a water/calcium material density pair. These
images express the density of water and the density of calcium in each voxel needed to
produce the observed linear attenuation coefficient.

3.2.5

Matched Model Pair Data Analysis
For each SECT attenuation (HU)-matched model pair, single-energy and dual-

energy voxel data (6,032 voxels/gel model) for both the hemorrhage model and the
calcification model were loaded into MATLAB software (R2012a; MathWorks, Natick, MA).
The single-energy and dual-energy voxel data were registered based on the image number
and voxel location data included in the region of interest data file.
A Gaussian mixture model (GMM) was performed to group the voxels into two
populations: calcification and hemorrhage. Using the measured SECT attenuation (HU),
water density and calcium density values for each voxel as input, a probability of belonging
to either the calcification or the hemorrhage population was calculated for each voxel (see
Chapter 8: Appendix), with a posterior probability of ≥0.5 as the criterion for population
assignment (100,101).The analysis was performed using a 50% training set, 50% validation
set approach to ensure that the data used to build the model (randomly assigned training
set) was distinct from the data the model was used to evaluate (randomly assigned
validation set) and was performed 1,000 times to ensure convergence in light of the nonstochastic nature of the GMM analysis.
The probabilistic assignments for the two populations (calcification and hemorrhage)
were tested against the gold standard of actual gel composition, and an overall model
accuracy was calculated as a function of the SECT attenuation (HU) of the matched model
pair.
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While Gaussian mixture model analysis can be quite powerful, its potential for
application in a clinical setting is low due to the time and processing power needed to apply
the technique. To provide a more clinically implementable test metric, a threshold plane
was derived from the GMM data. For all matched model pairs included in the study, voxels
receiving an assignment probability of 50 ± 1% (equal probabilities of being assigned to the
hemorrhage or calcification cluster) were isolated, and a line of best fit was determined
using regression analysis in three dimensions. Due to the correlated nature of the SECT
attenuation (HU) and dual-energy material density data, gel model voxel data were found to
be concentrated in a single plane in three-dimensional (3D) space (Figure 3.3). Using
principle component analysis, the centroid and inertia axes of the plane were calculated
and the equation for the plane of the data was determined. A second plane was then
calculated which included the line fit of the equal-probability points and was orthogonal to
the plane of the data, effectively bisected the voxel data into two groups. Based on the
equation of this threshold plane, voxels were sorted into either a hemorrhage group or a
calcification group according to their position relative to the threshold plane. For each
matched model pair, the predicted material composition for each voxel was compared with
actual composition, and the accuracy of the threshold plane’s differentiation was calculated
and plotted against the SECT attenuation (HU) of the matched model pair.
Statistical details describing the Gaussian mixture model formulation, fitting and
analysis are included in the Appendix (Chapter 8).
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Figure 3.3: 3D plot of voxel data from all calcification and hemorrhage gel models used in this
study, rotated to show the full distribution of the data (a) or the planar nature of these data in
the 3D coordinate space (b). Hemorrhage gel model voxel data are shown in red; calcification
gel model voxel data are shown in blue.
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3.3
3.3.1

Results
Calcification and Hemorrhage Phantom Models
The results of the SECT attenuation (HU) calculation for all iron oxide and

hydroxyapatite gels are shown in Figure 3.4, and indicate the concentration of the
compounds in each of gel types needed to produce gel models of a specific SECT
attenuation.

Figure 3.4: SECT attenuation (HU) for the concentration of iron oxide in the hemorrhage gel
models and the hydroxyapatite in the calcification gel models. Linear regression equations
and correlation coefficients are shown for each data set.

3.3.2

Fabrication of Matched Hemorrhage and Calcification Gel Models
The target concentration of iron oxide and of hydroxyapatite required to produce

each desired SECT attenuation (HU) is presented in Table 3.2. The exact weight of each
compound added to each gel vial is also presented and was calculated based on the
concentration and the known volume of the gel vials used in the study.
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Table 3.2: Concentrations and weights of iron oxide and hydroxyapatite needed to create
hemorrhage and calcification models of specific SECT attenuation (HU).

Target
attenuation
[HU]
10
20
30
40
50
60
70
80
90
100

Concentration [mg/mL]*

Weight [mg]†

Hydroxyapatite

Iron Oxide

Hydroxyapatite

Iron oxide

6.32
14.98
23.64
32.31
40.97
49.63
58.29
66.95
75.62
84.28

3.41
7.19
10.97
14.76
18.54
22.32
26.11
29.89
33.67
37.46

16.11
38.20
60.29
82.38
104.47
126.55
148.64
170.73
192.82
214.91

8.69
18.34
27.98
37.63
47.28
56.92
66.57
76.22
85.86
95.51

*Derived from the linear-fit equation in Figure 4. †Weights required to achieve the concentrations
listed were calculated based on the volume of specific gel vial used in the study.

3.3.3

Matched Model Pair Data Analysis
A total of 16 hemorrhage and calcification model pairs were matched. The average

SECT attenuation (HU) of each pair, as well as the mean and standard deviation of the
SECT attenuation (HU) for each gel model in the pair, is shown in Table 3.3.
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Table 3.3: Average SECT attenuation (HU) of each matched pair and mean SECT attenuations
(HU) for the hemorrhage gel model and the calcification gel model in each pair.

Average SECT attenuation of
matched model pair [HU]*
12
14
17
20
30
32
39
50
60
62
71
75
82
88
89
90

Mean SE attenuation [HU] ± SD
Hemorrhage model
Calcification model
(iron oxide)
(hydroxyapatite)
11.4 ± 8.5
12.7 ± 3.4
13.9 ± 3.2
14.2 ± 3.4
17.1 ± 3.8
16.9 ± 3.3
20.8 ± 3.4
19.7 ± 3.2
30.4 ± 4.6
30.6 ± 3.5
31.3 ± 3.4
31.8 ± 3.3
39.2 ± 5.3
38.8 ± 3.5
49.4 ± 3.2
51.3 ± 3.9
59.7 ± 4.8
60.6 ± 3.6
62.3 ± 4.0
62.3 ± 4.4
70.7 ± 4.0
71.1 ± 5.0
75.7 ± 4.0
74.7 ± 9.5
82.4 ± 6.2
82.3 ± 4.4
88.7 ± 6.6
87.5 ± 4.2
88.7 ± 6.6
89.6 ± 7.6
90.1 ± 6.6
89.6 ± 7.6

*Hemorrhage and calcification gel models with attenuation levels within 2 HU of each other
were organized into matched model pairs, and the average attenuation of each pair was the
rounded average of the hemorrhage model attenuation and the calcification model
attenuation.

As an example for the purposes of illustration, the voxel data for the 62-HU matched
model pair along with the GMM predicted and actual gel model compositions are shown in
Figure 3.5. For the GMM analysis (Figure 3.5), the accuracies for the calcification and
hemorrhage models were 99.7% and 97.7%, respectively.
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Figure 3.5: GMM assignment results for the 62-HU matched gel model pair (1 of 16 pairs).
Each point represents a voxel within the 6,032-voxel volume of interest in one of the two gel
models.

Matched calcification and hemorrhage gel model pairs were differentiated with
>90% accuracy using GMM analysis starting at 50HU (Figure 3.6). A slight drop to just
below the 90% threshold was seen at 60HU however, all subsequent matched model pairs
exceeded 90% accuracy. All matched model pairs over 50HU, with the exception of the
60HU pair, possessed very narrow accuracy distributions, with standard deviations of <1%.
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Figure 3.6: Accuracy of hemorrhage and calcification differentiation using the GMM and
threshold plane analysis method for all attenuation-matched model pairs. For the GMM
series, each point represents 1,000 iteratively filtered runs of the analysis. A third-order
polynomial (Poly.) was fit to each series to facilitate visual interpretation of the data.

In order to derive the threshold plane, eight hundred thirty-six voxels with posterior
probabilities of 50 ± 1% were isolated from the total 193,024 voxels on the basis of the 32
gel models included in this study. A coordinate system was established with the x-axis
defined as the dual-energy CT water density, the y-axis defined as the dual-energy CT
calcium density, and the z-axis defined as the SECT attenuation (HU). The line fit to the
equal probability points had the vector equation <x,y,z> = <998.17, 11.88, 23.18> + t<0.06,
-0.41, -0.91> where t is any real number. The 3D threshold plane had the equation -0.93x +
0.31y - 0.20z = -929.20 and clearly bisected the hemorrhage and calcification model voxel
data (Figure 3.7). Matched model pairs with SECT attenuation levels ≥50 HU were
differentiated with >90% accuracy for both the GMM analysis as well as its more clinically
implementable threshold plane metric (Figure 3.6).
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Figure 3.7: 3D plot of all voxel data (n = 193,024) from all 16 hemorrhage/calcification
matched model pairs. Hemorrhage gel model voxel data are shown in red; calcification gel
model voxel data are shown in blue. (a) Threshold plane viewed edge on as black line
[equation: -0.93x + 0.31y - 0.20z = -929.20]. (b) Voxel data viewed from an angle showing
hemorrhage and calcification data falling on the hemorrhage side of the threshold plane.
Bright blue calcification data would be incorrectly identified as belonging to the hemorrhage
population, with greyed-out blue data being correctly classified. (c) Voxel data viewed from
an angle showing hemorrhage and calcification data falling on the calcification side of the
threshold plane. Bright red hemorrhage data would be incorrectly identified as belonging to
the calcification population, with greyed-out red data being correctly classified.

3.4

Discussion
This study provides proof-of-concept in a phantom system that dual-energy CT can

distinguish intracranial calcification from hemorrhage below the 100 HU limit imposed by
currently available clinical modalities. Intracranial lesions over 100 HU are identifiable as
calcification using SECT, however lesions under this attenuation are impossible to classify.
Using conventional MR, both hemorrhage and calcification manifest as signal voids in
Gradient Echo images. Without additional information, the cause of the signal voids, be it
calcification or hemorrhage, cannot be determined.
The use of phase information in MR for the differentiation of diamagnetic materials,
such as calcification, and paramagnetic materials, such as hemorrhage, has been under
investigation for several years (79). Corrected gradient echo phase imaging (20),
susceptibility-weighted imaging (21), and quantitative susceptibility mapping (78) have all
been proposed to distinguish calcification from hemorrhage, however these methods have
not yet found wide clinical acceptance. In each of these studies, SECT was used as the
gold standard for presence of calcification, and thus the usefulness of these methods can
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be reported only for hemorrhage and calcification above 100 HU. Preliminary work
suggests that calcification and hemorrhage in glioma may be differentiable under the 100
HU limit using phase data derived from susceptibility-weighted imaging (77). However, the
transition from research to clinical use of phase-dependent MR techniques has been
difficult due to the sensitivity of the technique to magnetic field inhomogeneity, which is the
rule, rather than the exception in clinical applications.
In this study, dual-energy CT in combination with Gaussian mixture model analysis
was shown to be capable of differentiating intracranial calcification and hemorrhage models
far below the level possible using currently available clinical modalities. Overall, the
accuracy of the GMM differentiation of the hemorrhage and calcification model voxel data
increased with the matched model pair’s SECT attenuation (HU). Put simply, the denser the
lesion model, the easier it was to differentiate hemorrhage from calcification. Strong
differentiation with >90% accuracy can be seen starting at 50 HU. The dip in accuracy and
associated increase in accuracy distribution at 60 HU in the GMM analysis (Figure 3.6) may
be due to a higher heterogeneity in the SECT attenuation (HU) dimension from either the
calcification or the hemorrhage gel model due to variability in gel model fabrication.
Nevertheless, the overall trends in both the GMM and threshold plane accuracy results
support the use of 50 HU as a threshold for highly accurate differentiation.
Gaussian mixture model analysis was chosen as the statistical analytic method for
this study due to its ease of interpretation and to take advantage of the three dimensional
and potentially overlapping nature of the data collected. The Gaussian assumption of the
analysis was appropriate given the large amount of voxel data collected from each gel
model. Traditional t-test analysis was contraindicated by both the vast amount of data and
the differences in the manufacturing methods for the calcification and hemorrhage gel
model. (Because of the large numbers of data points, slight differences in heterogeneity
between the calcification and hemorrhage models resulted in statistically significant
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differences when in fact the model’s voxel data overlapped to a considerable extent. This
observation indicated that t-test analysis was inappropriate.) Additionally, the ability to
perform training/validation data set analysis using GMM allowed for a more robust test of
differentiation as well as lending itself to the development of a model-based threshold for
classification of unknown lesions.
For practical implementation of the GMM statistical separation procedure, we
derived a simple threshold plane to divide the voxels into calcification and hemorrhage
population. The discrimination performance of this plane was similar to the original GMM
analysis (Figure 3.6) and actually outperformed the GMM analysis at low densities, likely by
linearly extrapolating from higher densities to lower where the GMM itself became noiselimited.
To establish the use of dual-energy CT to discriminate calcification and hemorrhage
clinically, an initial phantom study is necessary to allow essential variables to be
interrogated and analysis tools and methods to be designed, trained, and optimized in a
controlled fashion. However, due to the inherent constraints requisite to use of a phantom
system there will always be limitations in the modeling. First, both hemorrhages and
calcifications were modeled as relatively large cylindrical lesions positioned centrally in the
brain. Second, both lesion types were modeled using an agar background and scanned in a
water-filled insert, which does not accurately represent brain tissue. Third, both lesion types
were modeled as uniform distributions, with no attempt made to model heterogeneous
distribution or influences of local environment on the lesion. Lastly, hemorrhage models
were created without any form of calcium contamination. It is likely that cross
contamination will occur clinically, where biology is always more complex than phantoms.
For example, it has been shown that cavernomas calcify in anywhere from 11-40% of cases
(102,103), and in those cases we may expect to see both calcification and hemorrhage in
the same lesion. Clearly there is potential for overlap and cross contamination between
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blood and calcium in clinical applications. Our current study lays a groundwork for a “clean”
uncontaminated case, leaving more complex mixture phantom models and more
importantly, clinical applications, to future work.
Future studies are planned to extend our approach to encompass other dual-energy
CT vendors, as well as to further test the limits of our method by varying the size and
location of the lesions, more accurately modeling the brain tissue background and
environment, and varying the imaging parameters of the dual-energy protocols to potentially
optimize differentiation. The resulting data will be used to develop appropriate scan
protocols based on the size and location of intracranial lesions for use in a prospective
human trial.
In conclusion, this work has shown that hemorrhagic and calcific lesions with SECT
attenuation levels between 50 and 100 HU can be reliably differentiated in a phantom
system using dual-energy CT and material decomposition. The equation for a simple
threshold plane of differentiation derived from the more complex GMM analysis provides a
simplified metric for future clinical application. The ability to differentiate between lowattenuation hemorrhagic and calcific lesions has multiple clinical applications, both
addressing current clinical needs, and also likely, future unforeseen applications. This data
provides justification for future clinical studies in patients.
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Chapter 4

4

Lesion Differentiation using a Biologically-Relevant Phantom

This chapter seeks to validate the results of the simplified physics model
investigated in Chapter 3, using a more biologically relevant phantom system. Instead of
agar, a spectrally-equivalent brain background material will be described that better mimics
the spectral properties of brain tissue. Intracranial lesions will be modeled at a range of
sizes and at varying locations within the cranial cavity. Acquisition parameters will be
varied in an effort to elucidate the optimal imaging technique, patient population constraints
and analysis methods for use in a future prospective clinical trial.

4.1
4.1.1

Materials and Methods
Phantom Preparation
For this project, an anthropomorphic nuclear

medicine head phantom was acquired (Capintec,
RS900T, Figure 4.1). The anthropomorphic nature of
the interior of the phantom allowed for the design of a
novel brain insert to hold lesion models of various
compositions and sizes at multiple locations within the
cranial cavity. Figure 4.2 shows the basic structure of
the intracranial lesion phantom design. Spectrally
equivalent brain slabs would be positioned to cover
two regions at opposite ends of the imaging spectrum:
the skull base surrounded by dense bone and the
cerebrum with little bony anatomy. The cerebrum slab

Figure 4.1: Interior of anthropomorphic
nuclear medicine phantom.
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houses six cylindrical inserts (three hemorrhage inserts and three calcification inserts) at
three diameters: 0.5 cm, 1 cm and 1.5 cm (Figure 4.2b). Due to its size as well as the
difficult imaging environment, the skull base slab houses only two cylindrical inserts: a 1.5
cm hemorrhage and a 1.5 cm calcification insert (Figure 4.2c).

Figure 4.2: Intracranial lesion phantom plan showing brain slabs in tan, hemorrhage lesion
models in red and calcification lesion models in blue. (a) sagittal view showing position of
cerebrum and skull base brain slabs. (b) axial view of cerebrum brain slab showing position
of hemorrhage and calcification lesion models. (c) axial view of skull base slab showing
position calcification and hemorrhage model.

In order to maintain the position of the brain slabs and to ensure artifact-free helical
imaging, a polyurethane rubber was used as a filler material between the slabs. The
polyurethane product chosen (PMC-121/30-Dry) was a minimally shrinking, amber-colored
rubber with a specific gravity of 1.04 and a mean CT number of 3 HU using a 120kVp scan
technique (http://www.smooth-on.com/tb/files/PMC-121_SERIES.pdf). To ensure the easy
release of the cured polyurethane rubber, the interior of the phantom was buffed with fine
grain sand paper. Any occlusions or holes in the phantom interior were filled with an acrylic
based epoxy and the final surface coated with several fine layers of aerosolized acrylic to
obtain a smooth and sealed interior surface. Olive oil was used as a release agent for the
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polyurethane due to its low effective Z composition in an attempt to avoid high Z
contamination from the more common silicon based release agents.

4.1.2

Spectrally Equivalent Brain Material
Spectrally equivalent materials were created by Gammex, Inc. as part of a special

custom order. Several samples of potential brain equivalent materials were supplied and
imaged using both a single-energy CT routine brain protocol and a dual-energy CT protocol
selected to match the imaging parameters and dose of the single energy protocol (Table
4.1). The monoenergetic dual-energy data was compared to existing data from a clinical
brain study. Based on these results, the material with the closest spectral HU curve to
human brain was selected. The final spectrally equivalent brain slab provided by Gammex
was validated using the protocol in Table 4.1 and defect free regions were selected for use.

Table 4.1: Imaging Technique for basic single-energy and matched dual-energy data
collection.

Name
Routine
Brain
GSI - 26
Brain

Scan
Type

Pitch

Rot

Beam
Width

Img Thk

Interval

SFOV

DFOV

kVp

mA

Filter

Helical

0.531

0.8s

20 mm

3.75 mm

3 mm

Head

25 cm

140

160

STND

Helical

0.531

0.7s

20 mm

3.75 mm

3 mm

Head

25 cm

NA

NA

STND

In order to obtain a detailed model of the interior of the nuclear medicine phantom, a
polyurethane cast was made of both the base and crown of the phantom. The
polyurethane filled phantom was then imaged using the single-energy protocol detailed in
Table 1 and the specific position and dimensions of the cerebrum and skull base slabs were
determined. The polyurethane casts were then removed and models of the slabs were cut
from the casts based on the measurements derived from the imaging. A projection view of
the greatest diameter of the polyurethane slab model was made and the spectrally
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equivalent brain material was cut to that shape. Orientation marks were added to the
surfaces of both the polyurethane models and the brain slabs and rough contours were
created using a belt sander. Fine details were later created using a combination of air
powered die grinders and dremmel tools. Once construction on both brain slabs was
complete, polyurethane filler slabs were created. The slabs were designed to be removable
to allow easy access to all lesion models. The polyurethane filler slabs were created in
sequence starting with the most inferior and working towards the most superior. To ensure
a subsequent pour did not cure to a prior filler slab, heavily oiled plastic wrap was placed
between the layers.

4.1.3

Lesion Models
Hemorrhage models were created by adding various concentrations of iron oxide to

the spectrally equivalent brain material, while calcification models were created by adding
various concentrations of calcium carbonate. Calcium carbonate was selected over our
previously used hydroxyapatite due to its similar high calcium content but relatively higher
ease of use. Lesion models ranging from 40 HU to 100 HU in 10 HU increments were
created by Gammex and sent for validation in the form of 2.7 cm diameter, 25 cm long rods.
These rods were validated using a Gammex Validation Phantom (Figure 4.3) consisting of
a 15 cm thick, approximately 20 cm diameter solid water phantom with 8 insert positions.
The two positions on either side of the target insert contained water balloons to provide an
optimal imaging environment. All other inserts were relatively low density and did not affect
imaging of the target insert in the 12 o’clock position. The validation phantom was imaged
using a combined protocol covering single-energy acquisitions, dual-energy acquisitions
and Gammex specific acquisitions (Table 4.2). The bold line denotes a break in the
protocol when the insert was repositioned to scan the second half due to its length relative
to the phantom (25 cm rod vs 15 cm thick phantom).
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Figure 4.3: Gammex validation phantom. Water balloons are positioned in insert
holes covered by tape. Target lesion was positioned at 12 o’clock.

Table 4.2: Imaging technique for validation of lesion model inserts. Bold line indicates break
in protocol where insert was repositioned to allow imaging of second half of insert extent.
Series 2 and 4 were not repeated since their relation to series 3 was already evaluated in the
first imaging setting. For all series: SFOV: Head, DFOV: 25 cm, Filter: Standard.
Beam
Width
(mm)

Name

Scan
Type

Interval
(mm)

kVp

2

Routine Brain

Helical

0.531

0.8

20

3.75

3

140

160

3

New Routine Brain

Helical

0.531

0.8

4

GSI - 26

Helical

0.531

0.7

20

3.75

3

120

220

20

3.75

3

NA

NA

5

GMX Val 80kV

Axial

1

1

40

5

40

80

250

6

GMX Val 100kV

Axial

1

40

5

40

100

250

7

GMX Val 120kV

Axial

1

1

40

5

40

120

250

8

GMX Val 140kV

Axial

1

1

40

5

40

140

250

9

GMX Val 80kV

Axial

1

1

40

5

40

80

250

10

GMX Val 100kV

Axial

1

1

40

5

40

100

250

11

GMX Val 120kV

Axial

1

1

40

5

40

120

250

12

GMX Val 140kV

Axial

1

1

40

5

40

140

250

13

New Routine Brain

Helical

0.531

0.8

20

3.75

3

120

220

Series

Pitch

Rot
(s)
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Img Thk
(mm)

mA

The single-energy images were downloaded and regions of interest (ROIs) were
applied using MATLAB. ROIs were of diameter 0.5 cm, 1 cm and 1.5 cm and covered the
entire length of the target lesion rod. The mean and standard deviation of each ROI for
each image were exported to Excel where the average mean and average standard
deviation of each ROI size were calculated for each rod. Outlier limits were set as ±2 HU
from the average for the mean values and +1 HU from the average for the standard
deviation. Using conditional formatting, outlier fields were highlighted in the rod data,
allowing identification of segments of the lesion rod that were within tolerance based on
both their mean value and their standard deviation. Based on the known thicknesses of the
brain slabs and thus the desired lengths of the lesion models, running averages of set
numbers of images were calculated. Those averages representing acceptable rod extents
were tabulated and the two regions representing a calcification lesion and a hemorrhage
lesion with equal ROI diameters that had the most similar mean CT number on the singleenergy protocol were selected. This process was repeated until regions on the rods were
identified for the creation of matched HU calcification and hemorrhage rods at all diameters
and lengths. The desired region on each rod was marked and then sent back to Gammex
for milling.

4.1.4

Selection of optimal keV level for simulated SECT scanning
The phantom was prepared with lesion models representing various SECT

attenuation (HU) levels filling the cerebrum brain slab. The skull base slab was left empty
for this experiment. Ultrasound gel was used to fill the space in the polyurethane at the
back of the cerebrum slab where the pull ribbon exited the phantom. The brain and
polyurethane filler slabs were positioned in the nuclear medicine phantom and the crown of
the phantom affixed to its base using tape.
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The phantom was then positioned in the CT head holder and aligned such that the
plane of division between the crown and the base of the phantom was parallel to the
imaging plane. The imaging protocol used is shown in Table 4.3. Data were collected from
all lesion models using 11.25 mm diameter ROIs for the 15 mm diameter lesion models, 7.5
mm diameter ROIs for the 10 mm diameter lesion models and 3.75 mm diameter ROIs for
the 5 mm diameter lesion models. ROIs were collected for each GSI-preset while in megamono mode to collect data from multiple monoenergetic keV levels simultaneously. The
predicted attenuation (HU) data for keV reconstructions of 40 to 140 keV in 5 keV steps
were then imported into excel where a second order polynomial was fit to the predicted
attenuation (HU) curve for Monoenergetic reconstructions from 60 to 80 keV. Using this
curve and the knowledge of the true SECT attenuation (HU) from series 2 of the protocol,
the optimal keV for simulated SECT scanning was calculated. The average optimal keV
across all GSI-presets and inserts was then calculated and the difference in attenuation
from the optimal keV reconstruction and the SECT acquisition was determined.
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Table 4.3: Imaging technique for intracranial lesion phantom scanning. For all series and
groups (except series 1): SFOV: Head, DFOV: 25 cm, Scan Type: Helical, Beam Width: 20 mm.
Rot
(s)

CTDIvol
(mGy)

Filter

220

0.8

64.8

Standard

80/140

375

0.7

36.7

Standard

Mega Mono

1.25

80/140

630

0.5

44.6

Standard

Mega Mono

1.25

80/140

640

0.6

54.7

Standard

Mega Mono

1.25

1.25

80/140

550

0.8

57.9

Standard

Mega Mono

0.969

1.25

1.25

80/140

600

0.8

64.2

Standard

Mega Mono

GSI-9

0.969

1.25

1.25

80/140

600

0.9

72.7

Standard

Mega Mono

GSI-26

0.531

1.25

1.25

80/140

375

0.7

67

Standard

Mega Mono

GSI-20

0.531

1.25

1.25

80/140

630

0.5

81.4

Standard

Mega Mono

GSI-19

0.531

1.25

1.25

80/140

640

0.6

99.8

Standard

Mega Mono

GSI-30

0.531

1.25

1.25

80/140

550

0.8

105.6

Standard

Mega Mono

GSI-14

0.531

1.25

1.25

80/140

600

0.8

117.1

Standard

Mega Mono

GSI-9

0.531

1.25

1.25

80/140

600

0.9

132.6

Standard

Mega Mono

Name

1

Scout

2

Routine
Brain

0.531

1.25

GSI-26

0.969

GSI-20
GSI-19

3

4

4.1.5

Pitch

Img Thk
(mm)

Series

Interval
(mm)

kVp

mA

120

10

1.25

120

1.25

1.25

0.969

1.25

0.969

1.25

GSI-30

0.969

GSI-14

DE Recon

Collection of Lesion Differentiation Data
Lesion models of a specific SECT attenuation (HU) level were loaded into the

cerebrum brain slab of the intracranial lesion phantom and imaged using the protocol found
in Table 4.3. This protocol allowed for the collection of lesion model data based on a variety
of different GSI-presets and pitch values. This process was repeated for all SECT
attenuation (HU) sets of lesion models. The data from all seven exams (representing the
seven lesion SECT attenuation (HU) levels evaluated) were reconstructed to allow for
collection of the optimal keV (determined in Chapter 4.1.4), Water(Calcium) and
Calcium(Water) material density data, as well as for additional variations in image thickness
and recon filter (Table 4.4).
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Table 4.4: Dual-energy reconstructions for intracranial lesion phantom protocol (detailed in
Table 4.3). Prospective recons are listed first and labeled with a P, followed by retrospective
recons labeled with an R.
Recon

Image Thickness (mm)

DFOV (cm)

Filter

DE Recon

P2
P3
P4
P5
P6

1.25
2.5
3.75
5
1.25

25
25
25
25
25

Standard
Standard
Standard
Standard
Standard

Water/Ca
Water/Ca
Water/Ca
Water/Ca
Ca/Water

P7
P8
P9
P10
R1
R2

2.5
3.75
5
1.25
2.5
3.75

25
25
25
25
25
25

Standard
Standard
Standard
Standard
Standard
Standard

Ca/Water
Ca/Water
Ca/Water
Optimal keV
Optimal keV
Optimal keV

R3

5

25

Standard

Optimal keV

R4
R5

1.25
2.5

25
25

Soft
Soft

Water/Ca
Water/Ca

R6
R7
R8
R9
R10
R11

3.75
5
1.25
2.5
3.75
5

25
25
25
25
25
25

Soft
Soft
Soft
Soft
Soft
Soft

Water/Ca
Water/Ca
Ca/Water
Ca/Water
Ca/Water
Ca/Water

R12
R13
R14
R15

1.25
2.5
3.75
5

25
25
25
25

Soft
Soft
Soft
Soft

Optimal keV
Optimal keV
Optimal keV
Optimal keV

R16
R17
R18
R19

1.25
2.5
3.75
5

25
25
25
25

Detail
Detail
Detail
Detail

Water/Ca
Water/Ca
Water/Ca
Water/Ca

R20
R21
R22
R23
R24
R25

1.25
2.5
3.75
5
1.25
2.5

25
25
25
25
25
25

Detail
Detail
Detail
Detail
Detail
Detail

Ca/Water
Ca/Water
Ca/Water
Ca/Water
Optimal keV
Optimal keV

R26
R27

3.75
5

25
25

Detail
Detail

Optimal keV
Optimal keV
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Data collection was repeated three times to form three separate studies. Studies 1
and 2 were performed on a single scanner, hereafter referred to as Scanner 1, while Study
3 was performed on a different scanner, hereafter referred to as Scanner 2. Repeat
analysis was performed to allow for combined data with reduced noise, as well as to assess
the inter-scanner and intra-scanner repeatability of this technique.

4.1.6

Data Organization and Structure

4.1.6.1 SQL Database
Because a large amount of image data were collected as part of this experiment, an
SQL database was built in 3DSlicer (Version 4.3.1) to aid with data sorting and
organization. The database contained one table with data about each series including the
corresponding exam number and path name, and a second table with file names of
individual images. This database was queried in Matlab (Version 2014a, MathWorks) using
Mksqlite (www.sourceforge.net/projects/mksqlite), and the Patient ID, exam number, and
the folder path name for each series were acquired and then stored in a Matlab structure.

4.1.6.2 Series Sorting
For each series, the folder path name was used to access the digital imaging and
communications in medicine (DICOM) header of a representative image and the pitch,
DFOV, image thickness, reconstruction filter, and GSI material/keV were acquired using the
dicominfo function (Image Processing Toolbox 2014a; MathWorks, Natick, MA). These
fields were then added to the existing Matlab structure for each series. In addition, any
series not needed for analysis (i.e. scouts and dose reports) were filtered and discarded.
The remaining series were then sorted first by exam number (which corresponded to the
HU of the lesion model pair), then pitch, reconstruction filter, image thickness, and
material/keV respectively.
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4.1.6.3 Region of Interest Selection
Images were viewed on an Advantage Workstation (AW) using GSI viewer software
(Version 2; GE Healthcare), and the image location extents corresponding to the top slab
and bottom slab were recorded for each exam and each image thickness. Regions-ofinterest (ROIs) corresponding to each of the six cerebral lesion models were placed on a
single image within the cerebrum (Table 4.5). Similarly, ROIs corresponding to both of the
skull base lesion models were placed on a single image in the skull base slab (Table 4.5).
This procedure was repeated for each exam within the study. The ROIs were saved to a
comma-separated-value (.csv) file on the AW, detailing the spatial location of each voxel.
The .csv file for each ROI was then imported into Matlab (2014a; MathWorks, Natick, MA)
and each voxel’s position within the image was extracted from the ROI data file and
converted to its corresponding image array position.

Table 4.5: ROI diameters and associated number of voxels based on lesion model size and
location.

Lesion Model Location
Cerebrum
Skull Base

Lesion Model
Diameter (mm)
15
10
5
15

ROI Diameter
(mm)
12
8
4
12

Number of Voxels
465
216
60
465

In order to allow direct comparison of results from the cerebrum and skull base
lesion models, the number of images analyzed would need to be identical. Since the
cerebrum slab was designed 1 cm thicker than the skull base slab, the number of images
analyzed from the cerebrum slab would need to be reduced to the maximum allowable in
the skull base. The number of available images, and the associated image locations, for
each acquired image thickness was determined using the AW and GSI-viewer software.
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ROIs of 11.25 mm diameter were placed on the two lesion models in the skull base and all
images where both models were within 5 HU of their mean model value were identified.
This image number/location extent was then consolidated to ensure identical extents over
all exams allowing inter-comparison. Due to the position the cerebrum slab within the
cranial cavity of the phantom, a number of images were affected by artifact from the gap
between the base and crown portions of the phantom (Figure 4.4). Images unaffected by
this phantom discontinuity were identified on each acquired image thickness. The image
number/location extents for the cerebrum were then consolidated to match the number of
images determined in the skull base and to ensure identical extents over all exams. The
final number of images and image extents for each acquired image thickness for both the
cerebrum and skull base slab can be found in Table 4.6.

Figure 4.4: Artifact caused by phantom discontinuity.
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Table 4.6: Number of images and extent analyzed for both the cerebrum and skull base brain
slabs.

Image Thickness (mm)
1.25
2.5
3.75
5
Number of Images
Extent (mm)

21
26.25

10
25

6
22.5

4
20

4.1.6.4 Voxel Data Extraction and Organization
Because the protocol included multiple scan groups within the same series (Table
4.3), multiple GSI presets were contained within the same series folder in the database. To
resolve this issue, as well as to isolate images from the cerebrum and skull base regions of
the phantom, a custom Matlab function was created. For each series folder in the structure,
the function read in the image thickness and exam number fields and determined the
appropriate image location extents for the cerebrum and skull base slabs based on Table
4.6. The function then accessed the DICOM header for each image and compared the
image location to the previously determined extents. If the image location was within the
extents for either the cerebrum or skull base brain slabs, this image information was
appended as a new field within the structure. While the DICOM header was open, each
image was also analyzed to determine the GSI preset used during acquisition. The
structure was then reorganized to include GSI preset in its overall organization.
Images tagged as belonging to the cerebrum slab extent were opened in Matlab
using the dicomread fuction (Image Processing Toolbox 2014a; MathWorks, Natick, MA).
The ROIs determined above were then applied to the images and the voxel data
concatenated into a single column vector and saved within the structure. This was
repeated for the skull base slab and a separate single column vector saved within the
structure. Table 4.7 shows the size of these column vectors based on the size of the lesion
model and image thickness of the series in question.
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Table 4.7: Total number of voxels included in analysis for both cerebrum and skull base
brain slabs based on image thickness and lesion diameter. Note: This total includes multiple
image locations as defined by Table 4.6.

Img Thk (mm)

Lesion Diameter (mm)
15

10

5

1.25

9765

4536

1260

2.5

4650

2160

600

3.75

2790

1296

360

5

1860

864

240

The Matlab structure was then collapsed by identifying matched series that had
identical exam number, GSI preset, pitch, image thickness and reconstruction filter fields
but different dual-energy reconstructions: optimal keV, Water(Calcium), or Calcium(Water).
For a given lesion model size and location (i.e. 10 mm diameter and cerebrum brain slab)
the ROI data in the column vectors for these three series were concatenated into an array
where each column represented a different dual-energy reconstruction type. The structure
then contained a list of series, each representing a unique acquisition type. For each
series, three-dimensional dual-energy data was present for all eight lesion models in the
intracranial lesion phantom: six lesion models in the cerebrum (1.5 cm hemorrhage model ,
1.5 cm calcification model, 1.0 cm hemorrhage model, 1.0 cm calcification model, 0.5 cm
hemorrhage model and 0.5 cm calcification model) and two lesion models in the skull base
(1.5 cm hemorrhage model and 1.5 cm calcification model).
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4.1.7

Determination of Differentiation Accuracy

4.1.7.1 Gaussian Mixture Model Analysis
For each series in the Matlab structure, the lesion models were paired based on
matching diameter and brain slab location. For each matched model pair, the threedimensional dual-energy voxel data for both the hemorrhage model and the calcification
model were loaded into Matlab and a three dimensional Gaussian mixture model and plane
analysis were performed as described in Chapter 3.2.5. The results of the GMM analysis,
as well as the matched model pair and series acquisition specifics from all three studies
conducted were printed to a text file and the Matlab workspace saved for future analysis.
Data derived from all three studies were used to assess trends in differentiation accuracy
based on all available lesion and acquisition parameters.

4.1.7.2 Support Vector Machine (SVM) Analysis
For each matched model pair and acquisition type (CTDIvol, image thickness and
recon filter) combination, the three-dimensional dual-energy voxel data for both the
hemorrhage model and calcification model were loaded into Matlab (Version 2014a,
MathWorks). This process was repeated for each exam, to build a distribution including all
SECT attenuation (HU) matched model pairs of the given acquisition parameters. Each
distribution was then analyzed using a Matlab supplied support vector machine (SVM)
process employing a 50% trainer, 50% validation approach. The SVM process determined
the equation of a plane that best separated the hemorrhage and calcification model data
using the trainer data set (Figure 4.5). This plane was then applied to the validation data
set and lesion type assignments were created for each voxel based on its position relative
to the plane. The resulting lesion type assignments for each voxel in the distribution were
then compared to the known voxel origin and the accuracy score was calculated. The
results of the SVM analysis, as well as the matched model pair and series acquisition
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specifics from all three studies conducted were printed to a text file and the Matlab
workspace saved for future analysis. Data derived from all three studies were used to
assess trends in differentiation accuracy based on all available lesion and acquisition
parameters.

Figure 4.5: Support vector machine plane (gray) based on identified support vectors (green)
for the hemorrhage (red) and calcification (blue) distributions.

4.1.7.3 Geometric Bisector (GB) Analysis
For each matched lesion pair and acquisition type distribution to be described in
Section 4.2.6.7, a simplified bisector analysis was performed. Using Matlab, a threedimensional linear regression was performed on both the hemorrhage and calcification data
sets to derive a fit line for both distributions. These two lines of best fit were compared and
the bisector was calculated. A bisector plane was then derived to include the bisector line
in three-dimensional space and be perpendicular to the plane of the data (see section
3.2.5) (Figure 4.6). Each voxel was then assigned a lesion type based on its position
relative to the geometric bisector plane. The resulting lesion type assignments for each
voxel in the distribution were then compared to the known voxel origin and the accuracy
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score was calculated. The results of the GB analysis, as well as the matched model pair
and series acquisition specifics from all three studies conducted were printed to a text file
and the Matlab workspace saved for future analysis. Data derived from all three studies
were used to assess trends in differentiation accuracy based on all available lesion and
acquisition parameters.

Figure 4.6: Geometric bisector plane (gray) shown separating the hemorrhage (red) and
calcification (blue) distributions. Three dimensional linear regressions of the two
distributions and the resulting bisector are shown in as color-matched lines.

4.1.7.4 Generalized Geometric Bisector (GGB) Solution
In order to pursue a generalized geometric bisector plane for optimum
differentiation, a database containing all voxel data collected in Study 1 was constructed
(see Chapter 4.1.6.1). These data were then randomly assigned to equal-sized trainer and
validation datasets. A geometric bisector plane was calculated based on all voxel data
within the trainer dataset. This plane represents the plane of optimal differentiation across
all lesions and acquisition parameters. To determine the effect of lesion and acquisition
parameters on this plane, this analysis was repeated for subsets of the data based on all
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available values within each lesion and acquisition parameter. For example, the full trainer
dataset was divided by image thickness of the protocol into 1.25 mm, 2.5 mm, 3.75 mm and
5 mm datasets. All data acquired using a given image thickness were used to create an
image thickness-specific plane, including data from all lesions and other acquisition
parameters. The general trainer dataset plane, and the parameter-specific planes, were
each applied to the full validation dataset and the accuracy of differentiation was calculated.
Each parameter-specific accuracy value was then compared to the general trainer dataset
accuracy value to determine major sources of variability in the definition of the geometric
bisector plane.

4.1.7.5 Inter-Method Correlation
To assess the correlation between the geometric bisector (GB) and support vector
machine (SVM) analysis methods, Bland-Altman and correlation graphs were created. To
assess sources of variability in this correlation, the analysis was repeated for subsets of the
data based on all available parameters: CTDIvol, rotation time, image thickness, study, and
lesion size and location. Investigation of rotation time was included due to its impact on
other concurrent projects (Chapter 6). Each parameter was investigated separately, while
including all values for other variables. For example, investigation of variability by image
thickness resulted in four graphs representing the investigated values (1.25, 2.5, 3.75 and 5
mm) with each graph containing all data from each of the other acquisition parameters
(CTDIvol, rotation time, study and lesion size and location). For all analyses, the coefficient
of variation (CV) was tabulated as a measure of data correlation, while the square of the
Pearson r-value (R2) was tabulated as a measure of correlation linearity. The CV and R2
from these parameter value specific Bland-Altman and correlation graphs were compared
to the values derived from Bland-Altman and correlation graphs for the full data set. Based
on visual assessment of minor and major sources of variability, static evaluation criteria
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were determined to facilitate comparison of correlation data. Parameter-value specific R2
values under 0.75 or CV values greater than 150% of the full data CV value were chosen
as cutoff criteria for the identification of major sources of variability in the method
correlation. Specific parameter values identified as major sources of variability were then
removed from the full data set and the Bland-Altman analysis was repeated.

4.1.8

Inter-Scanner and Intra-Scanner Correlation
To assess inter-scanner and intra-scanner correlation, Bland-Altman and correlation

graphs were created. Inter-scanner correlation was defined as the comparison of Study 1,
performed on Scanner 1, to Study 3, performed on Scanner 2. Intra-scanner correlation
was defined as the comparison of Study 1, performed on Scanner 1, to Study 2, performed
on Scanner 1. To assess sources of variability in this correlation, the analysis was
repeated for subsets of the data based on all available parameters: CTDIvol, rotation time,
image thickness, analysis method, and lesion size and location. Analysis was performed as
described in Chapter 4.1.7.5.

4.1.9

Validation of Lesion Attenuation

4.1.9.1 SECT attenuation (HU) correlation with optimal keV HU
Verification of the selection of the optimum keV for dual-energy CT scanning of
intracranial lesions was performed on Study 1.
The attenuation in HU derived from the optimal SECT corollary keV reconstructions
(determined in Chapter 4.1.4) for all DECT protocol variations were compared to SECT
attenuation in HU from reconstructions with matched image thickness and reconstruction
filter for each lesion model used in the study. Given that the SECT protocol was acquired
at a single dose level, comparisons were made between the single SECT protocol and each
CTDIvol value within the DECT protocol set. For each lesion model
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(Calcification/Hemorrhage, SECT attenuation (HU) level, lesion size and location) the mean
and standard deviation of the error in HU between the SECT and optimal keV methods was
calculated across all DECT protocol variations.
Bland-Altman analysis was performed to assess the correlation between the SECT
attenuation (HU) and optimal keV HU values. To assess sources of variability, the analysis
was repeated for subsets of the data based on all available parameters: CTDIvol, rotation
time, image thickness, lesion identity and lesion size and location (See Chapter 4.1.7.5).
The CV and R2 from the parameter-value specific Bland-Altman analyses were compared
to the values derived from the analysis of the full data set. Parameter-value specific R2
values under 0.75 or CV values greater than 150% of the full data CV value were identified
as major sources of variability in the method correlation. Specific parameter values
identified as major sources of variability were then removed from the full data set and the
Bland-Altman analysis was repeated.

4.1.9.2 Lesion Matching using SECT and optimal keV
To ensure the matching of the calcification and hemorrhage models within the
matched model pair, the difference in attenuation (HU) was calculated based on both SECT
and optimal keV attenuation. This was repeated for each matched model pair (SECT
attenuation (HU) level, lesion size and location) and the mean and standard deviation of the
difference in attenuation (HU) between the calcification and hemorrhage was calculated for
SECT and optimal keV image types across all DECT protocol variations.

4.2
4.2.1

Results
Spectrally Equivalent Brain Material
While all potential brain materials supplied by Gammex were equivalent to brain

tissue using a single-energy acquisition (data not shown), the materials possessed very
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different spectral characteristics using a dual-energy acquisition. The results of the spectral
HU analysis can be seen in Figure 4.7. The stock Gammex brain material, shown in the
figure as Gammex A, was similar to brain tissue on a single-energy acquisition using a 70
keV dual-energy reconstruction but differed greatly from brain tissue with respect to its
spectral signature. Gammex B and C were more spectrally equivalent and ultimately,
Gammex B was selected for our application based on this data.

Figure 4.7: Results of dual-energy analysis for potential spectrally equivalent brain materials.
Spectral data from a clinical brain study (GE, Waukesha, WI; personal contact) is shown in
black.

A sagittal reformat of the polyurethane filled nuclear medicine phantom can be seen
in Figure 4.8. This view indicated the optimal position and thickness for both the cerebrum
and skull base slabs within the cranial cavity. Because the bony anatomy only extends
upwards into the cranial cavity roughly 3 cm, the skull base slab was reduced from its
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planned thickness of 4 cm to 3 cm. The cerebrum brain slab was then positioned in line
with the phantom split so that equal portions of the slab thickness were in the base and
crown portions of the phantom. This position also allowed for some intervening space
between the end of the cerebrum slab and the start of the skull base slab. To simplify
construction, the center of the 4 cm thick cerebrum slab was aligned with the division
between the base and crown of the phantom.

Figure 4.8: Sagittal reformat of intracranial lesion phantom showing potential positioning of
cerebrum and skull base slabs. Red lines show the relative thickness of the cerebrum vs the
skull base brain slabs while the blue dotted line represents the upper bound of the imaging
area affected by the bony anatomy of the skull base.

Due to the organic shape of the phantom cranial cavity, the skull base brain slab
was simplified into its major features and reduced in size slightly to allow for polyurethane
to be poured around it in the final stage of phantom construction. Similarly, the shape of
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the cerebrum brain slab had to be simplified due to the organic shape, as well as, the
mismatch between the base and crown of the phantom. Because the edges of the skull
component of the phantom did not meet perfectly, the outer contour of the slab was
reduced to a simplified transition between the contours of the lower face of the slab to the
contour of the upper face of the slab (Figure 4.9). Additional material was removed as
needed for easy placement and removal of the brain slab. Polyurethane was then added to
the outer contour of the cerebrum slab to fill air gaps left from this simplification and to
ensure a tight fit in the phantom cranial cavity. Due to early experiences with the phantom,
the decision was made to provide some tool to aid the removal of the cerebrum slab from
the base of the phantom. A thin nylon ribbon was cured into the surrounding polyurethane
and fed under the cerebrum slab. This ribbon would then distribute the user’s force to the
whole slab and break the vacuum commonly created between the brain and filler slabs.

Figure 4.9: Simplified structure of cerebrum slab based on upper and lower curvatures with
arrow showing mismatch between phantom base and crown interiors.

61

4.2.2

Lesion Models

Based on the results of the lesion rod imaging and ROI analysis (Chapter 4.1.3),
calcification and hemorrhage lesion models free of any artifact or high variability were
chosen at the required SECT attenuation (HU) levels. Of the 28 lesion model pairs
isolated, only four had greater than 1 HU difference between the calcification and
hemorrhage models based on their mean HU value on the single-energy images (Table
4.8). The image location ranges and series numbers for the chosen lesion model positions
were translated into lengths in mm from the end of the rod and the lesion rods were marked
appropriately for milling.
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Table 4.8: Results of lesion rod imaging and ROI analysis using a SECT acquisition. Green
fields represent a matched model pair with < 1 HU difference between the calcification and
hemorrhage model while orange represents a difference > 1 HU but < 2 HU. Gray regions
represent data that’s not applicable given the skull base contained only 1.5 cm lesion models.

SECT HU Level
40

50

Cerebrum

60

70

80

90

100

40

50

Skull Base

60

70

80

90

100

Model
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair
Calcification
Hemorrhage
Pair

0.5 cm Lesion
Mean SECT HU
40.14
40.11
0.03
50.87
50.92
0.05
60.20
61.17
0.97
70.70
71.40
0.70
79.99
80.68
0.69
89.83
90.22
0.39
100.20
100.14
0.06

1.0 cm Lesion
Mean SECT HU
40.06
40.06
0.00
50.81
50.70
0.11
59.86
60.86
1.01
70.46
71.42
0.96
80.09
80.97
0.88
89.71
90.21
0.50
100.41
100.51
0.10
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1.5 cm Lesion
Mean SECT HU
40.10
40.32
0.22
50.44
50.62
0.18
60.10
61.39
1.29
70.37
71.64
1.26
79.92
80.79
0.87
89.97
90.53
0.56
100.08
99.81
0.27
39.92
40.28
0.36
50.78
50.65
0.13
60.25
61.37
1.12
70.08
71.00
0.93
79.92
80.51
0.59
90.20
90.79
0.59
99.98
99.61
0.37

Initial validation of milled lesion models identified two matched model pairs with suboptimal SECT attenuation (HU) matching (Table 4.9). Two matched attenuation lesion
pairs were identified as exceeding 3 HU error in matching between the calcification and
hemorrhage: 0.5 cm cerebrum lesions at 50 HU and 1.5 cm skull base lesions at 100 HU.
New regions were identified from the reserved lesion model rods for these two SECT
attenuation (HU) levels (50 and 100 HU) and marked for milling. These new lesion models
were imaged using the single-energy protocol detailed in Table 4.3 and compared to the
data from the old lesion models. New matched model pairs were identified which would
have matched attenuation to within 3 HU SECT (Table 4.10).

Table 4.9: Initial SECT attenuation (HU) matching of milled lesion model pairs (calcification
and hemorrhage). Green denotes matching < 2 HU, orange denotes matching < 3 HU and red

Skull Base

Cerebrum

denotes matching out of tolerance > 3 HU.

∆ Mean SECT HU
SECT HU Level 0.5 cm 1.0 cm 1.5 cm
40
0.24 0.21 0.08
3.99 0.22 0.77
50
60
1.14 0.51 1.48
70
2.24 1.42 1.07
80
1.67 1.01 1.61
90
2.24 0.78 0.21
100
2.29 0.80 1.21
40
1.42
50
0.46
60
0.17
70
0.21
80
0.15
90
1.46
3.46
100
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Table 4.10: Final SECT attenuation (HU) matching of lesion model pairs (calcification and
hemorrhage). Green denotes matching < 2 HU, orange denotes matching < 3 HU and red
denotes matching out of tolerance > 3 HU. Note the improved lesion matching of the 50 HU,
0.5 cm cerebrum and 100 HU, 1.5 cm skull base lesion pairs.
∆ SECT Mean

Skull Base

Cerebrum

SECT HU Level 0.5 cm 1.0 cm 1.5 cm

4.2.3

40

0.24

0.21

0.08

50

0.51

0.22

0.77

60

1.14

0.51

1.48

70

2.24

1.42

1.07

80

1.67

1.01

1.61

90

2.24

0.78

0.21

100

2.29

0.80

1.21

40

1.42

50

0.46

60

0.17

70

0.21

80

0.15

90

1.46

100

2.30

Selection of Optimal keV Level for Simulated SECT Scanning
In order to avoid the necessity of a separate single-energy acquisition that would

increase patient dose and motion artifacts, we endeavored to determine the keV of a
monoenergetic reconstruction that could be derived from the dual-energy acquisition but
provide accurate SECT attenuation (HU) data. Using the monoenergetic keV and the
resulting attenuation (HU), a second order polynomial was used to determine the
monoenergetic kVp necessary to produce an attenuation (HU) equivalent to that from a
SECT acquisition. This process was repeated for all inserts and dual-energy presets used
in the study. This optimal keV level for simulated single-energy scanning was found to
have a mean of 68 keV with a standard deviation of 1.75 keV. The minimum optimal keV
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across all lesion models and dual-energy protocols was 65 keV while the maximum was 74
keV. The average error in the estimated HU using 68 keV and the SECT acquisition over
all lesion models and dual-energy protocols was found to be 0.3 HU with a standard
deviation of 1.4 HU. The minimum and maximum errors were -2.6 HU and 2.6 HU
respectively.

4.2.4

Validation of Lesion Attenuation

4.2.4.1 SECT attenuation (HU) Correlation with 68 keV HU
Based on lesion data collected during Study 1, mean error was calculated between the
attenuation (HU) estimation by the 68 keV reconstruction and the attenuation from the
SECT acquisition performed as part of the overall protocol (Figure 4.10). Analysis was
divided by lesion identity and includes all protocol variations including reconstruction filter,
CTDIvol and image thickness. Mean errors based on protocol variation were within 3 HU for
all cerebrum lesion models, and within 6 HU for skull base lesion models. Averaging over
all lesion parameters and protocol variations, the average mean error was found to be 0.5
HU and 1 HU for calcification and hemorrhage respectively.
Bland-Altman analysis of the attenuation from 68 keV and SECT for all available
protocol and acquisition parameters resulted in a CV of 2.8% and an R2 of 0.990 (Figure
4.11). Repeated analysis for subsets of the data based on all available parameters yielded
no major sources of variability based on the stated criteria (Table 4.11).
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Figure 4.10: Error in attenuation (HU) measurement between SECT and 68 keV
reconstructions for both calcification and hemorrhage models. Error bars represent one
standard deviation (SD) of the distribution accounting for all image thickness, CTDI vol and
reconstruction filter protocol variations.

Figure 4.11: Bland-Altman and Correlation graphs for the correlation of SECT attenuation
(HU) to 68 keV HU. Data includes all protocol variations and lesion models.
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Table 4.11: Sorted results of Bland-Altman analysis of the correlation of attenuation (HU) from
68 keV and SECT acquisitions organized for subsets of the data based on available protocol
and lesion parameters. Parameters and values above the double line indicate worse
correlation or linearity than the analysis of the full data set while those below the double line
indicate improved correlation or linearity.

CV - Correlation
Full Data CV
Criteria
2.8
150%

Rsquared - Linearity
Full Data R2
Criteria
0.9903
< 0.75

Cutoff
4.2

Value
Lesion Model
1.5 cm Skull Base
CTDIvol
132.6
Image Thickness
2.5
CTDIvol
105.6
CTDIvol
117.1

CV
3.5
3.1
2.9
2.9
2.9

Parameter
CTDIvol
CTDIvol
CTDIvol
CTDIvol
Image Thickness

Value
132.6
99.8
105.6
117.1
2.5

R2
0.988
0.989
0.989
0.989
0.990

Image Thickness
CTDIvol

1.25
81

2.8
2.8

CTDIvol

81
1.5 cm Skull Base

0.990
0.990

CTDIvol
Lesion Identity
Image Thickness
Image Thickness
Rotation Time
Lesion Identity
CTDIvol
Rotation Time
Rotation Time
Rotation Time
CTDIvol
CTDIvol
CTDIvol

99.8
Hemorrhage
3.75
5
0.9
Calcification
67
0.5
0.6
0.8
44.6
54.7
64.2
0.5 cm Cerebrum
0.7
57.9
72.7
36.7
1.0 cm Cerebrum
1.5 cm Cerebrum

2.8
2.8
2.7
2.7
2.7
2.7
2.6
2.6
2.6
2.6
2.5
2.4
2.4
2.4
2.4
2.3
2.3
2.2
1.4
1.3

1.25
Hemorrhage
3.75
Calcification
5
0.5
0.9
0.6
0.8
44.6
67
54.7
64.2
57.9
72.7
0.5 cm Cerebrum
0.7
36.7
1.0 cm Cerebrum
1.5 cm Cerebrum

0.990
0.990
0.991
0.991
0.991
0.991
0.991
0.991
0.992
0.992
0.992
0.993
0.993
0.994
0.994
0.994
0.994
0.995
0.998
0.998

Parameter

Lesion Model

Rotation Time
CTDIvol
CTDIvol
CTDIvol
Lesion Model
Lesion Model

Lesion Model

Image Thickness
Lesion Identity
Image Thickness
Lesion Identity
Image Thickness
Rotation Time
Rotation Time
Rotation Time
Rotation Time
CTDIvol
CTDIvol
CTDIvol
CTDIvol
CTDIvol
CTDIvol
Lesion Model

Rotation Time
CTDIvol
Lesion Model
Lesion Model
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4.2.4.2 Lesion Matching using SECT and 68 keV
Average differences between the calcification and hemorrhage models within each
matched model pair are shown in Figure 4.12 for both 68 keV and SECT acquisitions. Error
bars represent one standard deviation (SD) based on the combined data across all protocol
variations. Based on evaluation using SECT, all matched model pairs had differences in
attenuation of less than 3 HU. Evaluation using 68 keV reconstruction closely followed the
SECT results, however the two methods agreed to a lesser extent in the skull base. This
result is not unexpected given the greater errors between SECT and 68 keV attenuation
measurements in the skull base, shown in Chapter 4.2.4.1.

Figure 4.12: Lesion matching results based on SECT and 68 keV attenuation evaluation.
Values represent mean difference in calcification and hemorrhage models across all available
protocol variations. Error bars represent one SD of this distribution.
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4.2.5

Determination of Differentiation Accuracy
Using the methods described in Chapter 4.1.5 and the scan protocol outlined in

Table 4.3 and Table 4.4, a total of 407,925 images were collected for analysis across the
three studies. Of those images collected, 95,571 images were used to collect a total of
230,517,252 unique voxels used in the analysis of lesion differentiation.

4.2.5.1 Gaussian Mixture Model Analysis
By averaging over all three studies and all imaging techniques investigated, the
effect of lesion size and location on GMM differentiation accuracy can be easily seen
(Figure 4.13). Error bars represent one standard deviation within each distribution.
Differentiation accuracy under 80% is shaded in dark gray while differentiation accuracy
between 80% and 90% is shaded in light gray. Averaged over all imaging protocols
investigated, the maximum average accuracy at 100 HU was 58%, 73% and 97% for the
0.5 cm cerebrum, 1.0 cm cerebrum and 1.5 cm cerebrum matched model pairs
respectively. The maximum average accuracy at 100 HU was 81% for the 1.5 cm skull
base matched model pair, reflecting the more challenging imaging environment of the skull
base.
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Figure 4.13: Accuracy of 3D GMM differentiation for intracranial lesion pairs based on lesion
model size and location. Displayed values represent mean of accuracy across the three
studies and all protocol variations: CTDIvol, image thickness and reconstruction filter. Error
bars represent one SD of the distribution.

Accuracy results were then graphed by relevant protocol factors including CTDI vol,
image thickness and reconstruction filter. In all graphs, darker colored lines were used to
indicate an increase in protocol value; be it an increase in dose level, image thickness, or
perceived noise. Accuracy results graphed by CTDIvol (mGy), revealed increasing GMM
differentiation accuracy with increasing dose level for 1.5 cm lesion models in the cerebrum
and skull base (Figure 4.14). No dose effect was observed in 0.5 cm or 1.0 cm cerebrum
lesion models. The effect of dose on differentiation accuracy was more pronounced at
higher matched model pair SECT attenuation (HU) levels.
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GMM Differentiation Accuracy by CTDIvol (mGy)
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Figure 4.14: Differentiation Accuracy using Gaussian Mixture Model (GMM) method analyzed
by CTDIvol. Displayed values represent mean of accuracy across the three studies and
additional protocol variations: image thickness and reconstruction filter. Error bars represent
one SD for each distribution.

Accuracy results graphed by image thickness (mm), revealed increasing GMM
differentiation accuracy with increasing image thickness (Figure 4.15) for all lesion models
except the 0.5 cm cerebrum. Again, the effect of increased image thickness on
differentiation accuracy was more pronounced at higher matched model pair SECT
attenuation (HU) levels.
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GMM Differentiation Accuracy by Image Thickness (mm)
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Figure 4.15: Differentiation Accuracy using Gaussian Mixture Model (GMM) method analyzed
by image thickness. Displayed values represent mean of accuracy across the three studies
and additional protocol variations: CTDI vol and reconstruction filter. Error bars represent one
SD for each distribution.

Accuracy results graphed by reconstruction filter showed that decreasing smoothing
increased GMM differentiation accuracy in the 1.0 cm cerebrum lesions (Figure 4.16). All
other lesions showed no effect of filter selection on GMM differentiation accuracy. Error
bars represent variation across CTDIvol, image thickness and study and show considerable
overlap between the reconstruction filter types.
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GMM Differentiation Accuracy by Reconsturction Filter
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Figure 4.16: Differentiation Accuracy using Gaussian Mixture Model (GMM) method analyzed
by reconstruction filter. Displayed values represent mean of accuracy across the three
studies and additional protocol variations: CTDIvol and image thickness. Error bars represent
one SD for each distribution

4.2.5.2 Gaussian Mixture Model Instability
Particularly of note from the GMM results was the unexpected plateau in
differentiation accuracy at 80 HU and above for the 1 cm cerebrum matched lesion pair.
Given the similarity in size between these lesion models and the gel vials used in the
physics model (Chapter 3), these results were unexpected. Investigation into the results of
the 1,000 GMMs for all lesion model attenuations for a given acquisition showed that the
distribution of the differentiation accuracies was, in fact, bimodal (Figure 4.17)
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Figure 4.17: Distribution of differentiation accuracy results from 7,000 GMMs (1,000 per
lesion pair) graphed versus the attenuation of lesion pair. Data represents 67 mGy CTDIvol,
3.75 mm image thickness, standard filter acquisition of 1 cm cerebrum matched lesion pairs.

Further analysis pursued by plotting the component accuracies, calcification model
accuracy and hemorrhage model accuracy, with the general matched model pair result
(Figure 4.18). The general matched model pair accuracy was in all cases primarily affected
by the calcification model component accuracy, while the hemorrhage model component
accuracy was always greater than 80%.
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Figure 4.18: Differentiation accuracy results for calcification model, hemorrhage model and
combined matched model pair. Error bars represent standard deviation in accuracy value
over the 1,000 GMM repetitions. Data represents 67 mGy CTDIvol, 3.75 mm image thickness,
standard filter acquisition of 1 cm cerebrum matched lesion pairs.

The 80 HU matched lesion pair data for this acquisition method was visualized and
seen to be non-Gaussian in nature (Figure 4.19). Outliers are assumed to be a result of
inadequate mixing of the compound additives, calcium carbonate or iron oxide, into the
background material leaving areas of reduced attenuation. Given that the prime
assumption of a Gaussian data distribution was invalidated, the GMM iterative fit of the two
potentially overlapping Gaussian distributions was unstable resulting in two general
solutions. The first solution yielded hemorrhage and calcification distributions that included
their respective outliers resulting in high calcification model accuracy and high overall
matched model pair accuracy. The second solution yielded a hemorrhage distribution
covering both the calcification and hemorrhage main distributions and a calcification
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distribution covering all outliers. This resulted in a low calcification model accuracy and
thus high overall matched model pair accuracy.

Figure 4.19: Top: Raw voxel data from a CTDIvol, 3.75 mm image thickness, standard filter
acquisition of 1 cm cerebrum matched lesion pairs at 80 HU. Lower Left: GMM solution
resulting in high calcification model and overall matched model pair accuracies. Lower
Right: GMM solution resulting in low calcification model and overall matched model pair
accuracies.

Based on these results revealing the instability of the GMM analysis, this method
was dropped from all further analysis, including Studies 2 and 3. Only the geometric
bisector and support vector machine methods were retained.

77

4.2.5.3 Support Vector Machine (SVM) Analysis
By averaging over all three studies and all imaging techniques investigated, the
effect of lesion size and location on SVM differentiation accuracy can be easily seen (Figure
4.20). Error bars represent one standard deviation within each distribution. Differentiation
accuracy under 80% is shaded in dark gray while differentiation accuracy between 80% and
90% is shaded in light gray. Averaged over all imaging protocols investigated, the
maximum average accuracy at 100 HU was 78%, 92% and 96% for the 0.5 cm cerebrum,
1.0 cm cerebrum and 1.5 cm cerebrum matched model pairs respectively. The maximum
average accuracy at 100 HU was 90% for the 1.5 cm skull base matched model pair,
reflecting the more challenging imaging environment of the skull base.
Compared to GMM analysis (Figure 4.13), SVM analysis increased the average
maximum differentiation accuracy by 20% for 0.5 cm cerebrum lesions, 29% for 1.0 cm
cerebrum lesions and 8% for 1.5 cm skull base lesions. No improvement was seen in 1.5
cm cerebrum lesions.

78

Overall SVM Differentiation Accuracy
100

Differentiation Accuracy

90
80
70
60
50

40
50
60
70
80
90
100
40
50
60
70
80
90
100
40
50
60
70
80
90
100
40
50
60
70
80
90
100

40

0.5

1

1.5

Cerebrum

SECT HU Level

1.5

Lesion Size (cm)

Skull Base

Location

Figure 4.20: Differentiation accuracy using support vector machine method. Displayed
values represent mean of accuracy across the three studies and all protocol variations:
CTDIvol, image thickness and reconstruction filter. Error bars represent one SD of the
distribution.

Accuracy results were then graphed by relevant protocol factors including CTDI vol,
image thickness and reconstruction filter. In all graphs, darker colored lines were used to
indicate an increase in protocol value; be it an increase in dose level, image thickness, or
perceived noise. Accuracy results graphed by CTDIvol (mGy), revealed increasing SVM
differentiation accuracy with increasing dose level (Figure 4.21). Note that error bars
represent variation across image thickness, reconstruction filter and study. The effect of
dose on differentiation accuracy was more pronounced at higher matched model pair SECT
attenuation (HU) levels.
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SVM Differentiation Accuracy by CTDIvol (mGy)
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Figure 4.21: Differentiation accuracy using support vector machine method analyzed by
CTDIvol. Displayed values represent mean of accuracy across the three studies and additional
protocol variations: image thickness and reconstruction filter. Error bars represent one SD
for each distribution.

Accuracy results graphed by image thickness (mm), revealed increasing SVM
differentiation accuracy with increasing image thickness (Figure 4.22). In this case, error
bars represent variation across CTDIvol, reconstruction filter and study. Again, the effect of
increased image thickness on differentiation accuracy was more pronounced at higher
matched model pair SECT attenuation (HU) levels.
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SVM Differentiation Accuracy by Image Thickness (mm)
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Figure 4.22: Differentiation accuracy using support vector machine method analyzed by
image thickness. Displayed values represent mean of accuracy across the three studies and
additional protocol variations: CTDIvol and reconstruction filter. Error bars represent one SD
for each distribution.

Accuracy results graphed by reconstruction filter showed no effect of filter selection
on SVM differentiation accuracy (Figure 4.23). Error bars represent variation across
CTDIvol, image thickness and study and show considerable overlap between the
reconstruction filter types. Based on these results, further analysis and visualization of
support vector machine data was limited to Standard filter to facilitate viewing of the multidimensional data gathered in this study.
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Figure 4.23: Differentiation accuracy using support vector machine method analyzed by
reconstruction filter. Displayed values represent mean of accuracy across the three studies
and additional protocol variations: CTDIvol and image thickness. Error bars represent one SD
for each distribution.

Surface plots for the SVM differentiation accuracy based on attenuation (HU) level
of the matched model pair and the CTDIvol of the acquisition were created for all lesion
sizes and locations (Figure 4.24, Figure 4.25). Data for all image thickness values
investigated are shown; all data shown are based on a Standard reconstruction filter. A
transparent gray plane was included to show 90% differentiation accuracy. The array of
plots shows the effect of these lesion (size and location) and acquisition parameters on the
final SVM differentiation accuracy. Increasing CTDIvol, attenuation (HU) level of the
matched model pair, image thickness and lesion size all resulted in increased SVM
differentiation accuracy.
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83

higher accuracies). The gray plane is fixed at 90% differentiation accuracy.

used for all visualizations. Color bar provided to assist in visualization of higher accuracy results (warmer colors correspond with

attenuation (HU) of the lesion pair (x-axis, right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses. Standard filter

Figure 4.24: Surface plots for SVM differentiation accuracy (z-axis) for 0.5 cm and 1.0 cm cerebrum matched model pairs based on the
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correspond with higher accuracies). The gray plane is fixed at 90% differentiation accuracy.

Standard filter used for all visualizations. Color bar provided to assist in visualization of higher accuracy results (warmer colors

based on the attenuation (HU) of the lesion pair (x-axis, right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses.

Figure 4.25: Surface plots for SVM differentiation accuracy (z-axis) for 1.5 cm cerebrum and 1.5 cm skull base matched model pairs

Based on a second order power fit of available data from studies 1-3, the CTDIvol
(mGy) to ensure 90% SVM differentiation accuracy for a given matched model pair
attenuation (HU) was calculated. The results of this calculation for all available SECT
attenuation (HU) levels and image thicknesses are shown in Table 4.12. Given that
reconstruction filter was found to have no effect on differentiation accuracy, the results were
limited to the standard filter to facilitate visualization of the data.
Curve fits of 90-100 HU 1 cm lesions in the cerebrum estimating dose necessary for
90% SVM differentiation accuracy resulted in CTDIvol values below the minimum
investigated level using 3.75 or 5 mm thick images. This implies that all dose levels
investigated would result in 90% differentiation accuracy using SVM method and 3.75-5 mm
thick images. This was also the case for 1.5 cm cerebrum lesions of 90-100 HU acquired
with 3.75 or 5 mm thick images. With the exception of 100 HU lesions acquired with 3.75-5
mm thick images, none of the 0.5 cm cerebrum lesions were differentiated with greater than
90% accuracy for any of the CTDIvol levels currently available for use on the DECT scanner.
In addition, a second order power fit of available data from studies 1-3 was used to
calculate the attenuation (HU) to ensure 90% SVM differentiation accuracy assuming a
specific CTDIvol (mGy) value. The results of this calculation for all available CTDIvol values
and image thicknesses are shown in Table 4.13. Given that reconstruction filter was found
to have no effect on differentiation accuracy, the results were limited to the standard filter to
facilitate visualization of the data. In general, the curve fit for 0.5 cm cerebrum lesions
resulted in attenuation values above 100 HU for most CTDIvol and image thickness
combinations. This implies that investigation of 0.5 cm cerebrum lesions using these
methods would not provide additional information beyond that already available using
SECT. Curve fits for 1.5 cm cerebrum lesions resulted in attenuation values under 100 HU
using all CTDIvol values investigated using either 3.75 or 5 mm image thickness. In general,
the HU value to ensure 90% differentiation accuracy decreased with both increasing image
85

thickness and CTDIvol, as expected. A graphical representation of these data is shown in
Figure 4.26 with the shaded region representing lesion attenuations already differentiable
using conventional SECT. The un-shaded region, therefore, represents previously undifferentiable lesion attenuations now differentiable with high accuracy using various DECT
imaging techniques.
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Table 4.12: CTDIvol (mGy) necessary for 90% SVM differentiation accuracy by HU of matched model pair based on a second order power

SECT HU Level of
Matched Model Pair
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Table 4.13: Lesion attenuation (HU) necessary for 90% SVM differentiation accuracy by acquisition parameters based on a second

CTDIvol (mGy)

SECT HU Predicted for 90% Differentiation Accuracy

Minimum SECT HU for 90% SVM Differentiation Accuracy by CTDIvol (mGy)
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Figure 4.26: Graphical representation of lesion attenuation (HU) necessary for 90% SVM
differentiation accuracy by acquisition parameters (Table 4.13). The un-shaded region
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the
current clinical limit of 100 HU imposed by SECT.

4.2.5.4 Geometric Bisector (GB) Analysis
By averaging over all three studies and all imaging techniques investigated, the
effect of lesion size and location on GB differentiation accuracy can be easily seen (Figure
4.27). Error bars represent one standard deviation within each distribution. Differentiation
accuracy under 80% is shaded in dark gray while differentiation accuracy between 80% and
90% is shaded in light gray. Averaged over all imaging protocols investigated, the
maximum average accuracy at 100 HU was 77%, 92% and 95% for the 0.5 cm cerebrum,
1.0 cm cerebrum and 1.5 cm cerebrum matched model pairs respectively. The maximum
average accuracy at 100 HU was 91% for the 1.5 cm skull base matched model pair,
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reflecting the more challenging imaging environment of the skull base. The average
differentiation accuracies predicted for 100 HU lesions for SVM (Figure 4.20) and GB
analyses were within 1%, potentially indicating a high degree of correlation between the
methods.
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Figure 4.27: Differentiation accuracy using geometric bisector method. Displayed values
represent mean of accuracy across the three studies and all protocol variations: CTDIvol,
image thickness and reconstruction filter. Error bars represent one SD of the distribution.

Accuracy results were then graphed by relevant protocol factors including CTDI vol,
image thickness and reconstruction filter. In all graphs, darker colored lines were used to
indicate an increase in protocol value; be it an increase in dose level, image thickness, or
perceived noise. Accuracy results graphed by CTDIvol (mGy), revealed increasing GB
differentiation accuracy with increasing dose level (Figure 4.28). Note that error bars
represent variation across image thickness, reconstruction filter and study. The effect of
90

dose on differentiation accuracy was more pronounced at higher matched model pair SECT
attenuation (HU) levels.
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Figure 4.28: Differentiation accuracy using geometric bisector method analyzed by CTDIvol.
Displayed values represent mean of accuracy across the three studies and additional
protocol variations: image thickness and reconstruction filter. Error bars represent one SD
for each distribution.

Accuracy results graphed by image thickness (mm), revealed increasing GB
differentiation accuracy with increasing image thickness (Figure 4.29). In this case, error
bars represent variation across CTDIvol, reconstruction filter and study. Again, the effect of
increased image thickness on differentiation accuracy was more pronounced at higher
matched model pair SECT attenuation (HU) levels.
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Figure 4.29: Differentiation accuracy using geometric bisector method analyzed by image
thickness. Displayed values represent mean of accuracy across the three studies and
additional protocol variations: CTDIvol and reconstruction filter. Error bars represent one SD
for each distribution.

Accuracy results graphed by reconstruction filter showed no effect of filter selection
on GB differentiation accuracy (Figure 4.30). Error bars represent variation across CTDIvol,
image thickness and study and show considerable overlap between the reconstruction filter
types. Based on these results, further analysis and visualization of geometric bisector data
was limited to Standard filter to facilitate viewing of the multi-dimensional data gathered in
this study.
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Figure 4.30: Differentiation accuracy using geometric bisector method analyzed by
reconstruction filter. Displayed values represent mean of accuracy across the three studies
and additional protocol variations: CTDIvol and image thickness. Error bars represent one SD
for each distribution.

Surface plots for the GB differentiation accuracy based on attenuation (HU) level of
the matched model pair and the CTDIvol of the acquisition were created for all lesion sizes
and locations (Figure 4.31, Figure 4.32). Data for all image thickness values investigated
are shown; all data shown are based on a Standard reconstruction filter. A transparent
gray plane was included to show 90% differentiation accuracy. The array of plots shows
the effect of these lesion (size and location) and acquisition parameters on the final GB
differentiation accuracy. Increasing CTDIvol, attenuation (HU) level of the matched model
pair, image thickness and lesion size all result in increased GB differentiation accuracy.
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higher accuracies). The gray plane is fixed at 90% differentiation accuracy.

used for all visualizations. Color bar provided to assist in visualization of higher accuracy results (warmer colors correspond with

attenuation (HU) of the lesion pair (x-axis, right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses. Standard filter

Figure 4.31: Surface plots for GB differentiation accuracy (z-axis) for 0.5 cm and 1.0 cm cerebrum matched model pairs based on the
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correspond with higher accuracies). The gray plane is fixed at 90% differentiation accuracy.

Standard filter used for all visualizations. Color bar provided to assist in visualization of higher accuracy results (warmer colors

on the attenuation (HU) of the lesion pair (x-axis, right) and the CTDIvol of the acquisition (y-axis, left) for all image thicknesses.

Figure 4.32: Surface plots for GB differentiation accuracy (z-axis) for 1.5 cm cerebrum and 1.5 cm skull base matched model pairs based

Based on a second order power fit of available data from studies 1-3, the CTDIvol
(mGy) to ensure 90% GB differentiation accuracy for a given matched model pair
attenuation (HU) was calculated. The results of this calculation for all available SECT
attenuation (HU) levels and image thicknesses are shown in Table 4.14. Given that
reconstruction filter was found to have no effect on differentiation accuracy, the results were
limited to the standard filter to facilitate visualization of the data.
Curve fits for 100 HU 1 cm lesions in the cerebrum estimating dose necessary for
90% GB differentiation accuracy resulted in CTDIvol values below the minimum investigated
level when using 5 mm image thickness. This implies that all dose levels investigated
would result in 90% differentiation accuracy using the GB method and 5 mm-thick images.
This was also the case for 1.5 cm cerebrum lesions of 90 to 100 HU acquired with 3.75 or 5
mm-thick images. None of the 0.5 cm cerebrum lesions were differentiated with greater
than 90% accuracy for any of the CTDIvol levels currently available for use on the DECT
scanner.
In addition, a second order power fit of available data from studies 1-3 was used to
calculate the attenuation (HU) to ensure 90% GB differentiation accuracy assuming a
specific CTDIvol (mGy) value. The results of this calculation for all available CTDIvol values
and image thicknesses are shown in Table 4.15. Given that reconstruction filter was found
to have no effect on differentiation accuracy, the results were limited to the standard filter to
facilitate visualization of the data.
With the possible exception of 105.6 and 132.6 mGy acquisitions reconstructed at 5
mm image thickness, curve fits for 0.5 cm cerebrum lesions resulted in attenuation values
above 100 HU for all CTDIvol and image thickness combinations. This implies that
investigation of 0.5 cm cerebrum lesions using these methods would not provide additional
information beyond that already available using SECT. Curve fits for 1.5 cm cerebrum
lesions resulted in attenuation values under 100 HU using all CTDIvol values investigated
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using either 3.75 or 5 mm image thickness. In general, the HU value to ensure 90%
differentiation accuracy decreased with both increasing image thickness and CTDIvol, as
expected. A graphical representation of these data is shown in Figure 4.33 with the shaded
region representing lesion attenuations already differentiable using conventional SECT. The
un-shaded region, therefore, represents previously un-differentiable lesion attenuations now
differentiable with high accuracy using various DECT imaging techniques.
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Table 4.14: CTDIvol (mGy) necessary for 90% GB differentiation accuracy by HU of matched model pair based on a second order power

SECT HU Level of
Matched Model Pair
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Table 4.15: Lesion attenuation (HU) necessary for 90% GB differentiation accuracy by acquisition parameters based on a second order

CTDIvol (mGy)

SECT HU Predicted for 90% Differentiation Accuracy

Minimum SECT HU for 90% GB Differentiation Accuracy by CTDIvol (mGy)
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Figure 4.33: Graphical representation of lesion attenuation (HU) necessary for 90% GB
differentiation accuracy by acquisition parameters (Table 4.15). The un-shaded region
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the
current clinical limit of 100 HU imposed by SECT.

4.2.5.5 Generalized Geometric Bisector (GGB) Solution
The results of the parameter-specific geometric bisector planes can be seen in Table
4.16. The major sources of variability identified were the 0.5 cm cerebrum lesions and 1.5
cm skull base lesions. All other accuracy differences were less than 2%. Plane coefficients
were remarkably stable across parameter-specific solutions. The equations for the three
generalized geometric bisector plane solutions can be found in Table 4.17.
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Table 4.16: Results of parameter-specific geometric bisector plane calculations. Both raw
accuracy and accuracy difference (relative to all data solution) are shown. Plane coefficients
follow the equation form Ax+By+Cz+D = 0, where x is water density, y is calcium density and
z is measured attenuation (HU) at 68 keV. Those parameters identified as major sources of
variability based on their accuracy difference are shown in red. Note: Location (Skull Base)
and Lesion Model (1.5 cm Skull Base) represent identical analysis because only 1.5 cm
lesions were evaluated in the skull base.
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Plane Equation Coefficients
Parameter

Value

A

B

C

D

Accuracy

Lesion Model

0.5 cm Cerebrum

-0.93

0.37

0.03

939.94

69.82

Accuracy
Difference
-5.74

Location

Skull Base

-0.94

0.33

-0.07

950.47

73.31

-2.26

Lesion Model
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Table 4.17: Generalized geometric bisector plane results assuming prior knowledge of lesion
location and size. Plane coefficients follow the equation form Ax+By+Cz+D = 0, where x is
water density, y is calcium density and z is measured attenuation (HU) at 68 keV.
Plane Equation Coefficients
Lesion Population

A

B

C

D

Cerebrum Lesions ≤ 0.5 cm diameter

-0.93

0.37

0.03

939.94

Cerebrum Lesions > 0.5 cm diameter

-0.94

0.33

-0.07

956.15

Skull Base Lesions

-0.94

0.33

-0.07

950.47

4.2.5.6 Inter-Method Correlation
Inter-method correlation of geometric bisector and support vector machine resulted
in a CV correlation of 2.6% and R2 linearity of 0.980. Repeated analysis for subsets of the
data based on all available parameters yielded one major source of variability based on CV
and R2 cutoff criteria: 0.5 cm Cerebrum matched model pairs (Table 4.18). Bland-Altman
and correlation graphs for the full data as well as the 0.5 cm Cerebrum matched model pair
data can be seen in Figure 4.34. Removing these data from analysis reduced the overall
CV correlation to 1.7% and increased the R2 linearity to 0.988.
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Table 4.18: Sorted results of Bland-Altman analysis for inter-method correlation between
SVM and GB methods for subsets of data based on available protocol and lesion parameters.
Parameters and values above the double line indicate worse correlation or linearity than the
full data set while those below the double line indicate improved correlation or linearity. Text
2

in red indicates a major source of variability based on CV or R cutoff criteria.

CV – Correlation
Full Data CV
Criteria
2.61
150%
Parameter

Cutoff
3.92

CTDIvol
ImageThickness
CTDIvol
CTDIvol
ImageThickness
CTDIvol
RotationTime
CTDIvol
RotationTime
CTDIvol
Study

Value
0.5 cm Cerebrum
36.7
5
54.7
132.6
3.75
72.7
0.9
105.6
0.6
99.8
3

R2
0.942
0.974
0.976
0.976
0.977
0.977
0.977
0.977
0.978
0.978
0.979
0.979

2.6

CTDIvol

81.4

0.980

2.6
2.5
2.5
2.5
2.5
2.45
2.5
2.5
2.4
2.3
2.3
2.1
2.1
1.6
1.2

RotationTime
RotationTime
Study
CTDIvol
CTDIvol
RotationTime
Study
ImageThickness
CTDIvol
CTDIvol
CTDIvol

0.7
0.5
1
44.6
57.9
0.8
2
2.5
117.1
64.2
67
1.5 cm Skull Base
1.25
1.0 cm Cerebrum
1.5 cm Cerebrum

0.981
0.981
0.981
0.981
0.981
0.981
0.981
0.982
0.982
0.983
0.983
0.984
0.985
0.985
0.994

ImageThickness
CTDIvol
Study
CTDIvol
ImageThickness
CTDIvol
CTDIvol
RotationTime
CTDIvol
RotationTime
CTDIvol

Value
0.5 cm Cerebrum
3.75
36.7
3
54.7
5
105.6
132.6
0.9
72.7
0.6
57.9

CV
4.9
2.8
2.8
2.8
2.8
2.8
2.8
2.8
2.8
2.67
2.7
2.6

RotationTime

0.7

RotationTime
CTDIvol
CTDIvol
Study
RotationTime
Study
CTDIvol
CTDIvol
ImageThickness
CTDIvol
CTDIvol

0.8
44.6
99.8
1
0.5
2
117.1
81.4
2.5
67
64.2
1.5 cm Skull Base
1.25
1.0 cm Cerebrum
1.5 cm Cerebrum

Lesion Model

Lesion Model

ImageThickness
Lesion Model
Lesion Model

Rsquared - Linearity
Full Data R2
Criteria
0.9803
< 0.75
Parameter
Lesion Model

Lesion Model

ImageThickness
Lesion Model
Lesion Model
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Figure 4.34: Bland-Altman and Correlation graphs for inter-method correlation between SVM
and GB methods. Top: Full data results including all protocol variations and lesion models.
Middle: Results for 0.5 cm cerebrum matched model pair, identified as a major source of
variability in Table 4.18. Bottom: Results for full data excluding 0.5 cm cerebrum matched
model pair values.
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4.2.6

Inter-Scanner and Intra-Scanner Correlation

4.2.6.1 Inter-Scanner Correlation
Support Vector Machine Inter-Scanner Correlation
Inter-scanner correlation of Study 1 and Study 3 based on support vector machine
differentiation accuracy data resulted in a CV correlation of 8.1% and R2 linearity of 0.824.
Repeated analysis for subsets of the data based on all available protocol and lesion
parameters yielded three major sources of variability based on CV and R2 cutoff criteria:
44.6 mGy CTDIvol, 0.5 cm Cerebrum matched model pairs and 0.5sec rotation time (Table
4.19). Bland-Altman and correlation graphs for the full data as well as the parameters and
values identified as major sources of variability can be seen in Figure 4.35. Removing the
data for these major sources of variability from analysis reduced the overall CV correlation
to 4.8% and increased the R2 linearity to 0.908. Note that extreme outliers in the correlation
were influenced by all three major sources of variability: 0.5 cm lesion models scanned
using 44.6 mGy CTDIvol and a 0.5sec rotation time.

106

Table 4.19: Sorted results of Bland-Altman analysis of SVM inter-scanner correlation for
subsets of data based on available protocol and lesion parameters. Parameters and values
above the double line indicate worse correlation or linearity than the full data set while those
below the double line indicate improved correlation or linearity. Text in red indicates a major
2

source of variability based on CV or R cutoff criteria.

CV - Correlation
Full Data CV
Criteria
8.1
150%
Parameter
CTDIvol
Lesion Model

RotationTime
CTDIvol
ImageThickness
CTDIvol
CTDIvol
ImageThickness
RotationTime
RotationTime
CTDIvol
CTDIvol
ImageThickness
RotationTime
CTDIvol
CTDIvol
CTDIvol
CTDIvol
ImageThickness
RotationTime
CTDIvol
Lesion Model
Lesion Model

CTDIvol
Lesion Model

Rsquared - Linearity
Full Data R2
Criteria
0.824
< 0.75

Cutoff
12.2

Value
44.6
0.5 cm Cerebrum
0.5
81.4
3.75
54.7
36.7
5

CV
15.2
14.9
12.5
9.7
9.6
8.5
8.5
8.4

0.7
0.6
57.9
67
2.5
0.9
72.7
99.8
132.6
64.2
1.25
0.8
105.6
1.0 cm Cerebrum
1.5 cm Skull Base
117.1
1.5 cm Cerebrum

7.8
7.7
7.6
7.3
7.3
7.1
7.1
7.0
7.0
6.6
6.3
6.3
5.5
5.5
5.4
5.1
4.1

Parameter
CTDIvol
Lesion Model

RotationTime
CTDIvol
ImageThickness
CTDIvol
ImageThickness
Lesion Model

RotationTime
CTDIvol
CTDIvol
RotationTime
CTDIvol
CTDIvol
ImageThickness
CTDIvol
CTDIvol
RotationTime
ImageThickness
CTDIvol
RotationTime
Lesion Model

CTDIvol
Lesion Model

CTDIvol
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Value
44.6
0.5 cm Cerebrum
0.5
81.4
3.75
36.7
5
1.0 cm Cerebrum

R2
0.467
0.561
0.596
0.756
0.764
0.795
0.802
0.817

0.7
54.7
67
0.6
57.9
99.8
2.5
64.2
72.7
0.9
1.25
132.6
0.8
1.5 cm Skull Base
105.6
1.5 cm Cerebrum
117.1

0.827
0.833
0.840
0.843
0.844
0.850
0.852
0.864
0.864
0.865
0.867
0.870
0.892
0.902
0.916
0.929
0.933
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of variability based on results in Table 4.19. Lower Left: Analysis of full data with the data associated with these major sources of variability removed.

Figure 4.35: Bland-Altman and correlation graphs for SVM inter-scanner correlation. Upper Left: Analysis of full data. Right: Analysis of major sources

Geometric Bisector Inter-Scanner Correlation
Inter-scanner correlation of Study 1 and Study 3 based on geometric bisector
differentiation accuracy data resulted in a CV correlation of 8.3% and R2 linearity of 0.814.
Repeated analysis for subsets of the data based on all available protocol and lesion
parameters yielded three major sources of variability based on CV and R2 cutoff criteria:
44.6 mGy CTDIvol, 0.5 cm Cerebrum matched model pairs and 0.5sec rotation time (Table
4.20). Based solely on R2 criteria, an additional two parameters were identified as major
sources of variability: 81.4 mGy CTDIvol and 3.75 mm image thickness. Bland-Altman and
correlation graphs for the full data as well as the parameters and values identified as major
sources of variability by both CV and R2 cutoffs can be seen in Figure 4.36. Removing the
data for these major sources of variability from analysis reduced the overall CV correlation
to 4.6% and increased the R2 linearity to 0.915. Note that extreme outliers in the correlation
were influenced by all three major sources of variability: 0.5 cm lesion models scanned
using 44.6 mGy CTDIvol and a 0.5sec rotation time.
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Table 4.20: Sorted results of Bland-Altman analysis of GB inter-scanner correlation for
subsets of data based on available protocol and lesion parameters. Parameters and values
above the double line indicate worse correlation or linearity than the full data set while those
below the double line indicate improved correlation or linearity. Text in red indicates a major
2

source of variability based on CV or R cutoff criteria.

CV - Correlation
Full Data CV
Criteria
8.3
150%
Parameter

Cutoff
12.4

RotationTime
CTDIvol
ImageThickness
CTDIvol
ImageThickness

Value
44.6
0.5 cm Cerebrum
0.5
81.4
3.75
36.7
5

R2
0.453
0.515
0.581
0.717
0.738
0.772
0.796

8.0

Lesion Model

1.0 cm Cerebrum

0.812

7.9
7.6
7.6
7.4
7.2
7.2
7.1
7.0
6.7
6.7
6.6
6.3
6.2
6.1
5.7
4.7
4.3

RotationTime
ImageThickness
CTDIvol
CTDIvol
CTDIvol
CTDIvol
RotationTime
CTDIvol
CTDIvol
RotationTime
ImageThickness
RotationTime
CTDIvol
CTDIvol
CTDIvol

0.7
2.5
54.7
57.9
72.7
99.8
0.6
67
64.2
0.9
1.25
0.8
132.6
105.6
117.1
1.5 cm Cerebrum
1.5 cm Skull Base

0.822
0.841
0.842
0.843
0.843
0.844
0.846
0.848
0.860
0.865
0.868
0.874
0.881
0.890
0.895
0.926
0.927

CTDIvol
RotationTime
CTDIvol
ImageThickness
CTDIvol
ImageThickness

Value
0.5 cm Cerebrum
44.6
0.5
81.4
3.75
36.7
5

CV
15.2
15.0
12.6
10.3
9.9
8.8
8.4

CTDIvol

54.7

RotationTime
CTDIvol
RotationTime
ImageThickness
CTDIvol
CTDIvol
CTDIvol
RotationTime
CTDIvol
RotationTime
CTDIvol
CTDIvol
ImageThickness
CTDIvol

0.7
57.9
0.6
2.5
72.7
67
99.8
0.9
132.6
0.8
64.2
105.6
1.25
117.1
1.0 cm Cerebrum
1.5 cm Skull Base
1.5 cm Cerebrum

Lesion Model

Lesion Model
Lesion Model
Lesion Model

Rsquared - Linearity
Full Data R2
Criteria
0.814
< 0.75
Parameter
CTDIvol
Lesion Model

Lesion Model
Lesion Model
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visualization. Lower Left: Analysis of full data with the data associated with these major sources of variability removed

of variability based on both CV and R cutoff criteria (Table 4.20). Sources of variability identified solely by R criteria were excluded for simplicity of

2

Figure 4.36: Bland-Altman and correlation graphs for GB inter-scanner correlation. Upper Left: Analysis of full data. Right: Analysis of major sources

4.2.6.2 Intra-Scanner Correlation
Support Vector Machine Intra-Scanner Correlation
Intra-scanner correlation of Study 1 and Study 2 based on support vector machine
differentiation accuracy data resulted in a CV correlation of 6.2% and R2 linearity of 0.886.
Repeated analysis for subsets of the data based on all available protocol and lesion
parameters yielded two major sources of variability based on CV and R2 cutoff criteria: 44.6
mGy CTDIvol and 0.5 cm Cerebrum matched model pairs (Table 4.21). Bland-Altman and
correlation graphs for the full data as well as the parameters and values identified as major
sources of variability can be seen in Figure 4.37. Removing the data for these major
sources of variability from analysis reduced the overall CV correlation to 3.7% and
increased the R2 linearity to 0.945. Note that extreme outliers in the correlation were
influenced by both major sources of variability: 0.5 cm lesion models scanned using a 44.6
mGy CTDIvol protocol.
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Table 4.21: Sorted results of Bland-Altman analysis of SVM intra-scanner correlation for
subsets of data based on available protocol and lesion parameters. Parameters and values
above the double line indicate worse correlation or linearity than the full data set while those
below the double line indicate improved correlation or linearity. Text in red indicates a major
2

source of variability based on CV or R cutoff criteria.

CV - Correlation
Full Data CV
Criteria
6.2
150%
Parameter

Cutoff
9.3

CTDIvol
RotationTime
CTDIvol
CTDIvol
RotationTime
CTDIvol
ImageThickness
RotationTime
CTDIvol
ImageThickness

Value
0.5 cm Cerebrum
44.6
0.5
54.7
36.7
0.6
81.4
5
0.7
99.8
3.75

R2
0.657
0.701
0.750
0.757
0.791
0.818
0.822
0.845
0.863
0.865
0.878

5.9

Lesion Model

1.0 cm Cerebrum

0.879

5.5
5.0
4.7
4.7
4.6
4.5
4.4
4.2
4.0
3.8
3.6
3.6
3.0

ImageThickness
CTDIvol
ImageThickness
CTDIvol
CTDIvol
CTDIvol
CTDIvol
RotationTime
RotationTime

2.5
67
1.25
64.2
105.6
57.9
72.7
0.8
0.9
1.5 cm Skull Base
117.1
1.5 cm Cerebrum
132.6

0.890
0.912
0.915
0.932
0.935
0.942
0.943
0.943
0.946
0.952
0.959
0.963
0.964

CTDIvol
RotationTime
CTDIvol
CTDIvol
RotationTime
CTDIvol
ImageThickness
RotationTime
CTDIvol
ImageThickness

Value
0.5 cm Cerebrum
44.6
0.5
54.7
36.7
0.6
81.4
5
0.7
99.8
3.75

CV
11.6
10.7
9.0
8.9
8.3
7.7
7.2
7.1
6.9
6.4
6.3

ImageThickness

2.5

CTDIvol
ImageThickness
CTDIvol

67
1.25
105.6
1.0 cm Cerebrum
57.9
64.2
0.8
72.7
0.9
1.5 cm Skull Base
132.6
117.1
1.5 cm Cerebrum

Lesion Model

Lesion Model

CTDIvol
CTDIvol
RotationTime
CTDIvol
RotationTime
Lesion Model

CTDIvol
CTDIvol
Lesion Model

Rsquared - Linearity
Full Data R2
Criteria
0.886
< 0.75
Parameter
Lesion Model

Lesion Model

CTDIvol
Lesion Model

CTDIvol

113

removed.
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sources of variability based on results in Table 4.21. Lower Left: Analysis of full data with the data associated with these major sources of variability

Figure 4.37: Bland-Altman and correlation graphs for SVM intra-scanner correlation. Upper Left: Analysis of full data. Right: Analysis of major

Geometric Bisector Intra-Scanner Correlation
Intra-scanner correlation of Study 1 and Study 2 based on geometric bisector
differentiation accuracy data resulted in a CV correlation of 6.1% and R2 linearity of 0.885.
Repeated analysis for subsets of the data based on all available protocol and lesion
parameters yielded three major sources of variability based on CV and R2 cutoff criteria:
44.6 mGy CTDIvol, 0.5 cm Cerebrum matched model pairs and 0.5sec rotation time (Table
4.22). Bland-Altman and correlation graphs for the full data as well as the parameters and
values identified as major sources of variability can be seen in Figure 4.38. Removing the
data for these major sources of variability from analysis reduced the overall CV correlation
to 3.3% and increased the R2 linearity to 0.946. Note that extreme outliers in the correlation
were influenced by all three major sources of variability: 0.5 cm lesion models scanned
using 44.6 mGy CTDIvol and a 0.5sec rotation time.
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Table 4.22: Sorted results of Bland-Altman analysis of GB intra-scanner correlation for
subsets of data based on available protocol and lesion parameters. Parameters and values
above the double line indicate worse correlation or linearity than the full data set while those
below the double line indicate improved correlation or linearity. Text in red indicates a major
2

source of variability based on CV or R cutoff criteria.

CV - Correlation
Full Data CV
Criteria
6.1
150%
Parameter
Lesion Model

CTDIvol
RotationTime
CTDIvol
CTDIvol
CTDIvol
RotationTime
ImageThickness
RotationTime
CTDIvol
ImageThickness
ImageThickness
CTDIvol
ImageThickness
CTDIvol
CTDIvol
CTDIvol
RotationTime
Lesion Model

RotationTime
CTDIvol
CTDIvol
Lesion Model

CTDIvol
Lesion Model

Rsquared - Linearity
Full Data R2
Criteria
0.885
< 0.75

Cutoff
9.2

Value
0.5 cm Cerebrum
44.6
0.5
36.7
54.7
81.4
0.6
5
0.7
99.8
3.75

CV
11.7
11.2
9.2
8.5
7.5
7.1
7.0
7.0
6.8
6.3
6.3

2.5
67
1.25
72.7
57.9
64.2
0.9
1.0 cm Cerebrum
0.8
132.6
117.1
1.5 cm Skull Base
105.6
1.5 cm Cerebrum

5.9
5.2
4.8
4.6
4.6
4.6
4.5
4.3
4.2
4.0
4.0
3.7
3.6
3.0

Parameter
Lesion Model

CTDIvol
RotationTime
CTDIvol
CTDIvol
CTDIvol
RotationTime
ImageThickness
CTDIvol
RotationTime
ImageThickness
ImageThickness
Lesion Model

ImageThickness
CTDIvol
CTDIvol
RotationTime
CTDIvol
CTDIvol
RotationTime
CTDIvol
Lesion Model

CTDIvol
CTDIvol
Lesion Model
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Value
0.5 cm Cerebrum
44.6
0.5
36.7
54.7
81.4
0.6
5
99.8
0.7
3.75

R2
0.610
0.659
0.739
0.778
0.824
0.825
0.846
0.847
0.861
0.865
0.872

2.5
1.0 cm Cerebrum
1.25
67
72.7
0.9
64.2
57.9
0.8
117.1
1.5 cm Cerebrum
132.6
105.6
1.5 cm Skull Base

0.888
0.895
0.915
0.922
0.923
0.929
0.930
0.940
0.945
0.946
0.954
0.954
0.959
0.964
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of variability based on results in Table 4.22. Lower Left: Analysis of full data with the data associated with these major sources of variability removed

Figure 4.38: Bland-Altman and correlation graphs for GB intra-scanner correlation. Upper Left: Analysis of full data. Right: Analysis of major sources

4.3
4.3.1

Discussion
Gaussian Mixture Model (GMM) Analysis
Prior work (Chapter 3) investigating the differentiation of calcification and

hemorrhage using 1.0 cm diameter agar gel lesion models and GMM analysis resulted in
90% differentiation accuracy starting at 50 HU. Repeat analysis of the same lesion size
using an equivalent protocol in the current project, resulted in a maximum differentiation
accuracy of 81% at 100 HU. In fact, the only lesion type differentiable using GMM analysis
was the 1.5 cm cerebrum lesion. Investigation of the reduced accuracy results from the
current project led to the identification of higher order heterogeneity in the epoxy resin
lesion models relative to the agar gel models used in the prior work. Although the
compound used in the calcification lesion type for this project was changed from
hydroxyapatite to calcium carbonate, the increase in heterogeneity was similar for both
hemorrhage and calcification model types, indicating the mixing method, rather than the
compound change, was likely responsible. The epoxy resin materials used in this project
were created by an outside vendor (Gammex, Middleton, WI) using an automated mixing
method. All lesion models were validated to ensure general homogeneity, however,
estimation of low frequency heterogeneity due to material fabrication would have required
more advanced analysis considered beyond the scope of this work.

4.3.2

Support Vector Machine and Geometric Bisector Analyses
While this heterogeneity had a negative impact on the GMM analysis by invalidating

the base assumption of a Gaussian distribution, the support vector and geometric bisector
analyses were unaffected. First, neither SVM nor GB analyses assume a specific
distribution type. Second, since the “tails” in the distribution (Figure 4.19) were simply due
to areas with less compound additive, they were in line with the full distribution of multiple
attenuation (HU) level lesion models. As a consequence, methods based on analysis of the
full multiple- SECT attenuation (HU) level distributions were less affected by the more
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heterogeneous models. Support vector analysis was found to increase the accuracy of
differentiation relative to GMM analysis for all lesions except the 1.5 cm cerebrum lesions,
where the limited overlap of the two distributions likely outweighed the effect of the tails for
the GMM method. The increase in accuracy of SVM relative to GMM analysis was less for
the 0.5 cm cerebrum and 1.5 cm skull base lesions, most likely due to the increased noise
found in these data sets. The 0.5 cm cerebrum lesions have a much smaller sample size
and are more likely to be affected by partial volume and sub-optimal ROI placement than all
other lesion types. The 1.5 cm skull base lesions, while large, are more heavily affected by
the surrounding bony anatomy than those lesions in the cerebrum, increasing both overlap
and spread of the distributions.
Several differentiation accuracy trends were identified based on acquisition
parameters using both the SVM and GB analysis methods. In general, increased accuracy
was associated with increased CTDIvol (Figure 4.21, Figure 4.28). As the number of
photons incident on the phantom (or patient) increases, the number of photons incident on
the detector increases. While the percentage of photons attenuated is constant, the
number of photons un-attenuated and thus reaching the detector is increased. More
photons at the detector means improved counting statistics and thus a richer data set to pull
from to characterize the attenuations of the materials within the phantom (or patient). In the
case of dual-energy CT, the increased dose benefits the lower 80kVp projections
preferentially, where a larger percentage of the beam is attenuated by the patient. If too
few of the 80kVp photons make it to the detector, the material decomposition process will
be poorly characterized, resulting in errors in both the material density and monoenergetic
images. Increased image thickness led to increased differentiation accuracy for both SVM
and GB methods (Figure 4.22, Figure 4.29). This is likely due to the reduction in low
frequency noise (mottled appearance on a level greater than the voxel scale) by data
averaging resulting in reduced lesion inhomogeneity. Reconstruction filter was found to
have no effect on differentiation accuracy using either SVM or GB method (Figure 4.23,
119

Figure 4.30). It seems that reduction in high frequency noise (white noise on the level of
the voxel scale) does not have as pronounced an effect as the reduction in low frequency
noise by data averaging.
Based on these trends, a generalized protocol can be recommended: high dose with
thick images using any of the investigated filters. Dose (CTDIvol) should be as high as
possible while balancing risk with clinical need. Image thickness should be as thick as
possible without exceeding the dimensions of the lesion and including partial volume effect
of the surrounding tissues. One recommendation would be the acquisition of data at 1.25
mm images followed by reconstruction at increasingly higher image thicknesses until the
maximum image thickness to avoid partial volume effect is determined. Since it has no
effect on differentiation accuracy, the reconstruction filter may be selected based on clinical
use at the institution and visual preference of the radiologists.
Results of the generalized geometric bisector solution indicate that a combination of
three plane definitions should provide equally accurate results to the un-generalized
geometric bisector method: cerebrum lesions less than 0.5 cm in diameter, cerebrum
lesions greater than 0.5 cm in diameter, and skull base lesions (Table 4.16). While this
would necessitate some prior knowledge of the lesion’s size and location, all protocol
variations were included in the creation of the plane, allowing physicians to determine
CTDIvol and image thickness on a case by case basis.

4.3.3

Inter- and Intra-Scanner Correlation
In addition to the similar trends discussed above, the SVM and GB methods were

found to have a high degree of correlation (CV of 1.7%) and linearity (R2 of 0.988) once the
effect of the 0.5 cm cerebrum lesions were removed from analysis. Neither method was
preferred for these lesions, instead the noise due to their small size, partial volume effects
and ROI placement variability simply obscured the correlation between the two analysis
methods (Figure 4.34). Given the high degree of correlation between the two methods, it is
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reasonable to recommend the GB over the SVM due to the former’s simplicity and ease of
use. While the support vector machine method requires iterative analysis and heavy
computational power, the geometric bisector method requires only linear regression and
simple geometric calculations. The simplicity of this method would also lead to easier
implementation and would allow for interim updates to the plane of optimal differentiation as
patient data is collected.

Table 4.23: Summary of inter-scanner (Study 1 versus Study 3) and intra-scanner (Study 1
versus Study 2) correlations based on both SVM and GB methods. Parameters identified as
2

major sources of variability are listed along with the initial CV and R for the full data, as well
2

as, the final CV and R with the sources of variability removed from analysis.
CV
(Initial)

R
(Initial)

InterScanner

SVM

8.1%

0.824

44.6 mGy
CTDIvol

GB

8.3%

0.814

44.6 mGy
CTDIvol

IntraScanner

2

Method

SVM

6.2%

0.886

44.6 mGy
CTDIvol

GB

6.1%

0.885

44.6 mGy
CTDIvol

Sources of Variability
0.5 cm
Cerebrum
Lesions
0.5 cm
Cerebrum
Lesions
0.5 cm
Cerebrum
Lesions
0.5 cm
Cerebrum
Lesions

0.5sec
Rotation
Time
0.5sec
Rotation
Time

0.5sec
Rotation
Time

2

CV
(Final)

R
(Final)

4.8%

0.908

4.6%

0.915

3.7%

0.945

3.3%

0.946

In general, intra-scanner correlations were better than inter-scanner correlations,
indicating that repeatability of the differentiation accuracy result would be greater if the
same scanner were used (Table 4.23). These differences were quite small however, and
as such, the clinical impact of scanner selection would be minimal, assuming the behavior
of the scanners investigated is representative of overall scanner behavior. In general,
correlations for the GB method were better than those of the SVM method, supporting
limiting future use to the simpler GB method. All evaluations of inter- and intra-scanner
correlation identified the same major sources of variability: 44.6 mGy CTDIvol, 0.5 cm
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cerebrum lesions and 0.5 cm rotation time. Intra-scanner correlation using SVM method
did not identify 0.5sec rotation time as a major source of variability; however, it was the
parameter with the next highest CV and next lowest R2 value (Table 4.21). The issues
associated with 0.5 cm cerebrum lesions have already been discussed and these issues’
effect on inter- and intra- scanner correlations is expected. Low dose (CTDIvol) has also
been discussed, however the CTDIvol level identified as a major source of variability was not
the lowest dose level investigated. By investigating the GSI-presets associated with the
two lowest CTDIvol values (36.7 mGy and 44.6 mGy), it was found that the preset
associated with the 36.7 mGy CTDIvol used a 0.7sec rotation time, while the preset
associated with the 44.6 mGy CTDIvol used a 0.5sec rotation time. Thus it is reasonable to
conclude that the 44.6 mGy CTDIvol level was identified due to a combination of its low dose
and a rotation time identified separately as a major source of variability. Concurrent work
has suggested that reduced rotation times have a detrimental effect on the fast-kVp
switching x-ray tube, specifically resulting in reduced uniformity (see Chapter 6.3.2.2).
Given the speed of the fast-kVp switching waveform, and the time required to transition
from one kVp to the other, it is reasonable to suggest that a faster rotation time may result
in reduced spectral separation between the high and low kVp projections. This reduced
separation may lead to reduced accuracy of the material decomposition process, errors in
material density and monoenergetic images and thus reduced differentiation accuracy
between calcification and hemorrhage.

4.3.4

Validation of Optimal keV Level for Simulated SECT Scanning

Calculation of the difference between 68 keV attenuation (HU) and the gold standard
SECT attenuation (HU) yielded errors within 3 HU for lesion models in the cerebrum (Figure
4.10). This is in line with error estimates of -2.6 HU to 2.6 HU from the initial selection of 68
keV as the optimal keV level for simulated SECT scanning (Chapter 4.2.3). The mean error
across all acquisition parameters for cerebrum lesions was found to be 0.5 HU, again
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supporting the estimated mean error of 0.3 HU during keV selection. Mean error in the
skull base was found to be 1.0 HU with a maximum error of approximately 6 HU,
surpassing the estimated error during the selection process. Since the keV selection
process was performed using only cerebrum lesions, it is not surprising that the keV was
not optimized for equivalent attention between 68 keV and SECT in the skull base. Due to
the increased bony anatomy in the skull base relative to the cerebrum, it is likely that the
80kVp beam was more highly attenuated, affecting the results of the material
decomposition. However, given the high degree of correlation (CV 2.8%) and linearity (R2
0.99) between the 68 keV and SECT attenuation (HU) across all lesion and acquisition
parameters (Table 4.11), 68 keV dual-energy reconstruction seems to be a reasonable
substitute for SECT acquisition for intracranial lesions in this attenuation range. An added
SECT acquisition does not appear warranted for in-vivo scanning at this time.

4.3.5

Power Fits for 90% Differentiation Accuracy
Second order power fits of available data yielded results in the form of CTDIvol

necessary for 90% differentiation accuracy based on a given lesion attenuation (HU) and
lesion attenuation (HU) necessary for 90% differentiation accuracy based on a given
protocol CTDIvol (mGy). In both cases, the relationship of the resulting values to the given
parameter was not linear. In other words, linearly increasing lesion attenuation (HU) did not
always result in a linear decrease in CTDIvol necessary for 90% differentiation accuracy.
This is likely an effect of the CTDIvol values being associated with specific GSI-presets.
These presets are a fixed combination of a dose (CTDIvol), beam width, mA, bowtie filter
and rotation time. In order to obtain data on a wide range of dose values, the scan protocol
used was generated with a wide range of GSI-presets with varying mA values and rotation
times. The effects of these other components of the GSI-preset cannot be controlled at this
time, and may have a substantial effect on the differentiation accuracy results. Given this
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constraint, the use of these tables showing the relationship of lesion attention (HU) and
dose (CTDIvol) for protocol development is limited.

4.3.6

Limitations
As with any phantom study, there are limitations stemming from the inexact

modeling of the biological system. Calcification and hemorrhage lesion models were
created using a cylindrical shape, and assessed at three sizes (0.5, 1.0 and 1.5 cm) and
two locations within the cranium (cerebrum and skull base). Given the large differences in
differentiation accuracy between the 0.5 cm and 1.0 cm cerebrum lesions, further
investigation into intermediate sizes is warranted. Lesion models were also created to be
homogeneous and without contamination, thus the usefulness of this technique for
heterogeneous or mixed lesions cannot be confirmed. Protocol recommendations are
based on fixed GSI-presets, limiting the ability to evaluate protocol parameters such as mA,
rotation time and CTDIvol directly. In addition, a range of CTDIvol values was created
through manipulating the pitch, which might have different effects on differentiation than
increasing the mA. The DFOV was limited to 25 cm to allow for visualization of the full
cranium. Reduced DFOV may aid the differentiation accuracy of the 0.5 cm cerebrum
lesions through an increase in sample size, reduction in partial volume effect and increased
ease of ROI placement. Finally, inter- and intra-scanner correlations were based on single
study comparisons which may affect the results.
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Chapter 5

5

Lesion Classification using Unknown Lesion Models

This chapter applies the methods and protocols developed in Chapter 4 to the
classification of unknown intracranial lesions of either hemorrhagic or calcific composition.
Unknown lesion models were created at varying attenuation, size and location within the
cranial cavity. The lesions were blinded for data acquisition (scanning) and analysis, and
the ability of DECT to correctly classify these lesions with 90% confidence was determined.

5.1
5.1.1

Materials and Methods
Fabrication and Evaluation of Unknown Lesion Models
To validate the results from Chapter 4, and move beyond differentiation and towards

identification, a new set of “validation” hemorrhage and calcification lesion models were
fabricated by the third party vendor (Gammex Inc., Middleton, WI) used for the previous
biologically relevant phantom (Chapter 4). Five calcification and five hemorrhage lesion
models were commissioned at varying SECT attenuation (HU) between 50 and 100 HU.
Given that the previous differentiation work was performed on calcification and hemorrhage
models within 3 HU of each decade between 40 and 100 HU, unknown lesions were
requested at varying SECT attenuation (HU) from 50 to 100 HU while avoiding ± 2 HU of
each decade. For example, in order to avoid a repeat measure of a 70 HU calcification
model, unknown lesions were ordered to be between 62 and 68 HU and between 72 and
78 HU. Each lesion type and attenuation level resulted in the fabrication of a 15 cm long,
2.8 cm diameter rod. In order to minimize the handling of the unknown lesion models by
the evaluation group, these rods were immediately machined to create each lesion size and
location specific model: 0.5 cm cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm
skull base. The lesion models were then grouped by the vendor into lesion composition
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and attenuation specific bags, each labeled with a letter to allow blinded material
verification, data collection and analysis. These lesion models (n=40) will be referred to
throughout this document as “unknown lesions”.
These pre-milled, unknown lesions were then simply evaluated for defects and
uniformity by a third party. The lesion models were imaged on the table top using a basic
protocol (Table 5.1). Single-energy, 60 keV and Iodine(Water) images were evaluated
visually for defects and overall homogeneity. This lesion model fabrication and verification
process differed from that used in the earlier differentiation work (Chapter 4). The original
lesion models used for evaluation of lesion differentiation were milled after extensive
verification of the bulk material (Chapter 4.1.3). This was necessary due to validate the
untested methods used by the lesion material manufacturer as well as to ensure the
attenuation matching of the calcification and hemorrhage matched model pairs. Given that
the lesion models needed for the lesion classification work did not require attenuation
matched model pairs and that the methods used by the manufacturer had been previously
validated, the validation methods were streamlined to allow for the pre-milling of the lesion
models by the manufacturer.

Table 5.1: Unknown lesion material verification and evaluation protocol. Both series were
acquired in helical mode, using a 20 mm beam width, 25 cm DFOV and Head SFOV. Images
were evaluated visually to confirm the lesion models were homogeneous and free of defects.

Series

Name

Pitch

1

SE

0.531

Image
Thickness
(mm)
3.75

2

GSI-26

0.531

3.75

Interval
(mm)

kVp

mA

Rot
(s)

CTDIvol
(mGy)

Filter

3.75

120

220

0.8

64

Standard

3.75

NA

375

0.7

67

Standard
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5.1.2

Unknown Lesion Data Acquisition
Unknown lesion models were scanned using the same phantom used for lesion

differentiation (Chapter 4). Each of the 10 lesion groups defined by a composition
(hemorrhage or calcification) and an attenuation (roughly 50-100 HU in decades) were
imaged individually. For each of the 10 exams, the four lesion sizes and locations (0.5 cm
cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm skull base) corresponding to that
lesion type and attenuation were inserted into the phantom. Low attenuation (40 HU) lesion
models from the prior differentiation work (Chapter 4) were used to fill the remaining four
available spaces (Figure 4.2).

5.1.2.1 Determination of Scan Protocol
Based on the results of the prior differentiation work (Chapter 4), a more limited
scan protocol was designed for validation of unknown lesion classification (Table 5.2).
Specifically, higher dose protocols reconstructed with thicker images were targeted for
investigation and the use of GSI-presets with 0.5sec rotation time was avoided. To this
aim, three CTDIvol levels were selected: 132.6 mGy to evaluate the highest dose available
on the system, 67 mGy to represent a dose level similar to the institution’s routine brain
protocol (Table 4.3, series 2), and 105.6 mGy as a midpoint between the two. All three dose
levels were evaluated using an image thickness of 3.75 and a standard filter to mimic
routine clinical practice. A single-energy 64 mGy acquisition was added to provide
verification of 68 keV attenuation values. All dual-energy acquisitions were reconstructed at
68 keV, Water(Calcium) and Calcium(Water) to allow for the collection of the threedimensional (3D) DECT signature data.
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Table 5.2: Unknown lesion validation protocol. For all acquisitions: helical, 20 mm beam
width, 25 cm DFOV, Head SFOV.

Series

Name

Pitch

1

SE

0.531

Image
Thickness
(mm)
3.75

GSI-26

0.531

GSI-30
GSI-9

2

Interval
(mm)

kVp

mA

Rot
(s)

CTDIvol
(mGy)

Filter

3.75

120

220

0.8

64

Standard

3.75

3.75

NA

375

0.7

67

Standard

0.531

3.75

3.75

NA

550

0.8

105.6

Standard

0.531

3.75

3.75

NA

600

0.9

132.6

Standard

5.1.2.2 Data Collection and Organization
Data were collected and organized following the same method used for the prior
differentiation work (Chapter 4.1.6.1-4). Series sorting was limited to relevant parameters
including, but not limited to, image number, GSI-preset, and dual-energy reconstruction
type. Matlab (Version 2014a, MathWorks) was used to query the database to combine the
dual-energy reconstructions to create 3D-DECT data for each lesion model based on
acquisition type. Given two lesion types (calcification and hemorrhage), five attenuation
levels (roughly 50 to 100 HU in decades), 4 lesion sizes/location combinations (0.5 cm
cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm skull base), and 3 DECT
acquisitions (67, 105.6 and 132.6 mGy), a total of 120 unique unknown lesion data sets
were collected.

5.1.3

Unknown Lesion Classification Methods

5.1.3.1 Geometric Bisector (GB) Method
Due to the equivalence of the support vector machine and geometric bisector
methods found in the prior differentiation work (Chapter 4), Geometric bisector was
selected due to its ease of use and overall simplicity. A lookup table was created in Matlab
based on the geometric bisector plane results from the prior differentiation work (Chapter
4.1.7.3) for all acquisitions and lesion size and locations investigated in this validation
study. 12 planes were compiled: 3 CTDIvol levels (67 mGy, 105.6 mGy and 132.6 mGy) for
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each lesion size and location (0.5 cm cerebrum, 1.0 cm cerebrum, 1.5 cm cerebrum and
1.5 cm skull base). Then 3D-DECT unknown lesion data was opened in Matlab and the
database queried for the matched-acquisition, matched-lesion parameter geometric
bisector plane (Figure 5.1). The mean of the 3D-DECT data for the unknown lesion model
(black diamond) was applied to the plane and lesion classification derived from the position
of the mean location relative to the plane (gray). . Mean values that shared the side of the
plane as the original hemorrhage differentiation data (red) were classified as hemorrhage
while mean values that shared the side of the plane as the original calcification
differentiation data (blue) were classified as calcification. The confidence in this
classification was defined as the percentage of voxels within the unknown lesion distribution
that were on the same side of the plane as the mean value (here, 90%).

Figure 5.1: Application of lesion and acquisition specific geometric bisector plane (gray) to
an example unknown lesion model. The lesion model mean is shown as a black diamond to
the left of the plane. The voxel data also on the left of the plane (and thus contributing to the
classification confidence) is shown in red, while the voxel data on the right side of the plane
(and thus counting against the classification confidence) is shown in blue.
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The final classification of each lesion was compared to the lesion composition and
the number of lesions with correct classification was calculated. Next, the number of
lesions correctly classified with greater than 80% and greater than 90% confidence was
calculated. To assess trends in classification confidence with CTDIvol, second order power
fits were employed to determine the lowest lesion attenuation (HU) necessary for 90% and
80% confidence given a particular CTDIvol. While this process was repeated in the past to
obtain the CTDIvol necessary given a certain lesion attenuation (HU), the limited number of
data points for CTDIvol made this curve fit highly unstable and thus was not pursued.

5.1.3.2 Generalized Geometric Bisector (GGB) Method
Based on the results of prior work comparing lesion and acquisition parameterspecific geometric bisector planes (Chapter 4.2.5.5), three parameters were identified as
major sources of variability in the geometric bisector plane solution (Table 4.16): cerebrum
lesions of 0.5 cm in diameter, cerebrum lesions of greater than 0.5 cm in diameter and skull
base lesions. In order to assess whether a more generalized geometric bisector plane
might provide similar results to lesion and acquisition parameter-specific planes, these
three generalized planes were evaluated for their ability to classify the validation unknown
lesions. Unknown lesion data were analyzed using lesion parameter-specific plane
(cerebrum lesions of 0.5 cm diameter, cerebrum lesions of greater than 0.5 cm diameter,
and skull base lesions) and the classification, and the confidence in that classification, was
calculated as described above (Chapter 5.1.3.1).

5.1.3.3 Probability Distribution (PD) Method
Using the raw 3D-DECT data collected as part of the prior differentiation work, a
distribution of calcification probability was derived. For each acquisition (n=3 based on
series 2 of Table 5.2) and lesion size and location (n=4) combination investigated as part of
the validation study, a distribution of the raw 3D-DECT data was created based on data
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from Study1 of the prior differentiation project described in Chapter 4. Using this prior
differentiation data collected in Study 1, each lesion (size and location) specific and
acquisition (CTDIvol, image thickness, reconstruction filter) specific matched model pair
(n=12) was analyzed using a multivariate logistic regression model (104). This model
correlated the 3D-DECT measurements (68 keV attenuation, water material density and
calcium material density) with the probability of being calcification. Odds ratios were then
derived based on the increased probability of being calcification given a unit increase in a
measurement (68 keV, Water(Calcium) or Calcium(Water)). In addition, the coefficients of
the multivariate logistic regression model were used to create a formula for the probability
the lesion is a calcification and probability the lesion is a hemorrhage based on input of the
mean lesion value in the 3D-DECT signature space (Equation 12,Equation 13,Equation 14).

Equation 12

ݐ݂݂݊݁݅ܿ݅݁ܥݕݐ݈ܾܾ݅݅ܽݎܲ݊݅ݏ݁ܮሺܥܲܮሻ ൌ
ܾͲ   ܾͳ ሺܹܽݕݐ݅ݏ݊݁݀ݎ݁ݐሻ  ܾʹ ሺݕݐ݅ݏ݊݁݀݉ݑ݈݅ܿܽܥሻ   ܾ͵ ሺͺܸܷ݇݁ܪሻ

Equation 13

Equation 14

ܲݕݐ݈ܾܾ݅݅ܽݎሺ݊݅ݐ݂݈ܽܿ݅݅ܿܽܥሻ  ൌ 

݁ ܥܲܮ
ሺͳ  ݁  ܥܲܮሻ

ܲݕݐ݈ܾܾ݅݅ܽݎሺ݄݁݃ܽݎݎ݉݁ܪሻ ൌ ͳ െ ܲݕݐ݈ܾܾ݅݅ܽݎሺ݊݅ݐ݂݈ܽܿ݅݅ܿܽܥሻ

Lookup tables were created in Matlab for these acquisition and lesion specific
probability formulas. Then 3D-DECT unknown lesion data was opened in Matlab and the
database then queried for the acquisition and lesion specific probability formula. The mean
unknown lesion value based on the 3D-DECT data was then input into the formula and the
probability the lesion is calcification was derived (Equation 12, Equation 13). The
probability the lesion is hemorrhage was then calculated using Equation 14. Unknown
lesions were classified as either calcification or hemorrhage based on a greater than 50%
probability. The probability was then used a measure of confidence in that classification.
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The final classification of each lesion was compared to the actual lesion composition
and the number of lesions with correct classification was calculated. Next, the number of
lesions correctly classified with greater than 80% and greater than 90% confidence was
calculated. To assess trends in classification confidence with CTDIvol, second order power
fits were employed to determine the lowest lesion attenuation (HU) necessary for 90% and
80% confidence given a particular CTDIvol.

5.1.4

Inter-Method correlation
To assess the correlation between the geometric bisector (GB) and probability

distribution (PD) analysis methods, Bland-Altman and correlation graphs were created. To
assess sources of variability in this correlation, the analysis was repeated for subsets of the
data based on all available parameters: lesion model composition, CTDIvol, rotation time
and lesion size and location. Investigation of rotation time was included due to its impact in
other concurrent analyses (Chapter 6). Each parameter was investigated separately, while
including all values for other variables. For all analyses, the coefficient of variation (CV)
was tabulated as a measure of data correlation, while the square of the Pearson r-value
(R2) was tabulated as a measure of correlation linearity. The CV and R2 from these
parameter value specific Bland-Altman and correlation graphs were compared to the values
derived from Bland-Altman and correlation graphs for the full data set. Parameter-value
specific R2 values under 0.75 or CV values greater than 150% of the full data CV value
were identified as major sources of variability in the method correlation (see Chapter 4.1.7.5
for description of criteria development). Specific parameter values identified as major
sources of variability were then removed from the full data set and the Bland-Altman
analysis was repeated.
This method was repeated to assess the correlation between the geometric bisector
and generalized geometric bisector analysis methods. Given that the correlation was
already assessed between the geometric bisector and probability distribution methods, and
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that the generalized geometric bisector was an extension of the geometric bisector method,
the correlation between the generalized geometric bisector and probability distribution
methods was not assessed.

5.2

Results

5.2.1

Fabrication and Evaluation of Unknown Lesion Models
All unknown lesion models were free of defects and homogeneous. None of the

lesion models required replacement or modification.

5.2.2

Probability Distribution Definition
Odds ratios correlating the 3D-DECT measurements with probability of being

calcification based on multivariate logistic regression model of differentiation data collected
as part of Study 1 in Chapter 4 can be seen in Table 5.3. The odds ratio represents the
increase in probability of calcification based on a unit increase on one of the 3D-DECT
image types. For example, an odds ratio of 1.59 means that the probability of being a
calcification is increased 59% by a unit increase in the voxel measurement on that image
type. Increased water and calcium density image measurements were significantly
associated with increased probability of calcification for all acquisitions and lesion
parameters save one: calcium density image for a 132.6 mGy acquisition of a 1.0 cm
cerebrum lesion. Decreased 68 keV monoenergetic image measurements were
significantly associated with increased probability of being calcification. This is most likely
due to hemorrhage lesion models having slightly higher attenuations than calcification
models but still within our 2 HU matching constraint for the differentiation study (Chapter
4.2.4.2).
Coefficients of the multivariate logistic regression model can be found in Table 5.4. For
a specific lesion and acquisition, the coefficients form a formula describing the point
estimate of a lesions probability of being calcification (Equation 11, Equation 12). While the
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coefficients themselves have 95% upper confidence levels (UCL) and 95% lower
confidence levels (LCL), no estimate can be made on the confidence interval of the lesion
probability.
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Table 5.3: Summary of multivariate logistic regression model results correlating water,
calcium, and 68 keV measurements with probability of the unknown lesion being calcification.
Odds ratio is for each unit increase in the measurement. Odds ratio greater than 1 means an
increased probability of being calcification. LCL and UCL refer to the lower and upper
confidence limits, respectively.
Lesion
Location

CTDIvol
(mGy)

Lesion Size
(cm)
0.5

67

1

1.5

0.5

Cerebrum

105

1

1.5

0.5

132

1

1.5

Skull Base

67

1.5

105

1.5

132

1.5

DECT Image
Type
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
Water
Calcium
68 keV
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Odds
Ratio
1.59
2.10
0.72
1.65
1.54
0.83
1.98
1.84
0.78
1.39
1.27
0.88
1.68
1.14
0.92
2.54
1.85
0.76
1.46
1.37
0.86
1.66
1.10
0.94
2.57
1.49
0.84
1.63
1.87
0.77
1.96
1.98
0.75
2.06
1.98
0.75

95%
LCL
1.51
1.85
0.69
1.60
1.42
0.80
1.92
1.71
0.76
1.32
1.11
0.84
1.62
1.03
0.89
2.44
1.69
0.74
1.38
1.19
0.81
1.59
0.99
0.90
2.46
1.35
0.81
1.60
1.78
0.76
1.91
1.85
0.73
2.00
1.85
0.73

95%
UCL
1.68
2.38
0.76
1.71
1.67
0.86
2.04
1.97
0.80
1.46
1.46
0.93
1.75
1.26
0.96
2.64
2.03
0.79
1.54
1.58
0.91
1.73
1.22
0.98
2.68
1.65
0.87
1.67
1.97
0.79
2.02
2.11
0.77
2.12
2.12
0.77

Pvalue
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0004
<.0001
<.0001
0.01
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.06
0.002
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001

Table 5.4: Summary of logistic regression model coefficients based on analysis of Study 1
differentiation data (Chapter 4). These coefficients work with Equations 12-14 to calculate the
probability of being calcification based on an unknown lesion’s mean 3D-DECT measurement.
Lesion Location

CTDIvol (mGy)

Lesion Size (cm)
0.5

67

1

1.5

0.5

Cerebrum

105

1

1.5

0.5

132

1

1.5

Skull Base

67

1.5

105

1.5

132

1.5
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Coefficient
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)
b0 (Intercept)
b1 (Water)
b2 (Calcium)
b3 (68 keV)

Estimate
-467.408
0.4656
0.7407
-0.3233
-507.724
0.5025
0.4331
-0.188
-690.804
0.6829
0.6082
-0.2475
-330.154
0.3271
0.2423
-0.1244
-528.486
0.5215
0.1315
-0.0782
-943.308
0.9316
0.6177
-0.2682
-381.112
0.3777
0.3165
-0.1521
-512.821
0.506
0.0953
-0.0612
-956.451
0.943
0.3992
-0.175
-493.734
0.4915
0.6266
-0.2599
-678.958
0.6745
0.681
-0.2863
-725.187
0.7204
0.6854
-0.2858

95% LCL
-517.763
0.4153
0.6145
-0.3737
-541.804
0.4685
0.3506
-0.22
-720.042
0.6538
0.5386
-0.2744
-382.396
0.2749
0.107
-0.1781
-569.166
0.4809
0.0317
-0.1168
-983.62
0.8914
0.5252
-0.304
-434.797
0.324
0.1761
-0.2079
-553.609
0.4653
-0.0057
-0.1003
-1000.16
0.8994
0.299
-0.2139
-514.718
0.4706
0.5759
-0.2797
-706.174
0.6474
0.617
-0.3111
-754.321
0.6913
0.6172
-0.3122

95% UCL
-417.052
0.5159
0.8669
-0.273
-473.644
0.5365
0.5155
-0.1561
-661.566
0.7121
0.6778
-0.2206
-277.912
0.3793
0.3776
-0.0707
-487.806
0.5621
0.2314
-0.0397
-902.997
0.9718
0.7102
-0.2323
-327.426
0.4314
0.4569
-0.0963
-472.033
0.5467
0.1963
-0.0222
-912.743
0.9866
0.4994
-0.1362
-472.75
0.5125
0.6772
-0.2402
-651.742
0.7017
0.745
-0.2614
-696.053
0.7495
0.7535
-0.2593

5.2.3

Classification of Unknown Lesions

5.2.3.1 Binary Classification
Geometric Bisector Method
Given binary classification (hemorrhage or calcification), 98% of unknown
lesions/acquisition combinations investigated (n=120) were classified correctly using the
GB method. Two lesions/acquisition combinations were misclassified: 49.9 HU, 0.5 cm
hemorrhage in the cerebrum imaged with 67 mGy and the same lesion model imaged with
132.6 mGy. 60% (73/120) of those were classified with greater than 90% confidence, while
74% (90/120) were classified with greater than 80% confidence. GB confidence for all
unknown lesions based on composition, location, size and attenuation can be seen in
Figure 5.2.

Geometric Bisector Method
100

Confidence in Classification

95
90
85
Calcification

80
75

Hemorrhage

70
65
60
55
50
50 58 62 73 78 56 65 73 85 91 56 66 75 86 94 58 68 74 85 91
0.5

1

1.5
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Figure 5.2: Classification confidence results for all unknown lesion models using the
geometric bisector method. Calcification lesion models are shown in blue while hemorrhage
models are shown in red.
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Generalized Geometric Bisector Method
96% of unknown lesions/acquisition combinations investigated (n=120) were
classified correctly using the GGB method. Three lesions/acquisition combinations were
misclassified: 49.9 HU, 0.5 cm hemorrhage in the cerebrum imaged with 67 mGy, 105.6
mGy and 132.6 mGy. 61% (75/120) of those were classified with greater than 90%
confidence, while 75% (92/120) were classified with greater than 80% confidence. GGB
confidence for all unknown lesions based on composition, location, size and attenuation
can be seen in Figure 5.3.

Generalized Geometric Bisector Method
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Figure 5.3: Classification confidence results for all unknown lesion models using the
generalized geometric bisector method. Calcification lesion models are shown in blue while
hemorrhage models are shown in red.
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Probability Distribution Method
98% of unknown lesions/acquisition combinations investigated (n=120) were
classified correctly using the probability distribution (PD) method. The two misclassified
lesion/acquisition combinations were the same as those misclassified by the GB method
above. Again, similarly to the GB and GGB methods, 59% (71/120) of lesion/acquisition
combinations were classified with greater than 90% confidence, and 74% (90/120) were
classified with greater than 80% confidence. Of the lesion/acquisition combinations
classified with greater than 90% confidence, 62 were so classified using all three methods
(84%, 83% and 87% agreement for GB, GGB and PD methods respectively). Of the
lesion/acquisition combinations classified with greater than 80% confidence, 84 were so
classified using all three methods (93%, 91% and 93% for GB, GGB, and PD methods
respectively). PD confidence for all unknown lesions based on composition, location, size
and attenuation can be seen in Figure 5.4.
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Probability Distribution Method
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Figure 5.4: Classification confidence results for all unknown lesion models using the
probability distribution method. Calcification lesion models are shown in blue while
hemorrhage models are shown in red.

5.2.3.2 Classification Trends with CTDIvol
Geometric Bisector Method
GB confidence trends with acquisition CTDIvol for all hemorrhage lesion models
(based on lesion composition not method classification) can be seen in Figure 5.5. GB
confidence trends with acquisition CTDIvol for all calcification lesion models can be seen in
Figure 5.6.
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Hemorrhage: Geometric Bisector Method by CTDIvol (mGy)
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Figure 5.5: Geometric bisector confidence in classification of hemorrhage unknown lesions.
Darker shades of red indicate higher CTDIvol levels.

Calcification: Geometric Bisector Method by CTDIvol (mGy)
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Figure 5.6: Geometric bisector confidence in classification of calcification unknown lesions.
Darker shades of blue indicate higher CTDIvol levels.
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Second order power fits of GB confidence data for all available lesion/acquisition
combinations resulted in the SECT attenuation (HU) necessary for 90% classification
confidence (Table 5.5). 0.5 cm calcification lesions in the cerebrum could not be classified
with greater than 90% confidence using any of the available CTDIvol levels. 1.0 and 1.5 cm
calcifications in the cerebrum could be classified with 90% confidence down to the minimum
investigated SECT attenuation (HU) using either 105.6 or 132.6 mGy CTDIvol.

Table 5.5: SECT attenuation (HU) necessary for 90% classification confidence using the GB
method. Gray regions represent lesion/acquisition combinations that would only be
classified with 90% confidence above the 100 HU limit imposed by SECT. Green regions
represent lesion/acquisition combinations that would be classified with 90% confidence
below the minimum SECT investigated. White regions represent lesion/acquisition
combinations that would be classified with 90% confidence within the investigated lesion
2

attenuation range. Text in red indicates a curve fit R with less than 0.8.
Lesion Composition

Calcification

CTDIvol
(mGy)

Lesion Location

Hemorrhage
Skull
Base

Cerebrum

Skull
Base

Cerebrum

Lesion Size (cm)

0.5

1.0

1.5

1.5

0.5

1.0

1.5

1.5

67.0

>100 HU

63 HU

62 HU

87 HU

70 HU

68 HU

67 HU

87 HU

105.6

>100 HU

58 HU

58 HU

81 HU

58 HU

64 HU

59 HU

70 HU

132.6

>100 HU

58 HU

58 HU

71 HU

59 HU

69 HU

63 HU

76 HU

Second order power fits of GB confidence data for all available lesion/acquisition
combinations resulted in the SECT attenuation (HU) necessary for 80% classification
confidence (Table 5.6). 1.0 and 1.5 cm calcification lesions in the cerebrum could be
classified with 80% confidence down the minimum investigated SECT attenuation (HU)
using any of the available CTDIvol levels. 1.5 cm hemorrhage lesions in either the cerebrum
or skull base could be classified with 80% confidence down to the minimum investigated
SECT attenuation (HU) using either 105.6 or 132.6 mGy CTDIvol.
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Table 5.6: SECT attenuation (HU) necessary for 80% classification confidence using the GB
method. Gray regions represent lesion/acquisition combinations that would only be
classified with 80% confidence above the 100 HU limit imposed by SECT. Green regions
represent lesion/acquisition combinations that would be classified with 80% confidence
below the minimum SECT investigated. White regions represent lesion/acquisition
combinations that would be classified with 80% confidence within the investigated lesion
2

attenuation range. Text in red indicates a curve fit R with less than 0.8.
Lesion Composition

Calcification

Lesion Location

Hemorrhage
Skull
Base

Cerebrum

Skull
Base

Cerebrum

0.5

1.0

1.5

1.5

0.5

1.0

1.5

1.5

CTDIvol
(mGy)

Lesion Size (cm)
67.0

>100 HU

58 HU

58 HU

70 HU

68 HU

59 HU

57 HU

65 HU

105.6

>100 HU

58 HU

58 HU

67 HU

60 HU

57 HU

56 HU

58 HU

132.6

>100 HU

58 HU

58 HU

62 HU

72 HU

61 HU

56 HU

58 HU

Generalized Geometric Bisector Method
GGB confidence trends with acquisition CTDIvol for all hemorrhage lesion models
(based on lesion composition not method classification) can be seen in Figure 5.7. GB
confidence trends with acquisition CTDIvol for all calcification lesion models can be seen in
Figure 5.8.
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Hemorrhage: Generalized Geometric Bisector Method by CTDIvol (mGy)
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Figure 5.7: Generalized geometric bisector confidence in classification of hemorrhage
unknown lesions. Darker shades of red indicate higher CTDI vol levels.

Calcification: Generalized Geometric Bisector Method by CTDIvol (mGy)
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Figure 5.8: Generalized geometric bisector confidence in classification of calcification
unknown lesions. Darker shades of red indicate higher CTDI vol levels.
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Second order power fits of GGB confidence data for all available lesion/acquisition
combinations resulted in the SECT attenuation (HU) necessary for 90% classification
confidence (Table 5.7). 0.5 cm calcification lesions in the cerebrum could not be classified
with greater than 90% confidence using any of the available CTDIvol levels. 1.0 and 1.5 cm
calcifications in the cerebrum could be classified with 90% confidence down to the minimum
investigated SECT attenuation (HU) using any of the investigated CTDIvol levels.

Table 5.7: SECT attenuation (HU) necessary for 90% classification confidence using the GGB
method. Gray regions represent lesion/acquisition combinations that would only be
classified with 90% confidence above the 100 HU limit imposed by SECT. Green regions
represent lesion/acquisition combinations that would be classified with 90% confidence
below the minimum SECT investigated. White regions represent lesion/acquisition
combinations that would be classified with 90% confidence within the investigated lesion
2

attenuation range. Text in red indicates a curve fit R with less than 0.8.
Lesion Composition

Calcification

CTDIvol
(mGy)

Lesion Location

Hemorrhage
Skull
Base

Cerebrum

Skull
Base

Cerebrum

Lesion Size (cm)

0.5

1

1.5

1.5

0.5

1

1.5

1.5

67.0

>100 HU

58 HU

58 HU

85 HU

70 HU

71 HU

70 HU

89 HU

105.6

>100 HU

58 HU

58 HU

74 HU

60 HU

65 HU

64 HU

75 HU

132.6

>100 HU

58 HU

58 HU

66 HU

59 HU

67 HU

65 HU

75 HU

Second order power fits of GGB confidence data for all available lesion/acquisition
combinations resulted in the SECT attenuation (HU) necessary for 80% classification
confidence (Table 5.8). All calcification lesions greater than 0.5 cm in diameter could be
classified with 80% confidence down the minimum investigated SECT attenuation (HU)
using any of the available CTDIvol levels. Hemorrhage lesions of any size in the cerebrum
could be classified with 80% confidence down to approximately 60 HU using any of the
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CTDIvol levels investigated. Hemorrhage lesions in the skull base could be classified with
80% confidence down to approximately 70 HU using any of the CTDIvol values investigated.

Table 5.8: SECT attenuation (HU) necessary for 80% classification confidence using the GGB
method. Gray regions represent lesion/acquisition combinations that would only be
classified with 90% confidence above the 100 HU limit imposed by SECT. Green regions
represent lesion/acquisition combinations that would be classified with 90% confidence
below the minimum SECT investigated. White regions represent lesion/acquisition
combinations that would be classified with 90% confidence within the investigated lesion
2

attenuation range. Text in red indicates a curve fit R with less than 0.8.
Lesion Composition

Calcification

Lesion Location

Hemorrhage
Skull
Base

Cerebrum

Skull
Base

Cerebrum

0.5

1

1.5

1.5

0.5

1

1.5

1.5

67

>100 HU

58 HU

58 HU

62 HU

60 HU

62 HU

62 HU

70 HU

105.6

>100 HU

58 HU

58 HU

62 HU

55 HU

59 HU

59 HU

64 HU

132.6

>100 HU

58 HU

58 HU

62 HU

55 HU

60 HU

59 HU

65 HU

CTDIvol
(mGy)

Lesion Size (cm)

Probability Distribution Method
PD confidence trends with acquisition CTDIvol for all hemorrhage lesion models
(based on lesion composition not method classification) can be seen in Figure 5.9. PD
confidence trends with acquisition CTDIvol for all calcification lesion models can be seen in
Figure 5.10.
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Hemorrhage: Probability Density Method by CTDIvol (mGy)
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Figure 5.9: Probability distribution confidence in classification of hemorrhage unknown
lesions. Darker shades of red indicate higher CTDIvol levels.

Calcification: Probability Distribution Method by CTDIvol (mGy)
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Figure 5.10: Probability distribution confidence in classification of calcification unknown
lesions. Darker shades of blue indicate higher CTDIvol levels.
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Second order power fits of PD confidence data for all available lesion/acquisition
combinations resulted in the SECT attenuation (HU) necessary for 90% classification
confidence (Table 5.9). With the exception of hemorrhage lesions imaged using 132.6
mGy, 0.5 cm cerebrum lesions could not be classified with greater than 90% confidence
using any of the available CTDIvol levels. 1.5 cm calcifications in the cerebrum could be
classified with 90% confidence down to the minimum investigated SECT attenuation (HU)
using all CTDIvol levels investigated. 1.5 cm cerebrum lesions of either calcification or
hemorrhage composition could be classified with greater than 90% confidence down to the
minimum investigated SECT attenuation (HU) using 132.6 mGy CTDIvol.

Table 5.9: SECT attenuation (HU) necessary for 90% classification confidence using the PD
method. Gray regions represent lesion/acquisition combinations that would only be
classified with 90% confidence above the 100 HU limit imposed by SECT. Green regions
represent lesion/acquisition combinations that would be classified with 90% confidence
below the minimum SECT investigated. White regions represent lesion/acquisition
combinations that would be classified with 90% confidence within the investigated lesion
2

attenuation range. Text in red indicates a curve fit R with less than 0.8.
Lesion Composition

Calcification

CTDIvol
(mGY)

Lesion Location

Hemorrhage
Skull
Base

Cerebrum

Skull
Base

Cerebrum

Lesion Size (cm)

0.5

1.0

1.5

1.5

0.5

1.0

1.5

1.5

67.0

>100 HU

79 HU

58 HU

94 HU

>100 HU

64 HU

61 HU

79 HU

105.6

>100 HU

58 HU

58 HU

78 HU

>100 HU

61 HU

55 HU

62 HU

132.6

>100 HU

58 HU

58 HU

62 HU

77 HU

64 HU

56 HU

66 HU

Second order power fits of PD confidence data for all available lesion/acquisition
combinations resulted in the SECT attenuation (HU) necessary for 80% classification
confidence (Table 5.10). 1.5 cm lesions in the cerebrum could be classified with greater
than 80% confidence down to the minimum investigated SECT attenuation (HU) for both
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lesion compositions and all CTDIvol levels investigated. 1.0 cm calcification lesions in the
cerebrum were classifiable with greater than 80% confidence down to the minimum SECT
attenuation (HU) investigated. 1.0 cm hemorrhage lesions in the cerebrum resulted in
SECT attenuation (HU) necessary for 80% confidence within 2 HU of the minimum
investigated value. Both lesion compositions in the skull base were classified with greater
than 80% confidence down to the minimum investigated SECT attenuation (HU) for both
105.6 and 132.6 mGy CTDIvol acquisitions.

Table 5.10: SECT attenuation (HU) necessary for 80% classification confidence using the PD
method. Gray regions represent lesion/acquisition combinations that would only be
classified with 80% confidence above the 100 HU limit imposed by SECT. Green regions
represent lesion/acquisition combinations that would be classified with 80% confidence
below the minimum SECT investigated. White regions represent lesion/acquisition
combinations that would be classified with 80% confidence within the investigated lesion
2

attenuation range. Text in red indicates a curve fit R with less than 0.8.
Lesion Composition

Calcification

CTDIvol
(mGY)

Lesion Location

5.2.4

Hemorrhage
Skull
Base

Cerebrum

Skull
Base

Cerebrum

Lesion Size (cm)

0.5

1.0

1.5

1.5

0.5

1.0

1.5

1.5

67.0

>100 HU

58 HU

58 HU

74 HU

85 HU

58 HU

56 HU

65 HU

105.6

>100 HU

58 HU

58 HU

62 HU

76 HU

57 HU

56 HU

58 HU

132.6

>100 HU

58 HU

58 HU

62 HU

72 HU

59 HU

56 HU

58 HU

Inter-Method Correlations
Inter-method correlation of geometric bisector and probability distribution methods

resulted in a CV correlation of 6.2% and R2 linearity of 0.824. Repeated analysis for
subsets of the data based on all available parameters yielded one major source of
variability based on R2 cutoff criteria: hemorrhage lesion models (Table 5.11). BlandAltman and correlation graphs for the full data as well as the hemorrhage lesion model data
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can be seen in Figure 5.11. Removing these data from analysis reduced the overall CV
correlation to 3.9% and increased the R2 linearity to 0.938. While the estimation of intermethod correlation for only a single lesion model type is not particularly informative, it was
assessed in an effort to provide uniform analysis of correlation with and without major
sources of variability across both the differentiation (Chapter 4) and unknown lesion
studies.

Table 5.11: Sorted results of GB vs PD inter-method Bland-Altman analysis for subsets of
data based on available protocol and lesion parameters. Parameters and values above the
double line indicate worse correlation or linearity than the full data set while those below the
double line indicate improved correlation or linearity. Text in red indicates a major source of
2

variability based on CV or R cutoff criteria.
CV - Correlation

Rsquared - Linearity
2

Full Data CV

Criteria

Cutoff

Full Data R

6.25

150%

9.37

0.8242

Parameter

Value

CV

Parameter

Lesion Model

0.5 cm Cerebrum

8.2

Model Composition

Hemorrhage

0.705

Model Composition

Hemorrhage

7.9

CTDIvol

105.6

0.791

CTDIvol

105.6

6.8

RotationTime

0.8

0.791

RotationTime

0.8

6.8

CTDIvol

132.6

0.820

CTDIvol

132.6

6.2

RotationTime

0.9

0.820

RotationTime

0.9

6.2

Lesion Model

1.5 cm Skull Base

0.831

CTDIvol

67

5.8

Lesion Model

0.5 cm Cerebrum

0.834

RotationTime

0.7

5.8

CTDIvol

67

0.850

Model Composition

Calcification

3.9

RotationTime

0.7

0.850

Lesion Model

1.5 cm Skull Base

3.8

Lesion Model

1.5 cm Cerebrum

0.918

Lesion Model

1.0 cm Cerebrum

2.6

Lesion Model

1.0 cm Cerebrum

0.925

Lesion Model

1.5 cm Cerebrum

2.3

Model Composition

Calcification

0.938

150

Criteria
< 0.75
Value

R

2

Figure 5.11: Bland-Altman and Correlation graphs for inter-method correlation between GB
and PD methods. Top: Full data results including all lesion/acquisition combinations.
Middle: Results for hemorrhage lesion models, identified as a major source of variability in
Table 5.11. Bottom: Results for full data excluding hemorrhage lesion model values.
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Inter-method correlation of geometric bisector and generalized geometric bisector
methods resulted in a CV correlation of 4.7% and R2 linearity of 0.899. Repeated analysis
for subsets of the data based on all available parameters yielded one major source of
variability based on CV cutoff criteria: 0.5 cm cerebrum lesion models (Table 5.12). BlandAltman and correlation graphs for the full data as well as the hemorrhage lesion model data
can be seen in Figure 5.12. Removing these data from analysis reduced the overall CV
correlation to 3.9% and decreased the R2 linearity to 0.8608. Given the 0.5 cm cerebrum
data was not identified as a major source of variability by the linearity criteria and in fact had
greater linearity than the general data set, it is not surprising the linearity decreased in this
way. It is likely this decrease has minimal clinical significance.
Table 5.12: Sorted results of GB vs GGB inter-method Bland-Altman analysis for subsets of
data based on available protocol and lesion parameters. Parameters and values above the
double line indicate worse correlation or linearity than the full data set while those below the
double line indicate improved correlation or linearity. Text in red indicates a major source of
2

variability based on CV or R cutoff criteria.
CV - Correlation

Rsquared - Linearity
2

Full Data CV

Criteria

Cutoff

Full Data R

4.72

150%

7.08

0.8990

< 0.75

Parameter

Value

CV

Parameter

Value

R

Lesion Model

0.5 cm Cerebrum

7.3

Lesion Model

1.5 cm Skull Base

0.802

CTDIvol

105.6

5.9

CTDIvol

105.6

0.818

RotationTime

0.8

5.9

RotationTime

0.8

0.818

Lesion Model

1.5 cm Cerebrum

4.5

Lesion Model

0.5 cm Cerebrum

0.875

Model Composition

Hemorrhage

4.4

Lesion Model

1.5 cm Cerebrum

0.881

CTDIvol

67

4.4

Model Composition

Calcification

0.906

RotationTime

0.7

4.4

CTDIvol

67

0.923

Lesion Model

1.5 cm Skull Base

4.4

RotationTime

0.7

0.923

Model Composition

Calcification

4.2

Lesion Model

1.0 cm Cerebrum

0.935

CTDIvol

132.6

3.7

CTDIvol

132.6

0.947

RotationTime

0.9

3.7

RotationTime

0.9

0.947

Lesion Model

1.0 cm Cerebrum

2.6

Model Composition

Hemorrhage

0.948

152

Criteria

2

Figure 5.12: Bland-Altman and Correlation graphs for inter-method correlation between GB
and GGB methods. Top: Full data results including all lesion/acquisition combinations.
Middle: Results for 0.5 cm cerebrum lesion models, identified as a major source of variability
in Table 5.12. Bottom: Results for full data excluding 0.5 cm cerebrum lesion model values.
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5.3
5.3.1

Discussion
Effect of Lesion Parameters on Classification Confidence
Intracranial unknown lesion models 1.0 cm and larger, were correctly classified to a

SECT attenuation (HU) level beyond that currently possible using SECT using DECT and
either GB or PD methods. This improvement was present regardless of lesion location or
CTDIvol used. In general, 1.0 and 1.5 cm cerebrum lesion models were correctly classified
with 80% confidence down to approximately 60 HU using either GB or PD method and
using any of the CTDIvol levels investigated. 1.5 cm skull base lesion models were correctly
classified with 80% confidence down to approximately 70 HU using either GB or PD method
and using any of the CTDIvol levels investigated.
Classification results for 0.5 cm cerebrum lesion were less encouraging, especially
in the case of the calcification models. For both GB and PD methods, the classification
confidence for 0.5 cm calcification models was substantially less than that of the
hemorrhage models (Figure 5.13). In order to determine the cause of this difference in
classification confidence, the distance of the lesion mean value to the matched-acquisition
GB plane was plotted (Figure 5.14). Calcification models show reduced relative Euclidian
distance to the plane within the 3D-DECT environment relative to hemorrhage models for
the 0.5 cm cerebrum lesions, consistent with lower confidence in classification as defined
by our methods. In addition, the 1.0 cm cerebrum, 1.5 cm cerebrum and 1.5 cm skull base
results showed a decrease in distance to the plane for the low attenuation hemorrhage
lesions, similar to the reduced confidence in the classification of these lesions shown in
Figure 5.13. Since the pattern in distance to the plane and classification confidence is so
similar, it is reasonable to assume the reduced confidence for the calcifications occurred
due to their proximity to the differentiating GB plane.
It is worth noting however that the correct classification of small intracranial
hemorrhage is of greater clinical importance than the correct classification of small
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intracranial classification. The incorrect classification of intracranial hemorrhage as
calcification would prompt physicians to administer potentially harmful anticoagulant
therapies to patients with high risk of repeat brain hemorrhage. The incorrect classification
of intracranial calcification as hemorrhage, on the other hand, may keep physicians from
administering anticoagulant therapies however would not lead to a life threatening outcome.

Figure 5.13: Summary of GB (solid lines) and PD (dashed lines) classification confidence
based on lesion size and location. Error bars represent one SD of the CTDIvol levels
investigated. Hemorrhage data is shown in red while calcification data is shown in blue.
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Figure 5.14: Distance between unknown lesion mean value and parameter-specific GB plane.
Error bars represent one SD of the CTDIvol levels investigated. Hemorrhage model data is
shown in red while calcification model data is shown in blue.

To assess if the unknown lesion models are in some way distinct from the
differentiation lesion models used in the prior work to determine the GB plane, the mean
lesion values for both populations were plotted together on a single figure. Figure 5.15 and
Figure 5.16 show the relative position of the unknown lesion mean values (shown as
circles) to the differentiation lesion mean values (shown as Xs) for a 0.5 cm and 1.0 cm
cerebrum lesion. GB plane and fit lines for both calcification and hemorrhage derived from
data collected as part of the prior differentiation work (Chapter 4) are shown as reference.
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Figure 5.15: Visualization of unknown lesion and prior differentiation lesion mean values for
a 1.0 cm cerebrum lesion imaged using 105.6 mGy, 3.75 mm image thickness, and Standard
reconstruction filter. Acquisition matched GB plane and hemorrhage and calcification line
fits shown.

Figure 5.16: Visualization of unknown lesion and prior differentiation lesion mean values for a
0.5 cm cerebrum lesion imaged using 105.6 mGy, 3.75 mm image thickness, and Standard
reconstruction filter. Acquisition matched GB plane and hemorrhage and calcification line
fits shown.
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Visual comparison of the unknown lesion and differentiation lesion mean values for
the 1.0 cm cerebrum lesion (Figure 5.15) seems to support that both data sets occupy the
same general region of space.
For both lesion types (calcification and hemorrhage) and both model populations
(differentiation lesions and unknown lesions), the lesion means seemed to trend at lower 68
keV attenuation towards higher water density values than the linear fit would have
predicted. This trend led to lower attenuation lesion models having skewed classification
confidence due to the deviation from the linear fits used to calculate the geometric bisector
plane. For example, low attenuation hemorrhage which trended towards higher water
density brought the lesion mean artificially closer to the geometric bisector line and leaded
to an artificially low classification confidence. On the other side, low attenuation
calcification which trended towards higher water density pushed the lesion mean artificially
farther from the geometric bisector line and leaded to an artificially high classification
confidence. This discrepancy between the predicted line fit and the lesion means at the
lower 68 keV attenuations is likely due to increased distributions overlap and variability in
this lower attenuation range. This led to the geometric bisector solution being ill
characterized at the lower attenuations and eventually led to the difference in the
classification confidence between the hemorrhage and calcification unknown lesion models.
Visual comparison of the unknown lesion and differentiation lesion mean values for
the 0.5 cm cerebrum lesion (Figure 5.16) showed a much smaller angle between the
hemorrhage and calcification distributions, resulting in lesion means much closer to the GB
plane. Visual comparison also showed higher variability in the distributions for both the
unknown lesion models and differentiation lesion models. The hemorrhage mean values
from the unknown lesion study (red circles) do appear to be farther from the geometric
bisector plane than the calcification mean values (blue circles). As discussed above, high
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variability and overlap directly lead to the definition of the GB plane being ill characterized.
Without strong separation between the calcification and hemorrhage distributions to form
the plane, the definition of the plane will be suboptimal. It is likely that the small angle
between the distributions is directly responsible for the larger discrepancy between the
classification confidences derived for the hemorrhage and calcification unknown lesion
models.
While both GB and PD methods showed a discrepancy between hemorrhage and
calcification classification confidence for 0.5 cm cerebrum lesions, the effect was greater for
the GB method than for the PD method. In addition to the position of the mean lesion value
relative to the plane, the GB method uses raw voxel data to determine the confidence in the
classification. This allows the GB method to account for the variance within the lesion
distribution. The PD method however, is limited to a point measurement of probability at
the mean lesion value and does not take into account the variance in the lesion distribution.
The effect of lesion variance on final classification confidence is likely the reason the two
methods were less correlated for hemorrhage lesions (Table 5.11).

5.3.2

Effect of CTDIvol on Classification Confidence
The effect of CTDIvol on calcification classification was minimal for 0.5 cm cerebrum

lesions using either GB or PD methods. Increased CTDIvol led to increased classification
accuracy for all other lesion sizes and locations using either method. The effect of CTDIvol
on hemorrhage classification was minimal for 1.0 and 1.5 cm cerebrum lesion models using
either the GB or PD method. 0.5 cm cerebrum and 1.5 cm skull base lesion models
showed increased confidence using either the 105.6 or 132.6 mGy CTDIvol levels relative to
the 67 mGy CTDIvol level. Increased CTDIvol from 105.6 mGy to 132.6 mGy did not
universally lead to an increase in hemorrhage classification confidence (Figure 5.5, Figure
5.9). While statistical significance cannot be assessed without repeat measures, the
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difference in classification confidence between the 105.6 mGy and 132.6 mGy acquisition is
likely below clinical significance.

5.3.3

Generalizability of the Geometric Bisector Plane Solution
Based on the results of prior differentiation work, the geometric bisector plane was

found to be generalizable across acquisition protocol (see Chapter 4.2.5.5). Lesion size
and location was found to have a major effect on the plane and thus three generalized
geometric bisector solutions were identified: cerebrum lesions of 0.5 cm diameter,
cerebrum lesions of greater than 0.5 cm diameter and skull base lesions. Assuming prior
knowledge of the lesion size and location, a generalized solution could be applied, allowing
physicians to select the acquisition protocol on a case by case basis. This added flexibility
did not highly influence the confidence in lesion classification, as shown by the high degree
of correlation between the two methods (Figure 5.12). Without prior knowledge of the
lesion size and location, a plane derived from all available data, or super generalized
geometric bisector (SGGB) plane could be employed, however the classification confidence
tends to suffer (Figure 5.17 and Figure 5.18). In some cases, the application of the SGGB
plane to the unknown lesion data seems to improve the confidence in classification. This is
however a simple bias in the results due to misregistration between the SGGB plane and
the unknown lesion data, and the overall confidence across the paired calcification and
hemorrhage lesion results is not improved. Because of this, the SGGB method should be
avoided.
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Figure 5.17: Summary of geometric bisector results for hemorrhage lesions by availability of
prior knowledge. GB (dotted line) is lesion and acquisition parameter-specific and thus
requires prior knowledge of the lesion size and location and acquisition to be used. GGB
(dashed line) requires knowledge of only the lesion size and location. SGGB (solid line)
assumes no prior knowledge of either the lesion or acquisition.
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Figure 5.18: Summary of geometric bisector results for calcification lesions by availability of
prior knowledge. GB (dotted line) is lesion and acquisition parameter-specific and thus
requires prior knowledge of the lesion size and location and acquisition to be used. GGB
(dashed line) requires knowledge of only the lesion size and location. SGGB (solid line)
assumes no prior knowledge of either the lesion or acquisition.

5.3.4

Protocol Recommendations for Optimal Classification Confidence
Based on the above discussed effect of lesion and acquisition parameters on

classification confidence, several recommendations can be formed. 105.6 and 132.6 mGy
CTDIvol acquisitions generally yielded similar results, with the exception of low-attenuation
calcification lesion models in the skull base where increased dose led to substantially
higher classification confidence. For both the calcification and hemorrhage lesion model
analysis, 67 mGy CTDIvol acquisitions led to substantially reduced classification confidence
in all lesion sizes and locations. Thus it is recommended that without prior knowledge of
lesion size, location or attenuation, CTDIvol values less than or equal to 67 mGy be avoided.
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Lesions known to be in the skull base would benefit from the added classification
confidence associated with the 132.6 mGy CTDIvol level.
Given that the GB and PD methods resulted in highly correlated data (Figure 5.11),
the GB method is recommended due to its increased simplicity and ease of use. The PD
method, while effective, requires additional statistical analysis and does not take into
account the distribution of voxels within the unknown lesion. While the lesion and
acquisition parameter-specific GB method is supported when both lesion and acquisition
specifics are known, the GGB method can be employed for more flexibility in protocol
selection.

5.3.5

Limitations
In addition to the limitations associated with phantom materials discussed in

Chapter 4.3.6, the results of this work are limited by the methods employed for unknown
lesion classification. Both the GB and PD methods assumed additive binary classification
and therefore did not allow for identification of materials other than hemorrhage and
calcification. Applying this method to intracranial lesions other than hemorrhage or
calcification would result in incorrect classification of the intracranial lesion as either
hemorrhage or calcification. In addition, the probability distribution method was employed
assuming voxel data was independent due to computational limits. Assuming some
structure or dependence within the voxel data might strengthen the model. Future work
includes pursuing this structured model as well as employing cross validation and
independent validation through a trainer-validation approach. Finally, a Bayesian logistic
model could be pursued to allow for the derivation of upper and lower confidence intervals
on the confidence in lesion classification.
While this project represents our best approximation of intracranial lesion
classification in patients, there are still several limitations on clinical implementation using
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these data. Calcification and hemorrhage lesion models were created using a cylindrical
shape, and assessed at three sizes (0.5, 1.0 and 1.5 cm) and two locations within the
cranium (cerebrum and skull base). Given the large differences in both differentiation
accuracy and classification confidence between the 0.5 cm and 1.0 cm cerebrum lesions,
further investigation into intermediate sizes is warranted. Calcification and hemorrhage
lesion models were created to be homogeneous and free of contamination and as such, the
effect of heterogeneity and contamination on classification confidence cannot be assessed.
Finally, the applicability of the geometric bisector plane equations to patient data cannot be
established without further investigation beyond that possible in a phantom study.
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Chapter 6

6

Dual-Energy CT Quality Control Program Development

This chapter investigates the accuracy and stability of dual-energy data derived from
DECT scanning based on a phantom and protocol variations. Given that the data collection
for Chapters 3-5 spanned several years, verification that the data and results collected
throughout the dissertation research are comparable is necessary. A dual-energy quality
control phantom system was developed to evaluate a number of test metrics including
uniformity, noise, iodine accuracy and monoenergetic attenuation (HU) stability. In order to
evaluate the effect of acquisition parameters on the results of these test metrics, quality
control protocols were developed to cover a wide range of protocol variation. In addition,
inter- and intra-scanner variances were assessed to inform the design of a future
prospective clinical trial.

6.1

Introduction
Recently, the ACR has released its recommendations for routine quality control of

computed tomography scanners, including daily monitoring of the mean and standard
deviation of the CT number of water and artifact analysis (105). While this document
represents an excellent standard for use with single-energy CT imaging, little attention has
been paid to quality control of clinical dual-energy CT systems. These scanners often
incorporate more advanced hardware such as the fast-kVp switching system used by GE
(29) or the dual-source system used by Siemens (27,28). In addition, dual-energy CT
scanners produce distinct image types such as virtual monoenergetic, virtual non-contrast
and material density images that are unique to dual-energy imaging (37,106). Neither the
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capabilities of this hardware nor the consistency of these unique image types can be
monitored using a single-energy quality control program.
Since the release of the first clinical dual-energy CT scanner in 2005 (27), many
studies have been performed in an attempt to characterize the system response. Of
particular interest was the use of the virtual monoenergetic reconstructions, which allow for
variable contrast by modulating the keV of the reconstruction and thus the relative influence
of photoelectric and Compton processes (22,35,99). Several studies have shown that
monoenergetic reconstructions of 65 to 72 keV provide improved iodine contrast-to-noise
ratio (CNR) compared to standard single-energy acquisitions of 100kVp or greater
(41,62,107). Evaluation of noise for the monoenergetic reconstructions has shown a similar
range of 65 to 77 keV to have equivalent or improved noise measurements relative to
traditional single-energy CT (41,42,48,63,107). Zhang et al. investigated the noise
properties of the monoenergetic reconstructions based on the fast-kVp switching technique.
They concluded that while the shape of the noise power spectrum (NPS) curve was similar
regardless of reconstruction keV, noise was optimal at 65 keV but lower energy
reconstructions resulted in higher noise (42). In addition to noise and CNR, dual-energy
images have also been evaluated for spatial resolution (42) and low contrast detectability
(43). Due to the theoretical reduction in beam hardening possible with dual-energy
techniques (22,35,99,106), monoenergetic images have been investigated for their
reduction in beam hardening from bone (48,108), as well as reduction in metal artifact
(109–113).
Since dual-energy CT is used in an increasingly quantitative fashion, it is vital to
validate the attenuations derived from monoenergetic reconstructions as well as the
material concentrations derived from material density images. Of particular interest has
been the accuracy of iodine, either using calculated concentration (56,114,115) or
enhancement (106,116,117) based on iodine overlay images provided by Siemens systems
166

or concentration values from a material density image provided by GE systems (42,118). In
general, measurements of iodine concentration and enhancement were found to be highly
correlated with true iodine concentration (56,115,118). Iodine accuracy was shown to vary
with position within a phantom by Zhang et al. (42), however the opposite was found by
Matsuda et al. (118). It is worth noting, however, that Matsuda et al. evaluated iodine
accuracy solely based on a 65 keV monoenergetic reconstruction and not with material
density images. Iodine accuracy was also shown to decrease with increasing phantom size
(115), however, this effect has been disputed by other studies (56,106,118). Evaluation of
the attenuation accuracy for monoenergetic reconstructions has shown dependence on
phantom size, as well as greater inaccuracies for dense materials for low keV
reconstructions (61). This effect may be due to lesser correction of beam hardening effects
for these energies. The presence of tin filtration has also been shown to effect the
attenuation from monoenergetic reconstructions created using the Siemens systems
(116,117).
While these studies have shed light on the characterization of these dual-energy CT
systems, evaluation has yet to be performed on multiple scanners over time in order to lay
the framework for a dual-energy quality control (DEQC) process. In this paper, we develop
a phantom system and protocol for collection of these data. Protocol development will
cover a wide range of acquisition parameters and dual-energy reconstructions. Metrics
evaluated will include iodine accuracy and stability of the attenuations derived from
monoenergetic reconstructions, as well as, single-energy QC analogs such as noise and
uniformity. Longitudinal data will be acquired in order to develop a clinically implementable
quality control program for long-term validation of dual-energy CT data.
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6.2
6.2.1

Materials and Methods
Phantom Design
In order to validate both body specific and neuro specific GSI-presets as part of our

DEQC program, a two-part phantom was designed (Figure 6.1). The outer shape of the
phantom was elliptical in design to better approximate the shape of the human torso. The
phantom dimensions were 30 cm in height by 40 cm in width to mimic the challenges of
imaging a somewhat larger patient with a waist circumference of 109 cm. This elliptical
body phantom contained an insert 22 cm in diameter which could be removed for separate
scanning of the neuro specific GSI-presets. When separate from the body phantom, this
insert will be referred to as the “head phantom”. Both phantoms were designed to be 15 cm
in length (z-direction) to allow for continuous helical acquisition.
Unfortunately a 15 cm thick piece of solid water could not be obtained for fabrication
of the phantom, therefore three separate 5 cm thick slabs were used. To ensure the slabs
would not drift apart with use, fixation bolts were added to keep the slabs tightly pressed
together. Two bolts were included in the head phantom, while four were included in the
body phantom. The bolts in the head phantom were constructed to allow for the inclusion
of a polyvinyl chloride (PVC) bar, 14 cm by 3.8 cm and 2.5 cm deep to provide a surface for
use of a bubble level on both phantoms (see Figure 6.1). The bolts were fabricated using
high density polyethylene (HDPE) and threaded on one side to allow for manual tightening.
The body and head phantom were both machined from the same pieces of solid water, so a
1 cm wide, HDPE slip-ring was needed between the head and body phantom portions to
replace material lost during milling. This ring was permanently affixed to the inside of the
body phantom and remained attached to the body phantom shell when the head phantom
was removed for separate scanning.
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Figure 6.1: Basic structure and measurements of DEQC phantom. Solid water components
are shown in dark brown, HDPE components in tan and PVC in light gray.

6.2.1.1 Tissue and Material Inserts
Due to DECT’s focus on tissue characterization and material separation, a variety of
tissue and material inserts were included in the DEQC phantom (Table 6.1). Insert
compositions were chosen based on current clinical applications of DECT, as well as the
prevalence of materials or tissue types in research studies and emerging applications. The
concentrations of various materials selected were then referenced to either clinically used
values, as in the case of the iodine enhancement rods, or relevant concentration in the
human body, as in the case of the calcium rods. For the calcium and iodine material
inserts, three concentrations were selected so that the linearity of the DECT response to
the material could be assessed over a range of concentrations in both the head and body
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phantom. The arrangement of the inserts within the phantom is shown in Figure 6.2 and
was determined based on the reduction of beam hardening and test metric considerations
(see Chapter 6.2.2). The insert rods measure 2.8 cm in diameter and extend the entire 15
cm length of the phantom.
Table 6.1: List of DEQC phantom insert types.
Insert
Blood
Blood
Blood
Calcium
Calcium
Calcium
Iodine
Iodine
Iodine
Iodine
Enhancement
Iodine
Enhancement
Soft Tissue
Adipose
Brain

Background
Solid Water
Solid Water
Solid Water
Solid Water
Solid Water
Solid Water
Solid Water
Solid Water
Solid Water
Solid Water
Solid Water
NA
NA
NA

Additive
Fe2O3
Fe2O3
Fe2O3
CaCo3
CaCo3
CaCo3
C6H5I
C6H5I
C6H5I
Fe2O3 +
C6H5I
Fe2O3 +
C6H5I
NA
NA
NA

HU at 120 kVp
40
70
100
198
334
838
51
128
356
40+50
40+100
35
-100
15

Biology Modeled
Blood
Clot (Normal)
Clot (Extreme)
Calcification
Bone
Bone (dense)
NA
NA
NA
Typical enhancement
threshold for neuro studies
Typical enhancement
threshold for thoracic studies
Soft Tissue
Adipose
Brain

Figure 6.2: DEQC insert layout with average 120kVp HU level of inserts labeled.
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To ensure repeatable positioning of the rod inserts within the DEQC phantom, a
thin, transparent polycarbonate plate was added to the back surface of the phantom (Figure
6.3a). This would allow the rods to be positioned flush with this fixed surface, allowing
repeatable positioning. In addition, the plate was designed with several 2 cm diameter
holes, matching the positions of the rod inserts so that a thin tool through the hole in the
plate and the inserts could be easily removed. The plate was affixed to the posterior slab of
the body phantom by three solid water bolts extending 2 cm into the body phantom. To
ensure the proper alignment of the head insert within the body phantom, an orientation peg
was added to the posterior surface of the head phantom, and a matching hole was drilled
through the acrylic plate (Figure 6.3b). The surface of the peg was rounded, allowing the
peg to naturally seek its corresponding hole in the acrylic alignment plate without significant
effort on the part of the user.

Figure 6.3: a) Polycarbonate plate attached to back of phantom with solid water bolts visible
at the bottom and side periphery of the phantom (white arrows). b) Detail of lower solid water
bolt as well as the orientation plug (red arrow) used to ensure proper alignment of the head
phantom within the body phantom.
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6.2.1.2 Insert Validation
Material and tissue equivalent inserts detailed in Table 6.1 were acquired from
Gammex, Inc. All inserts underwent both quantitative and qualitative testing to ensure
uniformity, accuracy and if needed, inter-comparability. Inserts were scanned using a
vendor-provided 20 cm diameter, 15 cm long solid water phantom with eight insert
positions. Two water balloons were inserted in the positions on either side of the DEQC
insert under evaluation to minimize artifacts or beam hardening. The phantom was then
imaged using the scan protocol in Table 6.2 which included several vendor-specified
protocols (series 3-6). Images were viewed with GSI viewer software (Version 2; GE
Healthcare). Using 20 mm x 20 mm ROIs, quantitative data (Table 6.3) was collected at
several points along the insert, and all images were viewed for any signs of defects. Any
inserts not uniform to within 2 HU along their length or showing any visible defects were
returned to the vendor for replacement. The three soft tissue inserts included in the
phantom were further validated to verify they were interchangeable based on both their
single-energy attenuation data and dual-energy spectral curves.

Table 6.2: DEQC insert validation protocol. For all series: SFOV: Head, DFOV: 25 cm, Filter:
Standard.
Series

Mode

1

SE

2

DE

3

SE

4

SE

5

SE

6

SE

Name
Routine
Brain
GSI - 26
Brain
Gammex
Val 80kV
Gammex
Val 100kV
Gammex
Val 120kV
Gammex
Val 140kV

Scan
Type

Pitch

Rot
(s)

Beam
Width
(mm)

Image
Thickness
(mm)

Interval
(mm)

kVp

mA

Helical

0.531

0.8

20

3.75

3

140

160

Helical

0.531

0.7

20

3.75

3

80/140

375

Axial

1

1

40

5

40

80

250

Axial

1

1

40

5

40

100

250

Axial

1

1

40

5

40

120

250

Axial

1

1

40

5

40

140

250
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Table 6.3: Reconstructions created from DEQC validation data and quantitative data acquired.
Series

Mode

Description/Reconstruction

1

SE

Routine Brain

Mean

SD

102

DE

50 keV

Mean

SD

102

DE

70 keV

Mean

SD

102

DE

100 keV

Mean

SD

102

DE

140 keV

Mean

SD

102

DE

Water (Iodine)

Mean

SD

102

DE

Iodine (Water)

Mean

SD

102

DE

Water (Calcium)

Mean

SD

102

DE

Calcium (Water)

Mean

SD

3

SE

Gammex Val 80kV

Mean

SD

4

SE

Gammex Val 100kV

Mean

SD

5

SE

Gammex Val 120kV

Mean

SD

6

SE

Gammex Val 140kV

Mean

SD

6.2.2

Quantitative Data Acquired

Test Metrics
SECT QC has converged on a number of routine tests reflecting important imaging

parameters: standard deviation of water (noise), mean CT# of water (absolute CT number
accuracy), artifact analysis (detector uniformity), Uniformity (field homogeneity) and
Linearity (relative CT number accuracy). Due to the unique capabilities and imaging
concerns revolving around DECT, as well as the structure of our DEQC phantom,
modifications were made to these standard SEQC tests.
Noise is usually assessed over a large ROI in a uniform phantom, however due to
the constraints of our phantom model, noise was assessed as the standard deviation within
the brain insert in the head phantom portion of the DEQC phantom system. This insert is
present during both body phantom and separate head phantom scanning and is the insert
with the SECT attenuation (HU) closest to water (15 HU vs 0 HU). This noise test metric
was applied to both monoenergetic and material density image types.
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Due to the ability of DECT to create virtual monoenergetic data visualizations at a
variety of different keV levels, the concept of absolute CT number accuracy takes on an
additional dimension. An effective DEQC program must not only test that the CT number is
consistent using a single protocol, but that it is also spectrally consistent over a range of
monoenergetic visualizations. This new test metric, Monoenergetic HU Stability, was
defined as the average CT number over all voxels within the three soft tissue rods in the
DEQC phantom. This definition provides positional independence due to the spacing of the
soft tissue rods within the phantom as well as basing the metric in a clinical CT number
range (approximately 35 HU). To allow for the verification of Monoenergetic HU Stability at
various points along the dual-energy spectral curve, four keV energy levels were chosen:
50 keV, 70 keV, 110 keV and 140 keV. These specific keV energy levels were selected
due to their common clinical use for iodine conspicuity – 50 keV (62), 120kVp corollary and
low noise – 70 keV (41,107), and metal artifact reduction – 140 keV (110,111,113),
respectively.
In SECT, linearity is assessed by documenting the mean CT number of several
substances, most commonly, water, air and acrylic. While the mean CT number of water is
meant to be an absolute measure of CT number accuracy, linearity, is more a relative
measure of CT number accuracy, because the Hounsfield unit is a material’s linear
attenuation relative to that of water. In DECT, the process of material decomposition is
used to create paired material density images which display the densities of two different
materials that together would mimic the attenuation properties of the target material or
tissue (29,37). These material density images are expressed in mg/mL and, unlike
Hounsfield numbers, are absolute measures of a physical quantity associated with the
material or tissue. These values can be quantitative if the material is made solely of the two
materials present in the material basis pair. For example, a water/iodine material
decomposition of a solution of iodine and water should yield accurate material densities on
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both images. To test the accuracy and linearity of this response, three inserts consisting
solely of solid water and iodine were included in the DEQC phantom, each with a different
known density of iodine. The accuracy of the material density on the iodine material density
image from a water/iodine material decomposition was then compared to the known iodine
density for each rod. This value was investigated as both absolute error and percent error
relative to the known iodine material density for each of the three rods.
While uniformity is commonly defined in a water phantom, the heterogeneity of our
DEQC phantom required modification from this classical definition. Soft tissue rods were
positioned at the center of the DEQC phantom, periphery of the DEQC head phantom and
periphery of the DEQC body phantom (Figure 6.2). To minimize the potential of beam
hardening from linearly positioned inserts, the head phantom peripheral inserts were offset
from body phantom peripheral inserts. Uniformity was then defined as the mean ROI value
of the most peripheral soft tissue rod minus the mean ROI value of the central soft tissue
rod. Uniformity was assessed on both monoenergetic and material density image types.
Both water and iodine material density images were assessed due to the differing influence
of the 80 and 140kV acquisitions on these image types. Water density images have a
higher percent contribution from the higher 140kV beam, while iodine density images have
a higher percent contribution from the lower 80kV beam. Given that the two energies would
likely be effected by phantom (or patient) size and beam hardening to different extents, the
collection of uniformity data using both water and iodine density images was pursued.
A full list of test metrics included in the DEQC program as well as applicable image
types can be found in Table 6.4.
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Table 6.4: List of test metrics included in DEQC program and their application to various
image reconstruction types, as well as the composition and position of the rods used to
evaluate the metric.

Test Metric

Noise

Monoenergetic
HU Stability

Iodine
Accuracy

Uniformity

Rod
Composition

Brain

Soft Tissue

Iodine

Soft Tissue

X
X
X
X
X
X

X
X
X
X

Image Type

Rod Position

50 keV
70 keV
110 keV
140 keV
Iodine (Water)
Water (Iodine)

6.2.3

X

X
X
X
X
X
X

Protocol Development

6.2.3.1 DEQC Protocol Version 1: Initial Data Collection
In order to determine which acquisition parameters may play a role in the overall
performance of the DECT system and would warrant further investigation, highly variable
scan protocols were designed for both the head and body phantoms. Both protocols
contained variations in CTDIvol, rotation time, image thickness and pitch. For the head
phantom, three GSI-presets were chosen covering a CTDIvol range of 36.7 to 132.6 mGy,
rotation times from 0.5 to 1s, pitch values of 0.531 and 0.969 and two image thicknesses,
1.25 and 3.75, selected for their clinical applicability (Table 6.5). For the body phantom,
four GSI-presets were chosen covering a CTDIvol range of 10.3 to 62 mGy, rotation times
from 0.5 to 1s, pitch values of 0.516 and 0.984 and two image thicknesses, 2.5 and 3.75,
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selected for their clinical applicability (Table 6.6). Both protocols included a single energy
acquisition selected to mimic a current routine SECT protocol.

Table 6.5: Head Phantom DEQC Protocol Version 1. All acquisitions used helical acquisition
mode, beam width of 20 mm, Head SFOV, DFOV of 25 cm, and Standard reconstruction
algorithm. A total of 5 images were acquired per group.
Series

Name

GSI-Preset

Pitch

Rot (s)

mA

CTDIvol (mGy)

Img Thk (mm)

2

Single Energy

(120kVp)

0.531

1

300

54.65

3.75

3

GSI-26

GSI-26

0.531

0.7

375

67

1.25

GSI-26

0.531

0.7

375

67

3.75

GSI-26

0.969

0.7

375

36.7

1.25

GSI-26

0.969

0.7

375

36.7

3.75

GSI-20

0.531

0.5

630

81.4

1.25

GSI-20

0.531

0.5

630

81.4

3.75

GSI-20

0.969

0.5

630

44.6

1.25

GSI-20

0.969

0.5

630

44.6

3.75

GSI-9

0.531

0.9

600

132.6

1.25

GSI-9

0.531

0.9

600

132.6

3.75

GSI-9

0.969

0.9

600

72.7

1.25

GSI-9

0.969

0.9

600

72.7

3.75

4

5

GSI-20

GSI-9
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Table 6.6: Body Phantom DEQC Protocol Version 1. All acquisitions used helical acquisition
mode, beam width of 40 mm, Large Body SFOV, 42 cm DFOV, and Standard reconstruction
algorithm. A total of 5 images were acquired per group.
Series

Name

GSI-Preset

Pitch

Rot (s)

mA

CTDIvol (mGy)

Img Thk (mm)

2

Single Energy

(120kVp)

0.984

0.5

400

12.46

2.5

3

GSI-36

GSI-36

0.516

0.8

260

19.6

2.5

GSI-36

0.516

0.8

260

19.6

5

GSI-36

0.984

0.8

260

10.3

2.5

GSI-36

0.984

0.8

260

10.3

5

GSI-1

0.516

0.5

630

33.9

2.5

GSI-1

0.516

0.5

630

33.9

5

GSI-1

0.984

0.5

630

17.8

2.5

GSI-1

0.984

0.5

630

17.8

5

GSI-10

0.516

0.8

600

48.6

2.5

GSI-10

0.516

0.8

600

48.6

5

GSI-10

0.984

0.8

600

25.5

2.5

GSI-10

0.984

0.8

600

25.5

5

GSI-5

0.516

1

600

62

2.5

GSI-5

0.516

1

600

62

5

GSI-5

0.984

1

600

32.5

2.5

GSI-5

0.984

1

600

32.5

5

4

5

6

GSI-1

GSI-10

GSI-5

Both the DEQC head and body protocols included several dual-energy
reconstructions. These reconstructions were selected based on the test metrics listed in
Chapter 6.2.2 and are shown in Table 6.7. They include monoenergetic reconstructions at
50 keV, 70 keV, 110 keV and 140 keV, used in tests of monoenergetic HU stability,
uniformity and noise. Also included were material density images from a water/iodine
material decomposition, used in tests of iodine accuracy, uniformity and noise. For all
reconstructions, the minimum number of images allowable were created to facilitate data
transmission and storage. The minimum number of images allowed using a material
density reconstruction was one, while monoenergetic reconstructions required the full
image set to be reconstructed.
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Table 6.7: Dual-energy reconstructions applied to all dual-energy acquisitions in both the
version 1 DEQC Body and Head protocols. The number of images reconstructed was based
on the minimum setting for each reconstruction type: five for monoenergetic and one for
material density.
Recon

Recon Name

Dual-energy Recon Details

No. of Images

R1

Mega Mono

70 keV + GSI Data File

5

R2

Water (Iodine)

Water(Iodine)

1

R3

Iodine (Water)

Iodine(Water)

1

R4

70 keV

70 keV

5

R5

110 keV

110 keV

5

R6

140 keV

140 keV

5

Manual

50 keV

50 keV

5

These protocols were used to scan the DEQC head and DEQC body phantoms ten
times over the course of two weeks on a single GE 750HD CT scanner to assess intrascanner repeatability, and twice on nine other scanners to assess inter-scanner
repeatability. The results of this trial were used to inform the development of the DEQC
protocol version 2 for extended data collection.

6.2.3.2 DEQC Protocol Version 2: Extended Data Collection
After the initial data collection based on DEQC Protocol Version 1, a second
protocol version was developed to target those factors found influential while removing
those found unnecessary for further investigation (see Chapter 6.3.1). Additional GSI
presets were included in both the head and the body protocols to better separate the dose
and rotation time effects. In each protocol, GSI presets were chosen that had similar
CTDIvol values but with different rotation times. Three such groups were found among the
body GSI presets, while only one dose matched pair was found among the head GSI
presets. Pitch was varied solely to provide additional variation in CTDIvol across the limited
GSI-preset options. Image thickness was reduced to a single value across both head and
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body phantom protocols to allow for more direct comparison of DEQC results. A 5 mm
thickness was selected due to its clinical applicability and reduced noise. Prep group
delays were added between all acquisitions to minimize tube cooling delays. The updated
DEQC head and body phantom protocols are shown in Table 6.8 and Table 6.9 for the
head and body phantoms, respectively.

Table 6.8: DEQC Head Phantom Protocol Version 2. All acquisitions used helical scan mode,
20 mm beam width, Head SFOV, 25 cm DFOV, and Standard reconstruction algorithm.
Series

GSI-Preset

Pitch

Rot (s)

mA

CTDIvol (mGy)

Img Thk (mm)

Prep (s)

1

GSI-30

0.531
0.531
0.531
0.969
0.531
0.969
0.969
0.969

0.8
0.5
0.7
0.6
0.8
0.5
0.7
0.8

550
630
375
640
208
630
375
208

105.6
81.4
67
54.7
47.8
44.6
36.7
26.2

5
5
5
5
5
5
5
5

0
15
15
15
15
15
15
15

GSI-20
GSI-26
GSI-19
GSI-39
GSI-20
GSI-26
GSI-39

Table 6.9: DEQC Body Phantom Protocol Version 2. All acquisitions used helical scan mode,
40 mm beam width, Large Body SFOV, 42 cm DFOV, and Standard reconstruction algorithm.
Series

GSI-Preset

Pitch

Rot (s)

mA

CTDIvol (mGy)

Img Thk (mm)

Prep (s)

1

GSI-5

0.516
0.516
0.516
0.984
0.984
0.984
0.516
0.516
0.984
0.984

1
0.8
0.5
1
0.8
0.5
0.6
0.7
0.5
0.8

600

62
48.6
33.9
32.5
25.5
17.8
17.4
17.2
10.3
10.3

5
5
5
5
5
5
5
5
5
5

0
15
15
15
15
15
15
15
15
15

GSI-10
GSI-1
GSI-5
GSI-10
GSI-1
GSI-54
GSI-48
GSI-51
GSI-36

600
630
600
600
630
275
260
360
260
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Table 6.10: Dual-energy reconstructions applied to all dual-energy acquisitions in both the
version 2 DEQC body and head protocols. The number of images reconstructed was based
on the minimum setting for each reconstruction type: five for monoenergetic and one for
material density.
Recon

Recon Name

Dual-Energy Recon Details

No. of Images

R1

Mega Mono

70 keV + GSI Data File

5

R2

Water(Iodine)

MD: Water(Iodine)

1

R3

Iodine(Water)

MD: Iodine(Water)

1

R4

70 keV

70 keV

5

R5

110 keV

110 keV

5

R6

140 keV

140 keV

5

Manual

50 keV

50 keV

5

Weekly DEQC scans were performed on ten GE 750HD CT scanners over a 12
week period in order to characterize the test metric dependence on acquisition parameters,
assess inter-scanner and intra-scanner variance and to inform the creation of a streamlined
DEQC protocol appropriate for clinical implementation.

6.2.4

Data Collection

6.2.4.1 DEQC Protocol Version 1
Due to inherent limitations on the GE 750HD CT scanners, 50 keV reconstructions
could not be made automatically and necessitated manual intervention. The GSI data file
for each acquisition was opened using the GSI viewer (version 2, Wakausha, WI) available
on the scanner at time of scan. A 50 keV reformat was then created and saved as a
separate series. This series, along with all other images acquired or reconstructed as part
of the DEQC Protocol Version1 were transferred to a local workstation where the data were
downloaded for further analysis. A representative image from the DEQC body phantom
data with an S0 image location was then opened using the GSI viewer (version 2,
Waukesha, WI) and 20 mm diameter ROIs were placed on all inserts. Each ROI was saved
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as a comma delimited file to retain the spatial coordinates of each voxel contained within
the ROI. This procedure was then repeated for a representative image from the DEQC
head phantom.
All images were loaded into Matlab (Version 2014a, MathWorks) and filtered to
retain only those images with an S0 image location. Comma delimited ROI files from both
the representative DEQC body and head phantoms were loaded into Matlab and the spatial
coordinates of each voxel were transformed into voxel locations using the known DFOV
and image matrix dimensions. The voxel locations for each ROI were then applied to the
appropriate phantom images and the mean and standard deviation calculated. Test metrics
were calculated for appropriate image types for both the DEQC body and head phantom.
The ROI summary statistics, as well as the results of the test metrics were then written out
to a text file for all images and exams.
Test metric results were plotted against a range of acquisition parameters to isolate
parameters with the greatest impact on dual-energy QC. Those with limited or well
established effects on test metrics were excluded, while acquisition parameters with
marked and uncharacterized effects on test metrics were retained for further study.

6.2.4.2 DEQC Protocol Version 2: Creation of an In-House AutoQC Program
Due to the large amount of data collected as part of this protocol as well as the long
duration of data collection, a more automated and robust analysis method was needed.
Weekly DEQC exams were sent to a DICOM server which archived all relevant images in a
MySQL database (Oracle, Redwood City, CA). A custom analysis program was written in
Python which processed the images allowing for collection of DEQC results and test
metrics. The analysis program, or AutoQC, queried unprocessed images from the MySQL
database with image location equal to S0. The AutoQC then segmented the phantom from
the surrounding air by means of k-means segmentation (119) followed by post-processing
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using a morphological closing operator to remove small air gaps and outliers (120). This
mask was then processed to identify the two centrally-located fixation bolts and the mask
was transformed using a Radon transform to produce a sinogram (121). In sinogram
space, the center of the phantom is identified by minimizing the sum of the squares of the
distance between the center of the phantom and its periphery, while any rotation in the
phantom was identified by the average of the angles between the phantom center and the
left and right fixation bolts. After the phantom image was centered and corrected for
rotation, 12 mm diameter ROIs were applied to all rods based on a lookup table which
contains distances from the center of the phantom as well as angles from the center of the
right fixation bolt. Mean and standard deviation values were calculated for each ROI and
saved to a separate MySQL database for archival.
A web interface was developed in Python (Python Software Foundation), to allow for
download of the DEQC ROI statistics as well as visualization of DEQC results. The
interface allowed both scanner-specific and date range searches of the database. For each
exam, a single representative image was shown as well as representative test metrics
calculated from the ROI statistics. Test metrics falling outside established constraints can
be displayed in red for increased ease of identification.

6.2.4.3 DEQC Protocol Version 2: Statistical Analysis
In order to assess whether changes in acquisition parameters resulted in statistically
significant changes in the test metric results, linear mixed models were used (122). This
method was able to take into account any correlation between the multiple measurements
from a given scanner. In the case where the overall likelihood ratio test was significant
implying differences between groups, pairwise comparisons with Tukey-Kramer adjustment
were performed between the values for a given acquisition parameter (122). In the case of
noise, values were logarithmically transformed before statistical modeling due to right
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skewness. Statistical significance was set at a two-sided p-value of 0.05. Variance
component analysis was performed on uniformity, iodine accuracy and monoenergetic HU
stability to estimate both inter-scanner and intra-scanner variation (122). All statistical
analysis was performed using SAS version 9 (SAS Institute, Cary, NC).

6.3
6.3.1

Results
Determination of Relevant Acquisition Parameters
Results of DEQC protocol version 1 (Chapter 6.2.4.1) are shown in Table 6.11 and

Table 6.12 for the DEQC body phantom and DEQC head phantom respectively. CTDIvol
was found to influence iodine accuracy, monoenergetic HU stability and noise for the DEQC
body phantom, and only iodine accuracy and noise for the DEQC head phantom. While the
relationship between CTDIvol and noise is known, the effect on the other two metrics
warranted further investigation. Rotation time was found to influence iodine accuracy,
uniformity and noise using both the DEQC body and DEQC head phantoms. Effects due to
CTDIvol and effects due to rotation time were compounded due to the fixed nature of the
GSI-presets. Future investigation would require the two parameters to be separated
through the selection of GSI presets where one parameter (e.g. CTDIvol) could be varied
independently of the other (e.g. rotation time). Other than the obvious association with
dose, pitch was found to have no effect on any of the test metrics for either the DEQC body
or DEQC head phantoms and was therefore excluded from further analysis. Image
thickness was only found to affect noise using either the DEQC body or DEQC head
phantom. Given that this effect is known and straightforward, image thickness was also
excluded from further analysis.
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Table 6.11: Results of DEQC protocol 1 for the DEQC Body phantom showing which factors
were found to influence the test metrics investigated. Marked cells indicate that the
acquisition parameter was found to have an effect on the test metric. Empty cells indicate no
effect was identified.

Test Metric

Acquisition Parameter
CTDIvol

Rotation
Time

Iodine Accuracy

X

X

Monoenergetic HU Stability

X

Uniformity

Pitch

Image
Thickness

X

Noise

X

X

X

Table 6.12: Results of DEQC protocol 1 for the DEQC head phantom showing which factors
were found to influence the test metrics investigated. Marked cells indicate that the
acquisition parameter was found to have an effect on the test metric. Empty cells indicate no
effect was identified.

Test Metric

Acquisition Parameter

6.3.2

CTDIvol

Rotation
Time

X

X

Iodine Accuracy

Pitch

Image
Thickness

Monoenergetic HU Stability
Uniformity
Noise

X
X

X

X

DECT Response by Test Metric
For each test metric under evaluation, results were plotted against all acquisition

parameters investigated to determine the parameter(s) responsible for trends in the test
metric results. In some cases, the effect was complex, requiring the visualization of primary
and secondary effects on the test metric. In the figures that follow, primary effects are

185

shown on the lower portion of the x-axis while secondary effects are shown directly above
the primary. Results are shown by scanner to allow for a visual interpretation of the interscanner variance. Results for the inter- and intra-scanner variance (based on statistical
analysis described in Chapter 6.2.4.3) were also investigated graphically and primary and
secondary effects determined.

6.3.2.1 Iodine Accuracy
DEQC Body Phantom:
Iodine accuracy using the DEQC body phantom was found to be affected primarily by
effective milliampere-second (mAs) and secondarily by CTDIvol for all three iodine rods
investigated (Figure 6.4). Images obtained using low mAs protocols tended to overestimate the iodine concentration in the case of the 2 mg/mL rod, however the iodine
concentration for the 5 mg/mL rod was under-estimated. Effects of both mAs and CTDIvol
were fairly limited for the 15 mg/mL rod. The variation in the effect of these parameters
could potentially be due to their position within the phantom and their surrounding
environment (e.g. the effect of surrounding material rods). Both inter- and intra- scanner
variance were primarily affected by CTDIvol and secondarily affected by mAs likely
indicating the effect of image noise on the repeatability of these results.
Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, mAs, on iodine accuracy in the DEQC body phantom can be seen in Table 6.13.
The over-estimation of the 2 mg/mL iodine rod and the under-estimation of the 5 mg/mL
iodine rod at low mAs values can been seen in the reversed ranking order.
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Figure 6.4: DEQC body phantom results for iodine accuracy. Left: Iodine accuracy trends
sorted primarily by mAs and secondarily by CTDIvol for 2 mg/mL, 5 mg/mL, and 15 mg/mL
iodine rods displayed by scanner. Right: Iodine accuracy inter- and intra-scanner variance
trends sorted primarily by CTDIvol and secondarily by mAs for 2 mg/mL, 5 mg/mL, and 15
mg/mL iodine rods.
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Table 6.13:DEQC body phantom results for the effect of mAs on iodine accuracy based on
linear mixed model analysis.
Iodine Rod
2 mg/mL
5 mg/mL
15 mg/mL

mAs effect on Iodine Accuracy
165 >> 182 > 208 >> 315 >> 180 = 480 >> 600
600 > 480 >> 315 >> 182 > 208 >> 180 >> 165
480 = 315 >> 600 > 182 = 208 >> 165 > 180
Legend

>>
>

Significantly Different
Not Significantly Different

P < 0.05
0.05 < P < 0.9

=

Statistically Equivalent

P > 0.9

DEQC Head Phantom:
Iodine accuracy using the DEQC head phantom was found to be affected primarily
by mAs and secondarily by CTDIvol, similar to that determined using the DEQC body
phantom (Figure 6.5). In contrast to the DEQC body phantom, lower mAs protocols
provided higher iodine accuracy, while higher mAs protocols provided lower iodine
accuracy, underestimating the concentration. It is worth noting however that the variance
between scanners is somewhat higher using these lower mAs protocols. This trend is
supported by the inter- and intra-scanner variance results showing increasing mAs has a
beneficial result on inter-scanner variance. However due to the matched scaling between
the DEQC body and DEQC head phantom results, this cannot easily be visualized. Intrascanner variance did not seem to be directly affected by any of the acquisition parameters
investigated. Compared to the results from the DEQC body phantom, the iodine accuracy
using the DEQC head phantom was much improved. The maximum error in the iodine
concentration measurement was approximately 20% using the DEQC body phantom, but
only 8% using the DEQC head phantom. Inter- and intra- scanner variances were also
reduced from a maximum value of 1.61% and 0.66%, respectively, to 0.009% and 0.012%.
This represents a dramatic improvement in result repeatability for the DEQC head phantom,
relative to that of the DEQC body phantom.
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Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, mAs, on iodine accuracy in the DEQC body phantom can be seen in Table 6.14.

Figure 6.5: DEQC head phantom results for iodine accuracy. Left: Iodine accuracy trends
sorted primarily by mAs and secondarily by CTDIvol for 2 mg/mL and 5 mg/mL iodine rods
displayed by scanner. Right: Iodine accuracy inter- and intra-scanner variance trends sorted
primarily by mAs and secondarily by CTDIvol for 2 mg/mL and 5 mg/mL iodine rods.
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Table 6.14: DEQC head phantom results for the effect of mAs on iodine accuracy based on
linear mixed model analysis.
Iodine Rod
2 mg/mL
5 mg/mL

mAs effect on Iodine Accuracy
315 >> 208 >> 262.5 > 440 > 384
208 >> 315 = 262.5 >> 440 >> 384
Legend

>>
>
=

Significantly Different
Not Significantly Different
Statistically Equivalent

P < 0.05
0.05 < P < 0.9
P > 0.9

6.3.2.2 Uniformity
DEQC Body Phantom:
Uniformity using the DEQC body phantom was affected primarily by rotation time and
secondarily by CTDIvol for all dual-energy reconstructions investigated (Figure 6.6, Figure
6.7). For 50 keV and Iodine(Water) reconstructions, low mAs protocols resulted in high
uniformity values (peripheral results greater than central), which was improved by
increasing the mAs. For 110 keV, 140 keV and Water(Iodine) reconstructions, low mAs
protocols resulted in slightly low (-2 HU on average) uniformity values (central results
greater than peripheral). Increasing the mAs resulted in initial improvement followed by
increasingly high (5-6 HU on average) uniformity values (peripheral results greater than
central). Uniformity response for 70 keV was flat across all rotation times investigated;
however, the uniformity result was routinely high with an average of approximately 4 HU.
Maximum absolute uniformity was found in 50 keV (17.8 HU) followed by Water(Iodine) (6.6 mg/mL), 70 keV (6.2 HU), Iodine(Water) (4.6 mg/mL), 140 keV (-4.2 HU), and finally
110 keV (-2.7 HU). Both inter- and intra-scanner variance was primarily affected by CTDIvol
and secondarily by mAs. With the exception of the inter-scanner variance for 50 keV
reconstruction, increasing CTDIvol and mAs were associated with reduced variance. In
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general, intra-scanner variance was greater than inter-scanner variance, with increased
intra-scanner variance corresponding with increased absolute uniformity.
Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, rotation time, on uniformity in the DEQC body phantom can be seen in Table
6.15. The opposite effects of increased rotation time on the 50 keV and Iodine(Water)
versus the 110 keV, 140 keV and Water(Iodine) can be seen in the reversed ranking order.
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Figure 6.6:

DEQC body phantom results for uniformity.

Left: Uniformity trends sorted

primarily by rotation time and secondarily by CTDI vol for 50, 70, 110 and 140 keV
monoenergetic reconstructions and displayed by scanner. Right: Uniformity inter- and intrascanner variance trends sorted primarily by CTDIvol and secondarily by mAs for 50, 70, 110,
and 140 keV monoenergetic reconstructions.
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Figure 6.7: DEQC body phantom results for uniformity.

Left: Uniformity trends sorted

primarily by rotation time and secondarily by CTDIvol for Water(Iodine) and Iodine(Water)
material density reconstructions and displayed by scanner. Right: Uniformity inter- and intrascanner variance trends sorted primarily by CTDIvol and secondarily by mAs for Water(Iodine)
and Iodine(Water) material density reconstructions.
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Table 6.15: DEQC body phantom results for the effect of rotation time on uniformity based on
linear mixed model analysis.
Dual-Energy Reconstruction
50 keV
70 keV
110 keV
140 keV
Water (Iodine)

Rotation Time effect on Uniformity

Iodine (Water)

0.6 >> 0.5 >> 0.7 >> 0.8 >> 1

0.6 >> 0.5 >> 0.7 >> 0.8 >> 1
0.6 >> 0.7 >> 1 = 0.5 = 0.8
1 >> 0.8 >> 0.7 >> 0.6 > 0.5
1 >> 0.8 >> 0.7 >> 0.5 = 0.6
1 >> 0.8 >> 0.7 >> 0.5 = 0.6

Legend
>>

Significantly Different

P < 0.05

>
=

Not Significantly Different
Statistically Equivalent

0.05 < P < 0.9
P > 0.9

The effect of rotation time, mAs and the keV of the monoenergetic reconstruction can
be seen in Figure 6.8. Uniformity is independent of reconstructed keV only using only one
of the protocols investigated: GSI-10 (0.8sec rotation time, 480mAs). Low rotation time
protocols resulted in wide variation in uniformity based on keV of the monoenergetic
reconstruction.
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Uniformity by Monoenergetic keV
14
12

Uniformity (HU)

10
8

50keV

6

70keV

4

110keV

2

140keV

0
-2
-4
180

315
0.5

165

182

0.6

0.7

208

480
0.8

600

mAs

1

Rotation Time (s)

Figure 6.8: DEQC body phantom results for uniformity sorted primarily by rotation time and
secondarily by mAs for 50, 70, 110 and 140 keV monoenergetic reconstructions.

DEQC Head Phantom:
Uniformity using the DEQC head phantom was found to be affected primarily by mAs
and secondarily by CTDIvol for all dual-energy reconstructions investigated (Figure 6.9,
Figure 6.10). Unlike the DEQC body phantom, uniformity was not noticeably affected by
rotation time. In addition, uniformity using the DEQC head phantom was universally
improved by increases in the primary acquisition parameter (mAs). Similarly to the DEQC
body phantom results, uniformity for 70 keV monoenergetic reconstruction was fairly
invariant to changes in acquisition parameter; however, the DEQC head phantom uniformity
result was much closer to 0 HU than that of the DEQC body phantom. Uniformity was
vastly improved for 50 keV monoenergetic reconstruction from a maximum absolute value
of 17.8 HU in the DEQC body phantom to 4.9 HU in the DEQC head phantom. Maximum
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absolute uniformity, representing the greatest deviation from the ideal value of zero, was
found in Water(Iodine) (5.2 mg/mL) followed by 50 keV (-4.9 HU), 140 keV (4.2 HU), 110
keV (3.5 HU), Iodine(Water) (-1.9 mg/mL), and finally 70 keV (-1.8 HU). Intra-scanner
variance was primarily affected by CTDIvol and secondarily by mAs and corresponded with
increased absolute uniformity. Inter-scanner variance was generally on the same order as
intra-scanner variance, however, none of the acquisition parameters investigated were
found to correlate with reduced inter-scanner variance.
Of note in Figure 6.9 are the abnormal uniformity results for CT 6 using 50 keV
monoenergetic reconstruction. For all protocols investigated, acquisitions on CT 6 resulted
in substantially higher uniformity values than the rest of the scanner population. This might
indicate a service issue present on this scanner, however, since the metric value is
improved relative to the other scanners, the appropriate course of action is uncertain at this
point.
Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, mAs, on uniformity in the DEQC head phantom can be seen in Table 6.16.
Although increased mAs did seem to lead to improved uniformity, statistical analysis
indicated that the 315 and 384 mAs protocols resulted in the best uniformity for the DEQC
head phantom. These results are supported by the simplified visualization of uniformity
results by mAs and reconstructed keV (Figure 6.11). The lowest mAs value investigated,
208mAs, results in wider uniformity variation with changes in the keV of the monoenergetic
reconstruction.
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Figure 6.9: DEQC head phantom results for uniformity.

Left: Uniformity trends sorted

primarily by mAs and secondarily by CTDI vol for 50, 70, 110 and 140 keV monoenergetic
reconstructions and displayed by scanner.

Right: Uniformity inter- and intra-scanner

variance trends sorted primarily by CTDIvol and secondarily by mA for 50, 70, 110, and 140
keV monoenergetic reconstructions.
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Figure 6.10: DEQC head phantom results for uniformity.

Left: Uniformity trends sorted

primarily by mAs and secondarily by CTDIvol for Water(Iodine) and Iodine(Water) material
density reconstructions and displayed by scanner. Right: Uniformity inter- and intra-scanner
variance trends sorted primarily by CTDI vol and secondarily by mA for Water(Iodine) and
Iodine(Water) material density reconstructions.
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Table 6.16: DEQC head phantom results for the effect of mAs on Uniformity based on linear
mixed model analysis.
Dual-Energy
Reconstruction
50 keV

384 >> 440 = 262.5 >> 315 >> 208

70 keV
110 keV
140 keV
Water (Iodine)
Iodine (Water)

208 >> 262.5 >> 440 = 384 >> 315
208 >> 262.5 >> 440 > 384 > 315
208 >> 262.5 > 440 >> 384 > 315
208 >> 262.5 > 440 >> 384 = 315
384 >> 440 = 315 > 262.5 >> 208

mAs effect on Uniformity

Legend
>>
>
=

Significantly Different
Not Significantly Different
Statistically Equivalent

P < 0.05
0.05 < P < 0.9
P > 0.9

Uniformity by Monoenergetic keV
4
3

Uniformity (HU)

2
50keV

1

70keV

0

110keV

-1

140keV

-2
-3
-4
-5
26.2

47.8
208

36.7
262.5

67

44.6

81.4
315

54.7

105.6

CTDIvol (mGy)

384

440

mAs

Figure 6.11: DEQC head phantom results for uniformity sorted primarily by mAs and
secondarily by rotation time for 50, 70, 110 and 140 keV monoenergetic reconstructions.

6.3.2.3 Monoenergetic HU Stability
DEQC Body Phantom:
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Monoenergetic HU Stability using the DEQC body phantom was found to be affected
primarily by mAs and secondarily by CTDIvol for all monoenergetic reconstructions
investigated (Figure 6.12). All visualizations are shown over a 30 HU range, however the
minimum and maximum attenuation shown is specific to the reconstruction. Using vendorprovided elemental composition for the soft tissue rods and acquired NIST attenuation
values, the predicted attenuation assuming a true monoenergetic acquisition was
calculated. These values, shown as black lines, demonstrate the varied attenuations, and
thus varied contrasts, supplied by monoenergetic imaging. For 110 and 140 keV
reconstructions, the accuracy of the attenuation is improved with increased mAs. In this
case, low mAs protocols overestimate the attenuation in the soft tissue rods. For 50 keV,
protocols with increased mAs do increase the attenuation, however none of the protocols
investigated provides an accurate attenuation. 70 keV monoenergetic reconstruction was
invariant to changes in protocol and in general was within 5 HU of the predicted attenuation.
Based on protocol and scanner variation, the range of possible attenuations provided by
50, 70, 110 and 140 keV reconstructions was 26 HU, 6 HU, 12 HU and 15 HU, respectively.
Intra-scanner variance was primarily affected by CTDIvol and secondarily affected by mAs.
Inter-scanner variance appeared to be equally affected by both parameters. In general,
inter- and intra-scanner variances were on the same order of magnitude, however interscanner variance was occasionally greater than intra-scanner variance for 50 keV
monoenergetic reconstruction.
Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, mAs, on monoenergetic HU stability in the DEQC body phantom can be seen in
Table 6.17. Increasing mAs had a statistically significant effect on improving
monoenergetic HU stability for both 110 and 140 keV. Results for 70 keV seem to indicate
an optimal mAs of 182, however given the limited variability of the result with mAs, it is
unlikely that this is clinically significant.
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Figure 6.12: DEQC body phantom results for monoenergetic HU stability. Left:
Monoenergetic HU stability trends sorted primarily by mAs and secondarily by CTDI vol for 50,
70, 110 and 140 keV monoenergetic reconstructions and displayed by scanner. Calculated
attenuations (using NIST values) based on vendor-provided elemental composition and true
monoenergetic acquisition are shown in black. Right: Monoenergetic HU stability inter- and
intra-scanner variance trends sorted primarily by CTDIvol and secondarily by mAs for 50, 70,
110, and 140 keV monoenergetic reconstructions.

Table 6.17: DEQC body phantom results for the effect of mAs on monoenergetic HU stability
based on linear mixed model analysis.
Dual-Energy Reconstruction
50 keV
70 keV

mAs effect on Monoenergetic HU Stability
600 >> 480 >> 315 >> 180 >> 182 = 208 >> 165
600 >> 315 >> 480 >> 180 >> 165 = 208 > 182

110 keV
140 keV

165 >> 180 > 208 > 182 >> 315 >> 480 >600
165 >> 180 > 208 = 182 >> 315 >> 480 >> 600
Legend

>>
>
=

Significantly Different
Not Significantly Different
Statistically Equivalent

P < 0.05
0.05 < P < 0.9
P > 0.9

Investigation of trends in monoenergetic HU stability by mAs and monoenergetic
keV show the effect of lower mAs protocols on the utility of monoenergetic imaging.
Protocols using 208mAs and below result in monoenergetic images with fixed attenuation,
and thus fixed contrast, across all monoenergetic energies. Protocols using 315mAs and
above provide variable attenuation, and thus variable contrast, across monoenergetic
energy values. This variable contrast is one of the added benefits provided by DECT. By
altering the keV of the monoenergetic reconstruction, the relative influence of photoelectric
and Compton processes is modulated and the relative contrast of high-Z materials can be
either enhanced or diminished. This ability has been shown to be particularly useful in the
improvement of iodine contrast compared to SECT (41,62,107).
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Figure 6.13: DEQC body phantom results for monoenergetic HU stability trends sorted
primarily by mAs and secondarily by CTDIvol for 50, 70, 110 and 140 keV monoenergetic
reconstructions. The dashed red line indicates a potential mAs cutoff for optimum efficiency
of monoenergetic visualizations.

DEQC Head Phantom:
Monoenergetic HU Stability using the DEQC head phantom was found to be affected
primarily by mA and secondarily by CTDIvol for all monoenergetic reconstructions
investigated (Figure 6.14). Similar to uniformity results from the DEQC phantom, CT 6
appears to deviate from the rest of the scanner population. All visualizations are shown
using a 16 HU range, however the minimum and maximum attenuation shown is specific to
the reconstruction. Using vendor-provided elemental composition for the soft tissue rods
and acquired NIST attenuation values, the predicted attenuation assuming a true
monoenergetic acquisition was calculated. These values, shown as black lines,
demonstrate the variable attenuation, and thus variable contrast, supplied by
monoenergetic imaging. For 110 and 140 keV reconstructions, the reconstruction
attenuation decreases as mA increases. This trend is reversed at the highest mA value
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investigated. Tube current (mA) values under 630mA appear to be fairly invariant to mA
changes. Two potential explanations for this pattern include: 1) attenuation does in fact
decrease with increasing mA, and the 640mA acquisition represents an unexpected change
in this pattern; 2) attenuation is stable as mA changes, and that the 630mA acquisitions
represent an unexpected change in this pattern. The correct interpretation of these results
is unclear at this point. 70 keV monoenergetic reconstruction follows a similar pattern to
110 and 140 keV, however to a much lesser extent with all results falling between 31 and
36 HU. 50 keV monoenergetic reconstructions show a similar pattern but inverted, with the
630mA acquisitions resulting in higher attenuations than expected and the 640mA protocol
resulting in lower attenuations. Based on protocol and scanner variation, the range of
possible attenuations provided by 50, 70, 110 and 140 keV reconstructions was 9 HU, 5
HU, 7 HU and 8 HU, respectively.
Inter- and intra-scanner variance were primarily affected by mA and secondarily
affected by CTDIvol. Variance for 50 keV monoenergetic reconstructions decreased with
increasing mA while variance for 110 and 140 keV increased with increasing mA. Variance
for 70 keV monoenergetic reconstructions was fairly stable across all mA values
investigated. Inter-scanner variance was considerably higher than intra-scanner variance
for 50 keV monoenergetic reconstructions acquired using protocols with lower than 630mA.
Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, mA, on monoenergetic HU stability in the DEQC head phantom can be seen in
Table 6.18. Attenuation was found to be statistically significantly different for all mA values
investigated using 110 or 140 keV reconstructions.
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Figure 6.14: DEQC head phantom results for monoenergetic HU stability. Left:
Monoenergetic HU stability trends sorted primarily by mA and secondarily by CTDI vol for 50,
70, 110 and 140 keV monoenergetic reconstructions and displayed by scanner. Calculated
attenuations (using NIST values) based on vendor-provided elemental composition and true
monoenergetic acquisition are shown in black. Right: Monoenergetic HU stability inter- and
intra-scanner variance trends sorted primarily by mA and secondarily by CTDI vol for 50, 70,
110, and 140 keV monoenergetic reconstructions.

Table 6.18: DEQC head phantom results for the effect of mA on monoenergetic HU stability
based on linear mixed model analysis.
Dual-Energy Reconstruction
50 keV
70 keV

mA effect on Iodine Accuracy
630 >> 640 > 550 > 375 >> 260
375 >> 640 = 260 >> 550 >> 630

110 keV
140 keV

260 >> 375 >> 640 >> 550 >> 630
260 >> 375 >> 640 >> 550 >> 630
Legend

>>
>
=

Significantly Different
Not Significantly Different
Statistically Equivalent

P < 0.05
0.05 < P < 0.9
P > 0.9

Investigation of trends in monoenergetic HU stability by mA and monoenergetic keV
show relatively stable attenuation response compared to the dramatic effect seen in the
DEQC body phantom. Attenuation with respect to keV of the monoenergetic reconstruction
was most variable (largest range) for 630mA protocols.
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Figure 6.15: DEQC head phantom results for monoenergetic HU stability trends sorted
primarily by mA and secondarily by CTDI vol for 50, 70, 110 and 140 keV monoenergetic
reconstructions.

6.3.2.4 Noise
DEQC Body Phantom:
Noise using the DEQC body phantom was found to be affected solely by CTDIvol for all
dual-energy reconstructions investigated (Figure 6.16, Figure 6.17). As expected, noise
was greatest for 50 keV monoenergetic reconstructions. Unexpectedly, 110 and 140 keV
reconstructions resulted in lower noise values than 70 keV for all CTDIvol values
investigated. This effect is likely due to reduction in beam hardening artifacts at the higher
monoenergetic reconstructions. Water(Iodine) reconstruction noise was higher than
Iodine(Water) noise at all CTDIvol values investigated, however, direct comparison of these
two noise values is inappropriate due to the large differences in the relative dynamic range
of the two image types. In general, voxel values from water density images tend to span
approximately 100 mg/mL, while voxel values from iodine density images tend to span
approximately 20-25 mg/mL.
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Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, CTDIvol, on noise in the DEQC body phantom can be seen in Table 6.19. A
statistically significant change in noise was seen for all incremental CTDIvol increases over 2
mGy for all dual-energy reconstructions.

Noise (HU)

Noise by Monoenergetic keV
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33.9

48.6

62
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Figure 6.16: DEQC body phantom results for noise trends sorted by CTDI vol for 50, 70, 110 and
140 keV monoenergetic reconstructions.
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Figure 6.17: DEQC body phantom results for noise trends sorted by CTDI vol for Water(Iodine)
and Iodine(Water) material density reconstructions.
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Table 6.19: DEQC body phantom results for the effect of CTDI vol on noise based on linear
mixed model analysis.
Dual-Energy Reconstruction
50 keV
70 keV
110 keV
140 keV
Water (Iodine)

CTDIvol effect on Noise
10.3 >> 17.4 > 17.8 = 17.2 >> 25.5 >> 32.5 >> 33.9 >> 48.6 >> 62
10.3 >> 17.8 >> 17.4 > 17.2 >> 25.5 >> 32.5 >> 33.9 >> 48.6 >> 62
10.3 >> 17.4 = 17.8 > 17.2 >> 25.5 >> 32.5 >> 33.9 >> 48.6 >> 62
10.3 >> 17.4 >> 17.8 = 17.2 >> 25.5 >> 33.9 = 32.5 >> 48.6 >> 62
10.3 >> 17.4 >> 17.8 = 17.2 >> 33.9 >> 32.5 >> 48.6 >> 62

Iodine (Water)

10.3 >> 17.4 >> 17.2 > 17.8 >> 25.5 >> 33.9 >> 32.5 >> 48.6 >> 62

Legend
>>

Significantly Different

P < 0.05

>
=

Not Significantly Different
Statistically Equivalent

0.05 < P < 0.9
P > 0.9

DEQC Head Phantom:
Noise using the DEQC head phantom was found to be affected solely by CTDIvol for all
dual-energy reconstructions investigated (Figure 6.18, Figure 6.19). As expected based on
the literature, noise was lowest for 70 keV monoenergetic reconstructions with higher keV
reconstructions resulting in slightly higher noise and 50 keV reconstructions resulting in the
greatest amount of noise. This represents a change in the noise pattern for higher keV
reconstructions relative to the DEQC body phantom, where the reduction in beam
hardening likely played a larger role due to the greater size of the phantom. Water(Iodine)
reconstruction noise was higher than Iodine(Water) noise at all CTDIvol values investigated,
however, given the large differences in the relative dynamic range of the two image types,
direct comparison of these two noise values is inappropriate.
Results of the linear mixed model analysis for the effect of the primary acquisition
parameter, CTDIvol, on noise in the DEQC body phantom can be seen in Table 6.20.
Statistically significant changes in noise were found across all dual-energy reconstructions
for each CTDIvol investigated except the 36.7 and 47.8 mGy protocols.
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Figure 6.18: DEQC head phantom results for noise trends sorted by CTDIvol for 50, 70, 110 and
140 keV monoenergetic reconstructions.
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Figure 6.19: DEQC head phantom results for noise trends sorted by CTDI vol for Water(Iodine)
and Iodine(Water) material density reconstructions.
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Table 6.20: DEQC head phantom results for the effect of CTDI vol on noise based on linear
mixed model analysis.
Dual-Energy Reconstruction
50 keV
70 keV
110 keV
140 keV
Water (Iodine)

CTDIvol effect on Noise
26.2 >> 36.7 >> 47.8 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6
26.2 >> 36.7 > 47.8 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6
26.2 >> 47.8 > 36.7 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6
26.2 >> 47.8 > 36.7 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6
26.2 >> 36.7 = 47.8 >> 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6

Iodine (Water)

26.2 >> 36.7 >> 47.8 > 44.6 >> 54.7 >> 67 >> 81.4 >> 105.6

Legend
>>

Significantly Different

P < 0.05

>
=

Not Significantly Different
Statistically Equivalent

0.05 < P < 0.9
P > 0.9

6.3.3

Recommendations on Clinical Implementation of DEQC Program
Although a scan protocol covering the full ranges of multiple parameters is vital for

the full characterization of a system, long term collection of such data for QC purposes is
impractical. In order to develop a long-term quality control program suitable for clinical
implementation, a streamlined protocol was developed based on the results from the first
13 weeks of analysis (Table 6.21). Given the similarity of the DEQC head and DEQC body
results, and the time required to setup and scan both phantoms, the finalized DEQC
program limited data collection and analysis to only the DEQC body phantom. Protocol
acquisitions were limited to a more clinical CTDIvol range of 17.2 to 33.9 mGy, while
maintaining those acquisitions necessary to separate out effects due to CTDIvol and rotation
time. Two such groups remained: approximately 33 mGy at 0.5 and 1.0sec rotation times,
and approximately 17.5 mGy at 0.5, 0.6 and 0.7sec rotation times.
A large dataset will be needed in order to determine the baseline values and
tolerances necessary for the establishment of a true DECT quality control program.
Streamlining the DEQC program from two phantoms with a combined 18 acquisitions to
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one phantom with 6 acquisitions allowed more consistent and frequent data collection. In
addition, by sampling only the data sets previously acquired from the earlier version, data
collection prior to the implementation of this finalized DEQC program could also contribute
to future analysis, increasing the size and scope of the data set. This finalized DEQC
program is currently established in the clinic and at the point of this publication has
collected 35 weekly or bi-weekly DEQC exams on 10 dual-energy CT systems, for a total of
350 DEQC exams.

Table 6.21: Final recommendations for the clinically implementable dual-energy quality
control protocol. All acquisitions performed in helical mode, using a 40 mm beam width,
Large Body SFOV, 42 cm DFOV and standard reconstruction filter.
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Discussion
While many studies have been performed to evaluate the effect of dual-energy

acquisition and processing on noise (41,42,48,63,107), iodine accuracy (42,56,106,114–
118) and the stability and accuracy of the attenuations derived from the monoenergetic
reconstructions (61), few have investigated the impact of acquisition parameters and none
have investigated long term trends in these values. This study sought to investigate the
relationship of various acquisition parameters to values important to the quantitative clinical
use of dual-energy CT such as iodine accuracy, uniformity, noise and the stability of the
attenuations derived from monoenergetic reconstructions. The end goal was to create an
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efficient and pertinent DEQC program for clinical implementation and long term data
collection.

6.4.1

Iodine Accuracy
Iodine accuracy was found to be primarily affected by protocol mAs with increasing

values leading to improved iodine accuracy and decreased intra- and inter-scanner
variances. At low mAs values in the DEQC body phantom, iodine accuracy was found to be
overestimated for the 2 mg/mL rod, underestimated for the 5 mg/mL rod, and the 15 mg/mL
rod remained generally unaffected by protocol variation. While the differences in iodine
concentration could certainly play a role, this effect is likely also influenced by differences in
location and local environment between the three iodine rods. For both the DEQC body
and DEQC head phantom, iodine accuracies converged to a -5% measurement error.
Given that independent verification of the concentration of iodine within the rods could not
be performed, it is possible that the error is due to incorrect fabrication. The iodine rods are
also based on a 0 HU epoxy resin solid water containing a range of elements not limited to
hydrogen and oxygen, which may affect the results of the water/iodine material
decomposition.

6.4.2

Uniformity
Uniformity measures using the DEQC body phantom were primarily affected by

rotation time, however the direction of the effect was dependent on the dual-energy
reconstruction. For 50 keV and Iodine(Water) reconstructions, increased rotation time led
to lower and improved uniformity values, while in 110 keV, 140 keV and Water(Iodine)
reconstructions it led to higher and degraded uniformity. 70 keV uniformity was not affected
by increased rotation time, however, it was consistently elevated. Given that these data
were collected using a fast-kVp switching technique, one might assume that faster rotation
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times would affect the efficiency of the kVp waveform and lead to reduced spectral
separation. However, longer rotation times seem to adversely affect uniformity in both the
110 and 140 keV reconstructions. Given the consistently elevated uniformity result for the
70 keV reconstruction, it is likely that some factor outside protocol variation is in play. If an
offset were applied to the data to correct for the elevated 70 keV results, 110 and 140 keV
uniformity would improve with increasing rotation time and 50 keV would initially improve
but then worsen as it overshoots the 0 HU goal. This result would be more consistent with
current understanding of the potential effect of rotation time on uniformity measures. This
“offset” in the uniformity results could be due to a number of outside factors, however, the
most likely factor is phantom design. Based on the local environment of the central soft
tissue rod used to evaluate uniformity, it is likely that these measurements might be
affected by beam hardening or photon starvation caused by the influence of the 198 and
334 HU calcium rods. This would cause a consistent reduction in the CT number of the
central soft tissue rod and thus an elevation in the uniformity value. This hypothesis could
be evaluated by replacing all non-soft tissue rods by solid water rods and repeating the
measurement. For all dual-energy reconstructions investigated, intra-scanner variance was
always equal to or greater than inter-scanner variance, which indicated that uniformity
would not be a concern for repeat scanning on varied scanners.
Uniformity measures using the DEQC head phantom were primarily affected by mAs
rather than rotation time. This reduced dependence on rotation time is likely due to the
reduction in phantom size from the DEQC body phantom to the DEQC head phantom. For
all dual-energy reconstructions, increased mAs led to similar or improved uniformity.
Uniformity measures for 50 keV reconstructions were much improved from the DEQC body
phantom with a reduction in maximum uniformity value from 18 HU for the DEQC body to
5.2 HU for the DEQC head phantom. Of note in the DEQC head phantom uniformity data is
the consistently higher uniformity values at 50 keV for CT6 compared to the rest of the
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scanner population. Daily single-energy quality control data, which is based on an in-house
QC program and measures uniformity in a similarly sized 22 cm diameter phantom (123),
showed passing values for uniformity over the complete duration of this study. This finding
highlights the serious need for a quality control program designed specifically to monitor the
dual-energy capabilities and specific reconstructions available on these scanners.

6.4.3

Monoenergetic HU Stability
Monoenergetic attenuation (HU) results using the DEQC body phantom were

dramatically affected by mAs. Protocols with less than 315mAs resulted in similar
attenuation measures across all monoenergetic reconstructions investigated. One of the
greatest advantages of dual-energy CT over single-energy CT is the variable contrast
based on reconstructed keV that is derived from the dual-energy data. In order to acquire
dual-energy data, both the 80kVp and 140kVp beams must penetrate through the patient in
sufficient quantities to be reconstructed into an image. In the case of the DEQC body
phantom, protocols below 315mAs did not provide sufficient tube output to result in
adequate photon collection at the detector. Having limited 80kVp data to draw from, the
material decomposition process is highly affected, resulting in fixed attenuation across all
monoenergetic reconstructions. Since this fixed attenuation is tied to over-attenuation of
the 80kVp beam, the mAs limit for this effect will be phantom (or patient) size dependent.
Due to this fixed attenuation at low mAs values, attenuation results varied widely
with acquisition protocol resulting in attenuation ranges of 25 HU, 6 HU, 12 HU and 17 HU
for 50, 70, 110 and 140 keV reconstructions, respectively. By constraining protocols to only
those with mAs of 315 and above, the attenuation ranges were reduced to 10 HU (61%
reduction), 5 HU (20% reduction), 6 HU (53% reduction) and 7 HU (54% reduction). These
results are within 1 HU of the attenuation ranges found using the DEQC head phantom
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where no attenuation discontinuity was identified, potentially indicating stable response due
to adequate 80kVp penetration.
Inter-scanner variance was greater than intra-scanner variance for measures of
monoenergetic HU stability for 50 keV reconstructions using both the DEQC body and
DEQC head phantoms. 50 keV monoenergetic reconstructions are routinely used to
increase the conspicuity of iodine (62). Given the high inter-scanner variance relative to the
intra-scanner variance, it is recommended that patients requiring repeat measures be
limited to a single scanner or imaged using a higher mAs protocol for increased
repeatability.

6.4.4

Noise
Noise values improved with increasing selected CTDIvol for both the DEQC body

and DEQC head phantom, as expected. Although several papers have shown optimal
noise values at 65-77 keV (41,42,48,63,107), data for the DEQC body phantom resulted in
lowest noise in the 110 and 140 keV reconstructions. Given the large size of the phantom
and the highly heterogeneous environment, it is likely this effect is due to enhanced
correction of beam hardening artifacts at the higher keV reconstructions. Data for the
DEQC head phantom does not show improved noise values for the 110 and 140 keV
reconstructions relative to 70 keV, likely due to the lesser extent of beam hardening in a
smaller phantom.

6.4.5

Differences in DEQC Body and DEQC Head Phantom Results
In general, the DEQC head phantom provided more stable and improved results

over the DEQC body phantom. Iodine accuracy results for the DEQC head phantom
showed 60% improvement in iodine accuracy relative to the DEQC body phantom. While
the DEQC body phantom provided inconsistent results on the effect of protocol mAs on
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uniformity, the DEQC head phantom provided consistent improvement in measured
uniformity with increasing protocol mAs. In addition, the uniformity for 50 keV
monoenergetic reconstructions was vastly improved from a maximum value of 18 HU in the
DEQC body phantom to 5 HU in the DEQC head phantom. Monoenergetic HU stability
results were dramatically improved in the DEQC head phantom due to the lack of overattenuation of the 80kVp beam. After eliminating those protocols with inadequate
transmission, the results for attenuation (HU) range across protocols were similar for both
phantoms.
In general, both inter- and intra-scanner variances for all test metrics evaluated were
lower in the DEQC head phantom than in the DEQC body phantom. Comparing the DEQC
head phantom results to those of the DEQC body phantom, there was a reduction in the
dependence on rotation time for both the uniformity and monoenergetic HU stability metrics.
Given the smaller size and uniform shape of the DEQC head phantom, the effect on the
fast-kVp switching waveform, and thus the material decomposition process is likely less
pronounced.

6.4.6

Impact of Results on Intracranial Lesion Characterization
While this project’s primary aim was to characterize the response of the DECT

scanner and develop a long-term, clinically-implementable quality control program, it also
served as validation for the comparison of data collected over time as part of the
intracranial lesion research projects. Iodine accuracy for the DEQC head phantom was
measured used two iodine rods; one at 2 mg/mL and a second at 5 mg/mL. When imaged
using a 120kVp single-energy protocol, these rods have attenuations of 51 HU and 128 HU.
This attenuation range is very similar to the attenuation range of intracranial lesions
investigated in Chapters 4 and 5. Iodine accuracy for these rods resulted in maximum
percent errors of 8 and 6% for the 2 mg/mL and 5 mg/mL rods respectively (Figure 6.5).
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Presented as a difference measure instead of a percentage, this translates to maximum
errors of 0.15 and 0.3 mg/mL. This, coupled with inter- and intra-scanner variances of
under 0.05 mg/mL indicates that iodine concentration measurements are consistent among
scanners and over time (at least for several months). Given that all basis material
reconstructions are linearly correlated (a calcium/water material density pair is derived from
an iodine/water material density pair), these iodine density data also validate the
comparison of calcium and water density data collected over time. Direct measure of the
calcium and iron rods included in the DEQC head phantom was initially pursued, however
use of a non-standard background material for these rods due to material engineering
requirements made accuracy measures less straightforward.
Monoenergetic HU stability measurements for the DEQC head phantom resulted in
relatively stable attenuation regardless of protocol for 70 keV reconstructions (Figure 6.14).
The maximum attenuation range, based on either protocol variation on a single scanner, or
scanner variation given a single protocol, was 2.9 HU, within the 3 HU matching of the
matched model pairs in Chapter 4. Inter- and intra-scanner variances were found to be
under 1 HU. These results support the comparison of the 68 keV monoenergetic data
collected over several months as part of the intracranial lesion work.
Uniformity data collected using the DEQC head phantom resulted in uniformities of
2 HU, 2 mg/mL and 6 mg/mL for 70 keV, Iodine(Water) and Water(Iodine) reconstructions
respectively (Figure 6.9, Figure 6.10). Results for the Water(Iodine) reconstruction were
higher than that of the Iodine(Water) reconstruction, though given the difference in the
dynamic range of these image types, the higher value for the Water(Iodine) reconstruction
is reasonable. Inter- and intra-scanner variances were found to be below 0.3 HU, 0.2
mg/mL and 1.8 mg/mL for 70 keV, Iodine(Water) and Water(Iodine) respectively. Given
that these uniformity errors are minimal, it is unlikely that uniformity errors would affect
lesion model data. This is especially likely given that none of the lesion models were
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evaluated close to the center of the phantom and instead were positioned midway between
the phantom center and periphery (Figure 4.2).
The DEQC head phantom results for iodine accuracy, uniformity and monoenergetic
HU stability all resulted in low inter- and intra-scanner variance for the 70 keV,
Iodine(Water) and Water(Iodine) reconstructions. This provides independent support for
the high inter- and intra-canner correlations found in Chapter 4. Coefficients of variation
(CV) were found to be approximately 5% for inter-scanner and 4% for intra-scanner
correlations, respectively (Table 4.23), supporting the comparison of results from both
different time points and different scanners.
While rod size was not varied as part of the DEQC head phantom, rotation time and
selected CTDIvol were identified as sources of variability, similar to the results of intermethod, inter-scanner and intra-scanner correlations investigated in Chapter 4. Results of
the DEQC head phantom also indicated mAs as a major parameter affecting multiple test
metrics. No analysis was performed based on variation in protocol mAs for the intracranial
lesion work, however for the protocols investigated, mAs monotonically increased with
selected CTDIvol for a given pitch. This would indicate that analysis by mAs would provide
similar results to analysis by selected CTDIvol. Given that the use of fixed GSI-presets does
not allow for independent investigation of these two parameters, it is possible that variation
in mAs may explain the relatively low success of the power fits for determining the
appropriate CTDIvol for 90% differentiation accuracy based on lesion attenuation.
In all cases, results of the DEQC head phantom support the comparison of
intracranial lesion data collected over the course of several months. The results show low
inter- and intra-scanner variability, potentially opening this method for intracranial
differentiation and classification to repeat measures on separate scanners. Iodine
accuracy, uniformity and monoenergetic HU stability measures using the DEQC head
phantom were all significantly improved compared to DEQC body phantom results. Given
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the difference in effective diameter of the DEQC head phantom (22 cm diameter) and the
biologically relevant brain phantom used in Chapters 4 and 5 (14 cm by 18 cm for an
effective diameter of 16 cm), it is likely that the smaller phantom size would lead to even
more stable results than those of the DEQC head phantom.

6.4.7

Limitations
Phantom design was heavily influenced by the desire to include the evaluation of a

wide range of material rods and test metrics. As a consequence, several aspects of the
phantom design may impact the results. First, in order to include relevant material rods, the
size of the DEQC head phantom was increased to 22 cm, larger than the approximately 17
cm diameter of the typical human head (124). Second, the profile of the DEQC head
phantom was simplified to a circle, enabling easy insertion and removal from the DEQC
body phantom. Third, the DEQC head phantom was not designed with anthropomorphic
features like a skull, which would influence its applicability to patient scans. Due to its size
and shape, the DEQC head phantom was imaged on a stand on the CT table instead of in
a head holder, which would better approximate clinical imaging. For both the DEQC head
and DEQC body phantoms, material rods were fixed to a single location. Although an
attempt was made to optimize the rod layout to minimize the effect of beam hardening on
the evaluation of test metrics, it is likely that test metric results were influenced by both a
rod’s location and local environment. This is especially true for noise, which was evaluated
within a single centrally located rod and not over a larger or more representative portion of
the phantom. Iodine accuracy was assessed using a material decomposition of pure iodine
and water, although the rods were fabricated by adding iodobenzene (C6H5I) to a 0 HU
epoxy resin material. This discrepancy between the fabrication materials and the basis
materials for the material decomposition may influence the accuracy of the iodine
concentration results.
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In addition to the phantoms, analysis was heavily limited due to the inability to
independently investigate acquisition parameters due to the use of fixed GSI-presets. This
is the current reality of dual-energy acquisition using the GE DECT system and while
complicating advanced analysis, it does force the quality control program to mimic clinical
care. The method to determine primary and secondary trends in test metrics was primarily
based on visual assessment and would benefit from more rigorous statistical analysis.
Finally, evaluation of iodine accuracy and monoenergetic HU stability both used nominal
values that could not be independently validated. In the case of iodine accuracy, the true
accuracy was derived from the stated iodine concentration by the rod manufacturer.
Without some way to independently verify this, errors in iodine accuracy could potentially be
due to errors in rod fabrication. In the case of monoenergetic HU stability, the predicted
attenuation added to the graphs was calculated assuming a true monoenergetic beam while
DECT reconstructions represent virtual monoenergetic values based on the material
decomposition results.

6.4.8

Future Work
Future work includes development of a dual-energy quality control process for dual-

source dual-energy systems. In addition, investigation will continue into the effect of
phantom (or patient) size on the mAs cutoff for static attenuation across monoenergetic
reconstructions, as well as the creation of a more advanced and rigorous noise metric. A
multivariate logistic model will be pursued to determine major sources of variability for test
metrics based on all available acquisition parameters. Data will continue to be collected in
order to determine baseline values and failure threshold criteria for the validation of longterm DECT scanner performance.
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Chapter 7

7

7.1

Conclusions

Summary of Major Findings
In this dissertation we have explored the application of dual-energy CT to the

differentiation of intracranial calcification and hemorrhage. Currently, single-energy CT is
able to positively identify intracranial lesions of over 100 HU as calcification, however,
lesions below this cut off are impossible to identify using this technique. We have shown
using a basic agar-gel based physics model (Chapter 3) that calcium, present in
calcification, and iron, present in hemorrhage have distinct enough spectral attenuation
curves to be differentiable using dual-energy CT over the attenuation range of interest.
Next, this method was expanded to better replicate the imaging environment of the
head and to evaluate a range of lesion sizes and locations (Chapter 4). A spectrally
equivalent brain material was created to mimic the spectral attenuation properties of brain
matter and an anthropomorphic phantom was used to mimic the shape and attenuation of
the skull. A range of protocol variations (CTDIvol, image thickness and reconstruction filter)
were used to elucidate the optimal acquisition and reconstruction parameters for this
method. While the initial goal was to create optimized protocols for each lesion size and
location, general trends were identified that influenced differentiation accuracy regardless of
these lesion specific parameters. Based on the protocol variations investigated,
differentiation accuracy increased with selected CTDIvol and image thickness. No effect
was observed based on changes in reconstruction filter. Although these factors were the
only parameters varied directly, due to the fixed nature of the GSI-presets available on the
GE 750HD scanner, a further parameter, rotation time, was found to affect differentiation
accuracy based on inter-method and inter-study correlation measurements. Rotation times
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of 0.5sec, in particular, were found to adversely affect both inter- and intra-scanner
correlation and should therefore be avoided.

SECT HU Predicted for 90% Differentiation Accuracy

Minimum SECT HU for 90% GB Differentiation Accuracy by CTDI vol (mGy)
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Figure 7.1: Graphical representation of lesion attenuation (HU) necessary for 90% GB
differentiation accuracy by acquisition parameters (Table 4.15). The un-shaded region
represents CTDIvol and image thickness values allow 90% differentiation accuracy under the
current clinical limit of 100 HU imposed by SECT.

The effect of selected CTDIvol and image thickness on differentiation accuracy can
be seen in Figure 7.1 (reproduction of Figure 4.33 for convenience) which shows the SECT
attenuation (HU) necessary to achieve 90% differentiation accuracy using geometric
bisector analysis. The shaded region represents differentiation currently available using
single-energy CT, while the un-shaded region represents additional differentiation ability
using dual-energy CT. Assuming a 132.6 mGy CTDIvol, a standard filter and 5 mm thick
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images, 90% differentiation accuracy using the geometric bisector method would be
possible down to approximately 60 HU, 55 HU and 70 HU for 1.0 cm cerebrum, 1.5 cm
cerebrum and 1.5 cm skull base lesions respectively (Figure 7.2).

Optimal Protocol Differentiation Accuracy
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GB Differentiation Accuracy

95
90
85
80
75
70
65
60
55
40
50
60
70
80
90
100
40
50
60
70
80
90
100
40
50
60
70
80
90
100
40
50
60
70
80
90
100

50

0.5

1

1.5

Cerebrum

SECT HU

1.5

Lesion Size (cm)

Skull Base

Location

Figure 7.2: Accuracy of intracranial lesion differentiation using geometric bisector method
with 132.6 mGy CTDIvol, 5 mm image thickness and standard filter. Error bars represent one
SD of the variation over the three studies collected.

Based on these differentiation results, an experiment was pursued to assess the
ability of dual-energy CT to classify unknown intracranial lesions using the geometric
bisector method (Chapter 5). Based on the results of the earlier differentiation project, and
current clinical parameters, a three tier protocol with fixed image thickness, fixed filter and
three separate CTDIvol values was designed. The CTDIvol values represented the current
routine brain protocol CTDIvol value, the maximum value available on the CT scanner, and a
midpoint value. All lesion models, except for 0.5 cm calcifications in the cerebrum, resulted
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in increased classification ability beyond that of single-energy CT. These results support
our hypothesis that DECT could be used to differentiate (and subsequently classify)
intracranial calcification and hemorrhage below the attenuation level possible using SECT.

7.2

Comments on Clinical Implementation
Several methods were investigated based on their ability to differentiate, and later

classify, intracranial hemorrhage and calcification. Although more simplistic, the geometric
bisector method was found to be as effective, if not more so, than the competing advanced
statistical methods (Gaussian mixture model method, support vector machine method, and
probability distribution method). This effect was seen for both differentiation and
classification studies. Analysis of the generalizability of the original lesion and acquisition
specific geometric bisector plane solution (Chapter 4.2.5.5), identified two major sources of
variability: small lesions under 0.5 cm diameter and lesions in the skull base. The ability to
use a generalized geometric bisector plane solution that has no dependence on acquisition
and reconstruction parameters will allow the radiologist more freedom to prescribe protocol
parameters on a case by case basis.
In addition, high correlation was seen between 68 keV attenuation and singleenergy CT attenuation for all lesion models investigated. Correlation was less optimal in
the skull base, likely due to increased beam hardening in that region of the brain. These
results indicate that a 68 keV reconstruction could be used for lesion attenuation measures
instead of a separate single-energy acquisition. By removing the necessity for a separate
single-energy acquisition, the total dose to the patient may be reduced by limiting the exam
to the dual-energy acquisition, or the dose of the dual-energy acquisition could be
increased, thus increasing the quality and accuracy of the exam.
While inter- and intra-scanner correlations were not assessed for intracranial
classification, results for the intracranial differentiation studies yielded coefficients of
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variation (CV) under 5% in both cases once major sources of variability were removed. For
the geometric bisector method, inter-scanner variance was higher than intra-scanner
variance, potentially indicating that repeat measures should be performed on the same
scanner. Since the difference between inter-scanner and intra-scanner correlation was
approximately 1.3%, the clinical impact of this effect would likely be minimal. These
conclusions are supported by the dual-energy quality control program results (Chapter 6),
indicating low inter- and intra-scanner variances in the DEQC head phantom across all test
metrics. Accurate and consistent quantitative results were observed for iodine accuracy,
uniformity and monoenergetic HU across a wide range of GSI-presets, further supporting
the inter-comparability of collected project data.

7.3

Limitations and Future Directions
The investigation of intracranial lesion classification using dual-energy CT has led to

several unresolved questions. First, lesion classification results for 0.5 cm and 1.0 cm
cerebrum lesions do not provide sufficient information to state the lesion size limitations of
this method. Further investigation would require the creation of intermediate size models,
the evaluation of which would not be possible without modification of this phantom.
Furthermore, since neither heterogeneity nor cross contamination between the lesion types
were investigated as part of our phantom model, the usefulness of this method for
heterogeneous or mixed lesions cannot currently be confirmed. Further investigation using
various levels of heterogeneity or differing mixture ratios of calcification and hemorrhage
may provide further insight. Finally, display field of view remained constant throughout this
study. Reduction in DFOV from 25 cm to 12 cm may improve classification confidence for
smaller lesions by increasing sample size, reducing partial volume effect and increasing
ease of ROI placement.
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The dual-energy quality control program will be generalized to include dual-source
dual-energy CT systems. In addition, further investigation of the effect of phantom size on
the mAs required for variable attenuation and contrast (when using variable keV
monoenergetic reconstruction options) is warranted. A multivariate logistic model will be
pursued to statistically determine major sources of variability in DEQC test metrics based
on all acquisition parameters investigated. DEQC data collection will continue in order to
determine the baseline and failure threshold criteria necessary for validation of long-term
DECT scanner performance.
In conclusion, these studies into the characterization of intracranial lesions have
supported the hypothesis that DECT could be used to differentiate, and further classify,
intracranial calcification and hemorrhage below the attenuation level possible using SECT.
Chapter 3 (Specific Aim 1) supports the idea that calcium, associated with calcification, and
the iron, associated with hemorrhage, have distinct enough attenuation curves to allow for
differentiation of these two lesion types using dual-energy CT. Chapter 4 (Specific Aim 2)
verified these differentiation results for various size and location lesions using a more
biologically relevant and spectrally equivalent phantom model resulting in recommended
acquisition parameters and analysis models for optimal differentiation accuracy. Chapter 5
(Specific Aim 3) validated the protocol recommendations and analysis methods developed
in Chapter 4 by showing dual-energy CT’s ability to classify unknown lesions below the 100
HU cutoff imposed by SECT. Finally, Chapter 6 (Specific Aim 4) established the effect of
protocol acquisition parameters on a number of DEQC test metrics, as well as the inter- and
intra-scanner variance in these metrics, allowing both validation of the collected research
data and assessment of the validity of repeat measures in patients. Together these
findings establish the added benefit of dual-energy CT evaluation for intracranial lesion
characterization and provide justification for future clinical evaluation in patients.
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Chapter 8

8 Appendix

This chapter is based upon:
JL Nute, LG Le Roux, AG Chandler, V Baladandayuthapani, D Schellingerhout, DD Cody.
Differentiation of low-attenuation intracranial hemorrhage and calcification using dualenergy computed tomography in a phantom system. Invest Radiol. 2015; 50(1): 9-16. doi:
10.1097/RLI.0000000000000089
Written permission has been obtained from the journal for use of these materials in
this dissertation. Wolters Kluwer Health Lippincott Williams & Wilkins © No modifications
will be permitted.

8.1

Gaussian Mixture Model Formulation
The basic data collected from our experiments had a three dimensional structure

with the x-axis defined as the dual-energy CT water density, the y-axis defined as the dualenergy CT calcium density, and the z-axis defined as the SECT attenuation (HU). Our basic
scientific question of characterizing this three-dimensional data cloud into distinct (sub-)
populations corresponding to water and calcium can be construed as a clustering problem
i.e. at each HU we wish to identify how well these distinct clusters are separated. Visually
inspecting the data we found that at lower HU these clusters are not very well separated but
the distinction increases with SECT attenuation (HU) levels and we would like accurately
quantify the uncertainty of this process. The most commonly used clustering algorithms are
mixture models (125). Mixture models are a common statistical tool for clustering and allow
properties of multiple subpopulations (distributions) to be statistically inferred from pooledpopulation data. Gassuian mixture models (GMM) are a special case of mixture models and
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was chosen for this study because of its ease of interpretation and to take advantage of the
3D and potentially overlapping nature of the data collected. The basic GMM can be
expressed concisely as:
ܭ

Equation 15

ܲሺܺሻ ൌ   ܰ ݇ሺߤ݇ ǡ ȭ݇ ሻ
݇ൌͳ

where P(X) represents the joint distribution of the 3-D water/calcium/HU data, K is
number of mixture components,  is the mixture weights/prior probability and ܰሺߤ ǡ ȭ )
represents the Gaussian (normal) density with mean ߤ and variance-covariance matrix ȭ
corresponding to the cluster k respectively. All of these quantities are treated as unknown
parameters and are estimated by the data as detailed below.

8.2 GMM Fitting and Analysis
We used MATLAB Statistics Toolbox™ software, and specifically
the gmdistribution class to fit an unsupervised GMM analysis using a 50% training set, 50%
validation set approach. GMM analysis uses an expectation maximization(EM) algorithm
(126) to iteratively fit two potentially overlapping Gaussian distributions to the combined
hemorrhage-calcification model pair data and consists of two steps: the Expectation (E)
step which calculates the expected values for the membership weights of each data point
as functions of the mixture weights  and the maximization (M) step which uses the
membership weights obtained from the E step, and recomputes the distribution of the
Gaussian distributions ߤ and ȭ respectively (127). This procedure is repeated iteratively
until convergence is achieved.
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Posterior probability calculations
Once these distributions are optimally estimated using the EM algorithm, the
analysis provides for each voxel the probability that the voxel belongs to the hemorrhage
cluster and (vice-versa) the probability that the voxel belongs to the calcification cluster
which is calculated using the Bayes theorem as:

Equation 16

ܲ ൌ ܾܲݎሺܸ݈݁ݔȁݎ݁ݐݏݑ݈ܥሻ ൌ ܾܲݎሺݎ݁ݐݏݑ݈ܥȁܸ݈݁ݔሻܾܲݎሺܸ݈݁ݔሻ

where the probabilities on the right-hand side are calculated using the (weighted)
ratio of the Gaussian densities corresponding to each cluster estimated via the EM
algorithm. An example plot of these posterior probabilities for one HU pair is show in Figure
8.1. Voxels were assigned to a cluster if their probability of belonging to a cluster (P)
exceeded a median probability threshold of 50%. The voxel identities predicted by the GMM
were then compared to the true voxel identities and the true hemorrhage and true
calcification values were calculated. The accuracy with which the GMM differentiated the
calcification gel model from the hemorrhage gel model was then calculated as the sum of
the true hemorrhage and calcification values divided by the total number of voxels in the
two gel model data sets. Because of the stochastic nature of iterative approaches such as
GMM analysis, the method was repeated over 1,000 runs for each matched model pair to
assess the stability of model configurations. Each run used a different starting point
randomly selected as part of the gmdistribution.fit function. Any runs whose final log
likelihood value differed from that of the median results by my more than 3 standard
deviations were presumed to be influenced by local minima (128), and were removed from
the results. The analysis was repeated with new initial values until there were 1,000
successful runs for each matched model pair. The accuracy was calculated for each
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successful run, and then the mean and standard deviation of the accuracy was calculated
for the 1,000 runs of each attenuation matched model pair.
To determine whether the initial random separation of data into training and validation
sets affected the accuracy results, the random selection, as well as the 1,000-GMM-run
analysis, was repeated 10 times for each SECT attenuation-matched model pair. For each
matched model pair, the 10 random splits were found to yield identical results (data not
shown), indicating the random separation of the data into training and validation data sets
did not affect the final GMM accuracy results.

Figure 8.1: Posterior probabilities for the calcification cluster based on the GMM results of
the 50 HU matched model pair. Red indicates a very high probability the voxel is calcification,
while blue indicates a very low probability.
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